<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel><atom:link href="http://www.visiongain.com/Reports_Feed.aspx?" rel="self" type="application/rss+xml" />
	<title>visiongain - Latest Reports</title>
	<link>http://www.visiongain.com/</link>
	<description />
	<webMaster>dipesh_hirani@byteart.com (Dipesh Hirani)</webMaster>
	<docs>http://cyber.law.harvard.edu/rss/rss.html</docs>
	<image><url>http://www.visiongain.com/graphics/logo.gif</url><title>visiongain - Latest Reports</title><link>http://www.visiongain.com/</link></image>
	<ttl>60</ttl>
	<item>
		<title>The Floating Liquefied Natural Gas (FLNG) Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/759/The-Floating-Liquefied-Natural-Gas-(FLNG)-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/759/The-Floating-Liquefied-Natural-Gas-(FLNG)-Market-2012-2022</guid>
		<category>energy</category>
		<description>The global market for floating liquefied natural gas (FLNG) can be divided into two distinct areas: the conceptual floating liquefaction plants and the operational floating regasification units. Visiongain's new report addresses both of these markets, quantifying the opportunity for growth expected over the next ten years. In 2012, visiongain calculates the global FLNG market to be worth $2.92bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 01 Feb 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Carrier Ethernet Report 2012-2017</title>
		<link>http://www.visiongain.com/Report/757/Carrier-Ethernet-Report-2012-2017</link>
		<guid>http://www.visiongain.com/Report/757/Carrier-Ethernet-Report-2012-2017</guid>
		<category>telecoms &amp; IT</category>
		<description>Carrier ethernet is currently in the growth stage of its lifecycle and is one of the few sectors of the telecoms industry that saw positive growth during the recession. With Next Generation Networks converging with rising smartphone and tablet adoption rates, the strain on service providers for backhaul and content rich applications continues apace. It is clear the ethernet services, products, solutions and equipment are set to see continued growth between 2012 and 2017. Visiongain calculates that the global carrier ethernet equipment market will reach $34.2bn in 2012.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 31 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Drug Delivery Technologies: Commercial Prospects 2012-2022</title>
		<link>http://www.visiongain.com/Report/758/Drug-Delivery-Technologies-Commercial-Prospects-2012-2022</link>
		<guid>http://www.visiongain.com/Report/758/Drug-Delivery-Technologies-Commercial-Prospects-2012-2022</guid>
		<category>pharma</category>
		<description>What does the future hold for drug delivery technologies? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions. This decade, many commercial opportunities for improved drug delivery exist. You discover sales predictions to 2022 at world market, submarket, application and national level.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 31 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Fuel Efficiency Technologies in the Commercial Aviation Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/756/Fuel-Efficiency-Technologies-in-the-Commercial-Aviation-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/756/Fuel-Efficiency-Technologies-in-the-Commercial-Aviation-Market-2012-2022</guid>
		<category>aviation</category>
		<description>The development of fuel efficient technologies to reduce fuel burn and lower carbon emissions is viewed as a necessity to the future of air travel. Volatile fuel prices have placed the very solvency of many airlines in question. Airlines must reduce their consumption of oil-based jet fuel by investing in more fuel-efficient technologies, nurturing the growth of alternative energies, and, more immediately, optimising their business models. Visiongain calculates the global fuel efficient technologies in the commercial aviation market, defined as spending on new aircraft engines, biofuels, advanced composites for airframe design and air traffic management systems, to be $48.30bn in 2012.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 30 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Next Generation FTTX: Fibre Optics Innovations 2012-2017</title>
		<link>http://www.visiongain.com/Report/755/Next-Generation-FTTX-Fibre-Optics-Innovations-2012-2017</link>
		<guid>http://www.visiongain.com/Report/755/Next-Generation-FTTX-Fibre-Optics-Innovations-2012-2017</guid>
		<category>telecoms &amp; IT</category>
		<description>The future of telecommunications is steadfastly driving towards IP convergence. Next generation networks require a reliable and future-proof base for the increasing demands of both fixed and wireless connectivity. Fibre optics communication is currently the fastest and most resilient technology available and already forms the core network of international submarine cables connecting the different regions of the world. In order to anticipate the ever-growing demand for data and the resulting traffic loads, telecom operators and governments alike are rolling-out new terrestrial fibre networks and upgrading existing copper-based ones with fibre technology. Visiongain expects the number of global FTTX subscribers to reach 148 million in 2012</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 26 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Needle-Free Delivery: Technology and Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/754/Needle-Free-Delivery-Technology-and-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/754/Needle-Free-Delivery-Technology-and-Market-2012-2022</guid>
		<category>pharma</category>
		<description>The technology and devices for needle-free delivery of drugs/vaccines has been available in the market since several decades. Although their market penetration has been low, the recent years have seen an increase in adoption, driven by the need for pain free delivery. Currently, the market for needle-free delivery devices is dominated by small medical device companies and academic researchers. These small scale companies are developing innovative needle-free delivery technologies, with the pharmaceutical companies entering into partnership with the device developers for using the technology for delivery of the company's drug.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 24 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Cell-Based Assays: World Market Prospects 2012-2022</title>
		<link>http://www.visiongain.com/Report/753/Cell-Based-Assays-World-Market-Prospects-2012-2022</link>
		<guid>http://www.visiongain.com/Report/753/Cell-Based-Assays-World-Market-Prospects-2012-2022</guid>
		<category>pharma</category>
		<description>What does the future hold for cell-based assays in pharma? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions. Our study analyses products and services for cell-based testing. It covers activities of product developers and pre-clinical contract research organisations. You discover sales predictions to 2022 at world market, main submarket and national levels.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 23 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Tablet Market Report 2012-2017</title>
		<link>http://www.visiongain.com/Report/752/The-Tablet-Market-Report-2012-2017</link>
		<guid>http://www.visiongain.com/Report/752/The-Tablet-Market-Report-2012-2017</guid>
		<category>telecoms &amp; IT</category>
		<description>In a matter of two years, the tablet has grown from a minor, niche product to become one of the world's fastest growing media platforms. A mere blip on technological consciousness before 2010, it took less than two years for tablets to overtake global netbook PC sales. Millions of consumers are adoption this new technology as a light, portable entertainment and media device, while enterprises are using them to replace notebook PCs, access files and cloud storage remotely, and substitute paper filing systems. Visiongain has calculated that global tablet market will reach $31.86bn in 2012, breaking the 100 million unit shipment barrier the same year.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 20 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Plastic Packaging Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/749/The-Plastic-Packaging-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/749/The-Plastic-Packaging-Market-2012-2022</guid>
		<category>packaging</category>
		<description>The Plastic Packaging Market 2012-2022 analyses recent trends in the dynamic plastic packaging industry and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also surveys current trends and reveals the market's strengths and weaknesses revealing areas that will experience growth and present new business opportunities. Visiongain's analysis has concluded that the global value of the plastic packaging market will reach $196.42bn in 2012.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Remotely Operated Vehicles (ROV) and Autonomous Operated Vehicles (AUV) in the Energy Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/750/Remotely-Operated-Vehicles-(ROV)-and-Autonomous-Operated-Vehicles-(AUV)-in-the-Energy-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/750/Remotely-Operated-Vehicles-(ROV)-and-Autonomous-Operated-Vehicles-(AUV)-in-the-Energy-Market-2012-2022</guid>
		<category>energy</category>
		<description>The energy sector has used unmanned underwater vehicles for around 40 years. Since their first introduction, functions and applications have grown extensively, becoming a vital component of the offshore oil &amp; gas industry. An increase in underwater vehicle manufacturers has boosted competition and technological development, both improving vehicle capabilities and driving down costs. This change in market dynamics has led to a stable, exciting sector capable of significant market growth over the next ten years and more. Visiongain calculates that global expenditure on ROVs and AUVs in the energy sector in 2012 will total $1.52bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Plastic Packaging Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/751/The-Plastic-Packaging-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/751/The-Plastic-Packaging-Market-2012-2022</guid>
		<category>plastics</category>
		<description>The Plastic Packaging Market 2012-2022 analyses recent trends in the dynamic plastic packaging industry and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also surveys current trends and reveals the market's strengths and weaknesses revealing areas that will experience growth and present new business opportunities. Visiongain's analysis has concluded that the global value of the plastic packaging market will reach $196.42bn in 2012.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Dermatological Drugs: World Market Prospects 2012-2022</title>
		<link>http://www.visiongain.com/Report/746/Dermatological-Drugs-World-Market-Prospects-2012-2022</link>
		<guid>http://www.visiongain.com/Report/746/Dermatological-Drugs-World-Market-Prospects-2012-2022</guid>
		<category>pharma</category>
		<description>Where are dermatological treatments heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. This study assesses drugs to treat human skin disorders. You discover sales predictions at world market, therapeutic submarket, product and national levels to 2022. How will 24 leading drugs - Valtrex, Zovirax, Protopic, Enbrel and others - perform from 2012? Our report gives you business research and analysis with many sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 18 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Soldier Modernisation Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/747/The-Soldier-Modernisation-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/747/The-Soldier-Modernisation-Market-2012-2022</guid>
		<category>defence</category>
		<description>The soldier modernisation market has begun to emerge over recent years as various national programmes have developed from their conceptual origins in the 1990s to become reality. Leading military nations have demonstrated a determination to equip large numbers of troops with suites of soldier modernisation equipment, and Visiongain's calculations indicate that the value of the soldier modernisation market will reach $802.4m in 2012.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 18 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Petrochemical Infrastructure Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/748/The-Petrochemical-Infrastructure-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/748/The-Petrochemical-Infrastructure-Market-2012-2022</guid>
		<category>energy</category>
		<description>The petrochemical infrastructure market has seen rapid growth over the past decade. Growth in demand for petrochemical products has been the major underlying driver of growth. The manufacturing and production of modern industrial and consumer goods requires polymers and derivatives of petrochemicals which are integral to almost every product. There is no sign of a change in this practice, as petrochemicals can provide a low cost and optimal product for the majority of manufacturing situations. Visiongain calculates global investment in the petrochemical infrastructure market will reach $64.1bn in 2012.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 18 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Helicopter Modernisation, Upgrade &amp; Retrofit Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/745/The-Military-Helicopter-Modernisation-Upgrade-Retrofit-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/745/The-Military-Helicopter-Modernisation-Upgrade-Retrofit-Market-2012-2022</guid>
		<category>defence</category>
		<description>The military helicopter modernisation, upgrade &amp; retrofit market is a fluctuating market, with spending strongly tied to available budgets. High flexibility from militaries within the market concerning the time frame for implementing upgrades means that programmes can be postponed or brought forward as necessitated in order to satisfy both operational and financial factors. As a consequence, major projects causing peaks to spending, and significant periods of delay, are common within the military helicopter modernisation, upgrade &amp; retrofit market. Visiongain has determined that the value of the military helicopter modernisation, upgrade and retrofit market in 2012 will reach $3.98bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 13 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Endoscopy Devices: World Market Outlook 2012-2022</title>
		<link>http://www.visiongain.com/Report/744/Endoscopy-Devices-World-Market-Outlook-2012-2022</link>
		<guid>http://www.visiongain.com/Report/744/Endoscopy-Devices-World-Market-Outlook-2012-2022</guid>
		<category>pharma</category>
		<description>How will the endoscopy devices market perform from 2012? Our new report shows you potential sales and trends to 2022, discussing opportunities and prospects. See sales predictions and discussions for the leading segments in the endoscopy device market, including laparoscopy, urology, and gastrointestinal endoscopy devices markets.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 11 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Antithrombotic/Anticoagulant Drugs: World Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/743/Antithrombotic-Anticoagulant-Drugs-World-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/743/Antithrombotic-Anticoagulant-Drugs-World-Market-2012-2022</guid>
		<category>pharma</category>
		<description>Where are antithrombotic and anticoagulant treatments heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. This study assesses drugs to treat abnormal blood clotting in human beings. Discover sales predictions at world market, therapeutic class, product and national levels to 2022. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 10 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Utility Infrastructure Security Market 2012-2022: Cybersecurity &amp; Smart Grids</title>
		<link>http://www.visiongain.com/Report/740/The-Utility-Infrastructure-Security-Market-2012-2022-Cybersecurity-Smart-Grids</link>
		<guid>http://www.visiongain.com/Report/740/The-Utility-Infrastructure-Security-Market-2012-2022-Cybersecurity-Smart-Grids</guid>
		<category>utilities</category>
		<description>The Utility Infrastructure Security Market 2012-2022: Cybersecurity &amp; Smart Grids is Visiongain's latest energy report, analysing how this important market will develop over the next ten years. The report quantifies the market in terms of global size and breaks the market down into two global security markets with eight sub-markets, four utility sectors and seven regional markets with forecasts and analysis provided for each regional market and industry sub-market from 2012-2022. The report also examines the major drivers and restraints influencing the market over the next decade and explains the major technologies within the market and analysing which nations will drive capital expenditure into the utility infrastructure security market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 06 Jan 2012 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Point of Care Diagnostics: World Market Outlook 2012-2021</title>
		<link>http://www.visiongain.com/Report/739/Point-of-Care-Diagnostics-World-Market-Outlook-2012-2021</link>
		<guid>http://www.visiongain.com/Report/739/Point-of-Care-Diagnostics-World-Market-Outlook-2012-2021</guid>
		<category>pharma</category>
		<description>How will the point of care diagnostics market perform from 2011? Our new report shows you potential sales and trends to 2021, discussing opportunities and prospects.
Discover sales for the point of care diagnostics market at segment and national/regional levels.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 23 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Cloud Computing Industry Outlook Report: 2011-2016</title>
		<link>http://www.visiongain.com/Report/737/Mobile-Cloud-Computing-Industry-Outlook-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/737/Mobile-Cloud-Computing-Industry-Outlook-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Until recently, cloud computing has been thought of within the context of the evolution of the Web and PC. In 2011, we are seeing a paradigm shift in business models, with mobile becoming a key feature in cloud computing conundrum. 
Mobile cloud has the potential to change the life of consumers and enterprises beyond what can be conceived today. We believe that the size of the mobile cloud market is poised to reach over $45 billion by 2016.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 16 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Infrastructure Security Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/738/The-Oil-Gas-Infrastructure-Security-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/738/The-Oil-Gas-Infrastructure-Security-Market-2012-2022</guid>
		<category>energy</category>
		<description>Over the next decade, global demand for oil &amp; gas is set to rapidly increase as rising populations and economic growth help to drive the industry. This will create a need for additional oil &amp; gas infrastructure to be constructed. At the same time, many countries around the world are currently facing a number of security challenges stemming from civil unrest, terrorist activities, and a competitive global market. Together, these factors will create substantial opportunities for companies involved in the oil &amp; gas infrastructure security market as a range of products and services will be needed to protect both existing and future assets.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 16 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Low Cost Handsets, Feature Phones and Entry Level Smartphone Report 2011-2016</title>
		<link>http://www.visiongain.com/Report/736/Low-Cost-Handsets-Feature-Phones-and-Entry-Level-Smartphone-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/736/Low-Cost-Handsets-Feature-Phones-and-Entry-Level-Smartphone-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain believes that not only is the feature phone still relevant but in the next five years it will become even more essential as an essential device in handset manufacturers portfolios. Over 70% of handsets shipped in 2011 were feature phones and as emerging economies come to fruition we believe the popularity of these devices will remain stable.
We discuss the two main segments of feature phones that will come to prominence in under developed markets, the low cost and ultra low cost handsets.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 15 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Radar Systems Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/733/The-Military-Radar-Systems-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/733/The-Military-Radar-Systems-Market-2011-2021</guid>
		<category>defence</category>
		<description>Developed economies are seeking to maintain dominance in new radar technological developments and, as new radar development will normally take between five and 10 years to reach production and deployment stage, countries are willing to inject large sums into radar development. Meanwhile, the surge in ability and willingness of developing and high-growth markets to acquire more advanced systems in recent years shows no sign of abating. Visiongain's calculations indicate that the global military radar market is set to reach $9.16bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 13 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biobanking for Medicine: Technology and Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/734/Biobanking-for-Medicine-Technology-and-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/734/Biobanking-for-Medicine-Technology-and-Market-2012-2022</guid>
		<category>pharma</category>
		<description>What does the future hold for biobanks? Visiongain's report shows you potential revenues and trends to 2022. Find data, forecasts and discussions for biobanking in medicine. Discover sales predictions at overall market, submarket and national levels to 2022. Our study gives you business research, analysis and opinion for applications in medical research, pharmaceuticals and diagnostics. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 13 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Messaging Market Report 2011-2016</title>
		<link>http://www.visiongain.com/Report/735/Mobile-Messaging-Market-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/735/Mobile-Messaging-Market-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile messaging is evolving due to the increasing use of mobile broadband by users to communicate with each other. The SMS and MMS platforms are facing intense competition from instant communication and email on many smart devices. The accessibility of 3G networks and the technical capabilities of smart devices are enabling ever-faster access to data. Visiongain expects global mobile IM users to grow from 311.2 million users in 2010, to over 1.6 billion by 2016.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 13 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Cyber Security Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/732/The-Cyber-Security-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/732/The-Cyber-Security-Market-2012-2022</guid>
		<category>defence</category>
		<description>The proliferation of cyber attacks over the past decade has meant that many companies and government organisations are now fully aware of the dangers exposed to them through under-protected networks or from individual negligence. The growth of the internet has meant that cyber attacks represent a borderless challenge to security operators, who must now find solutions that are successful within the entire cyber domain rather than a specific tangible location. As a consequence, Visiongain has determined that the value of the global cyber security market in 2012 will reach $61.10bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 12 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Aircraft Modernisation, Upgrade &amp; Retrofit Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/731/The-Military-Aircraft-Modernisation-Upgrade-Retrofit-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/731/The-Military-Aircraft-Modernisation-Upgrade-Retrofit-Market-2011-2021</guid>
		<category>defence</category>
		<description>The Military Aircraft Modernisation, Upgrade &amp; Retrofit Market 2011-2021 report provides an analysis of global government spending on military aircraft modernisation, upgrade and retrofit programmes, encompassing airframe and powerplant (A&amp;P), and avionics upgrades. The report assesses the business opportunities presented by this critical marketplace. Our study examines the 10 leading national markets for government spending on military aircraft modernisation, upgrade and retrofit programmes by sales, plus five aircraft type submarkets and two upgrade type submarkets, as well as assessing the wide range of factors that are driving sales growth around the world.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 09 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Heavy Oil Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/729/The-Heavy-Oil-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/729/The-Heavy-Oil-Market-2011-2021</guid>
		<category>energy</category>
		<description>Discoveries of conventional sources of light easy-to-access crude oil are becoming less common and current oil production levels are struggling to match demand. New non-conventional sources of oil will need to be developed in order to supplement the conventional oil supply, which is seeing a slowdown in production growth. Heavy oil provides a fairly low risk option with vast known quantities of oil in place around the world. The increasing interest in this market has seen capital expenditure on upstream development of heavy oil resources reach $27.5bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 08 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Small Hydropower Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/730/The-Small-Hydropower-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/730/The-Small-Hydropower-Market-2011-2021</guid>
		<category>renewable energy</category>
		<description>The Small Hydropower Market 2011-2021 report analyses one of the key renewable energy markets over the next ten years. In-depth analyses and forecasts for both the market size and small hydropower capacity are given for the seven regional markets from 2011-2021.The report also examines the main drivers and restraints influencing the small hydropower market; examines individual national developments within each regional market, and provides a unique SWOT analysis for small hydropower technology.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 08 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Cardiac Rhythm Management Devices: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/728/Cardiac-Rhythm-Management-Devices-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/728/Cardiac-Rhythm-Management-Devices-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>How will the cardiac rhythm management devices market perform from 2011? Discover sales for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation market at segment and national levels. Our report gives you business research, analysis and data.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 07 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Chinese Pharmaceutical Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/726/Chinese-Pharmaceutical-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/726/Chinese-Pharmaceutical-Market-2012-2022</guid>
		<category>pharma</category>
		<description>Where is the pharma market in China heading? Discover sales predictions at overall market and submarket levels. See how Chinese submarkets can perform to 2022 - patented brands, generics, OTC products, traditional medicines, anti-infectives, vaccines, cardiovascular/cerebrovascular, alimentary/metabolic, cancer and CNS drugs.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 06 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Quad Play Report 2011-2016: Strategies for a Converged Future</title>
		<link>http://www.visiongain.com/Report/727/Quad-Play-Report-2011-2016-Strategies-for-a-Converged-Future</link>
		<guid>http://www.visiongain.com/Report/727/Quad-Play-Report-2011-2016-Strategies-for-a-Converged-Future</guid>
		<category>telecoms &amp; IT</category>
		<description>With price wars ongoing, revenues dwindling, and an industry leaning towards fixed-mobile convergence in many markets, what can operators do to stay ahead of the curve? Multi play packages are emerging as a dominant strategy in markets across the globe, as their promises of convergence, personalisation, ease of use, financial savings, and unified billing prove increasingly attractive to customers in a competitive market. Quadruple play - the bundling of broadband, television, fixed-line and mobile telephony, enlisted from a single service provider - is the commercial zenith that telcos and cablecos are building towards.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 06 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Cyberwarfare Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/725/The-Cyberwarfare-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/725/The-Cyberwarfare-Market-2012-2022</guid>
		<category>defence</category>
		<description>Cyberwarfare systems and services are sought by governments the world over who continue to be concerned with securing information and vital infrastructure against the looming threat posed by hostile cyber attacks, whilst striving to develop the capability to strike back if necessary. With the number of attacks against the secured systems of government and defence contractors is on the rise, and with recent high profile incidents thrusting the issue of cyberwarfare into the public eye, the perceived threat from foreign states, and non-state actors at home and abroad remains high.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 05 Dec 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Antibacterial Drugs: World Market Prospects 2012-2022</title>
		<link>http://www.visiongain.com/Report/724/Antibacterial-Drugs-World-Market-Prospects-2012-2022</link>
		<guid>http://www.visiongain.com/Report/724/Antibacterial-Drugs-World-Market-Prospects-2012-2022</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for antibacterial treatments? Discover sales predictions at world market, therapeutic class, product and national levels to 2022. How will 20 leading products - including Levaquin, Zyvox, Avelox, Augmentin, Zosyn, Merrem, Cubicin, Primaxin and Cravit - perform to 2022?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 28 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Paper Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/722/The-Paper-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/722/The-Paper-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>The global packaging market is fast-changing and has an organic quality, evolving to meet the increasing demands of the modern day consumer. New opportunities for packaging companies are constantly arising for those that can deliver intelligent, innovative packaging in this increasingly consumer driven market. Although the performance of the paper packaging industry, like every industry, is tied intimately to global economic trends, it has proven itself to be relatively resilient against the backdrop of the economic crisis of 2008.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 23 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Multiple Sclerosis Treatment: World Drug Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/723/Multiple-Sclerosis-Treatment-World-Drug-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/723/Multiple-Sclerosis-Treatment-World-Drug-Market-2012-2022</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for multiple sclerosis treatment? Discover revenue predictions for multiple sclerosis (MS) treatments at world market, product and national levels to 2022. How will the drugs Copaxone, Avonex, Rebif, Betaseron/Betaferon, Tysabri, Extavia and Gilenya perform to 2022?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 23 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Corrosion Prevention Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/721/The-Oil-Gas-Corrosion-Prevention-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/721/The-Oil-Gas-Corrosion-Prevention-Market-2011-2021</guid>
		<category>energy</category>
		<description>The oil and gas corrosion prevention market has great potential and a wide array of applications. In the oil and gas industry all companies from upstream exploration and production to those downstream in the distribution of oil and gas can benefit from the products and services of the corrosion prevention market. A number of solutions are available in corrosion prevention for both offshore and onshore protection and some of these solutions can be used in combination to provide long lasting corrosion protection. Visiongain calculates the global oil and gas corrosion prevention market to be worth $18.72bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 22 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Medical Device Contract Manufacturing: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/719/Medical-Device-Contract-Manufacturing-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/719/Medical-Device-Contract-Manufacturing-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>The medical device industry has witnessed explosive growth in recent years. According to visiongain estimates, the global market was worth $236.1bn in 2010. Much of this growth is linked to the rising prevalence of diseases worldwide, most notably cardiac and neurological disorders. As most of the prominent companies in the industry operate globally, the growth of the industry is highly dependent on the economic conditions prevailing in the international market. As a result, the industry was not immune to the recent global recession and faced numerous issues including price/volume concerns, healthcare reforms and a more restrictive regulatory environment.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 21 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Carbon Capture &amp; Storage / Sequestration (CCS) Technologies Market 2012-2022</title>
		<link>http://www.visiongain.com/Report/720/The-Carbon-Capture-Storage-Sequestration-(CCS)-Technologies-Market-2012-2022</link>
		<guid>http://www.visiongain.com/Report/720/The-Carbon-Capture-Storage-Sequestration-(CCS)-Technologies-Market-2012-2022</guid>
		<category>energy</category>
		<description>Carbon Capture &amp; Storage / Sequestration (CCS) is an alternative and convenient technology to eliminate carbon dioxide before it is released in the atmosphere. It is one of the most innovative clean energy markets which will experience stable growth rates in the next ten years. Reduction in carbon dioxide emission has received increasingly global attention in the past few years because of accelerating climate change issues. Visiongain calculates that global expenditure on CCS technologies in 2012 will total $13.70bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 21 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Counter-IED Market 2011-2021: Systems and Technologies for Force Protection</title>
		<link>http://www.visiongain.com/Report/718/The-Counter-IED-Market-2011-2021-Systems-and-Technologies-for-Force-Protection</link>
		<guid>http://www.visiongain.com/Report/718/The-Counter-IED-Market-2011-2021-Systems-and-Technologies-for-Force-Protection</guid>
		<category>defence</category>
		<description>Improvised explosive devices (IEDs) have proven to be an effective and increasingly preferred weapon by insurgents, primarily in Iraq and later in Afghanistan, along with many other places in the world. Many of the world's leading armed forces have responded by spending heavily on equipment that will protect against IEDs, such as mine-resistant vehicles, jammers that block radio signals meant to detonate IEDs, detection and disposal systems, and robots and unmanned aerial vehicles (UAVs) intended to detect the deadly menace.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 14 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Advanced Wound Care: World Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/716/Advanced-Wound-Care-World-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/716/Advanced-Wound-Care-World-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>The wound care devices and biologics segment within the advanced wound care market are set for rapid growth over the next ten years. The growth in the market will be driven primarily by the increasing prevalence of diabetes and obesity, coupled with the aging population, which will increase the incidence of chronic wounds. The adoption of expensive but more effective wound care devices and biologics will increase in the developed countries in the near future. Visiongain calculates the total advanced wound care market to be worth $6.7bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 11 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Small Cells Report 2011-2016: Analysing the Business Case of Heterogeneous Networks</title>
		<link>http://www.visiongain.com/Report/717/Small-Cells-Report-2011-2016-Analysing-the-Business-Case-of-Heterogeneous-Networks</link>
		<guid>http://www.visiongain.com/Report/717/Small-Cells-Report-2011-2016-Analysing-the-Business-Case-of-Heterogeneous-Networks</guid>
		<category>telecoms &amp; IT</category>
		<description>Major vendors such as Alcatel Lucent, Ericsson, NEC and Huawei are building a strong case for small cell architectures to be deployed for both 3G and 4G, offering significant commercial and performance benefits. Visiongain expects small cells to become fully proven and complete solutions by 2013 with surveys suggesting over 35% of operators considering deploying pico and micro cells in 3G/ 4G networks from 2012. This report quantifies the small cells market (femto cells, pico cells, micro cells) and Wi-Fi, analyses the market drivers, the key market players and their strategies.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 11 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Connected Homes Report 2011-2016: A Paradigm Shift in the Way we Live</title>
		<link>http://www.visiongain.com/Report/715/Connected-Homes-Report-2011-2016-A-Paradigm-Shift-in-the-Way-we-Live</link>
		<guid>http://www.visiongain.com/Report/715/Connected-Homes-Report-2011-2016-A-Paradigm-Shift-in-the-Way-we-Live</guid>
		<category>telecoms &amp; IT</category>
		<description>In an increasingly saturated market place operators continually struggle to find new revenue streams. The Connected Home offers the best potential for increased revenues, as operators partnered with content providers and OEMs can capitalise on the unique monestiable opportunities offered by an ecosystem of smart devices.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 10 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Consumer MVNOs Report 2011-2016: Designing Successful Strategies for Monetising Smartphone &amp; LTE Growth</title>
		<link>http://www.visiongain.com/Report/713/Consumer-MVNOs-Report-2011-2016-Designing-Successful-Strategies-for-Monetising-Smartphone-LTE-Growth</link>
		<guid>http://www.visiongain.com/Report/713/Consumer-MVNOs-Report-2011-2016-Designing-Successful-Strategies-for-Monetising-Smartphone-LTE-Growth</guid>
		<category>telecoms &amp; IT</category>
		<description>The misguided conception that MVNOs have passed their heyday is unfortunately linked to the high failure rates of many ill-prepared ventures. The MVNO business model has been popular in the last two decades in mature telecom markets, especially in Europe. This popularity has been marred by injudicious strategies and a failure to understand the key elements of sustaining an MVNO. The market potential for establishing a viable MVNO exists; the issue is how to effectively harness it. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 09 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Virtual Reality (VR) Training and Simulation Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/714/The-Oil-Gas-Virtual-Reality-(VR)-Training-and-Simulation-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/714/The-Oil-Gas-Virtual-Reality-(VR)-Training-and-Simulation-Market-2011-2021</guid>
		<category>energy</category>
		<description>The oil &amp; gas virtual reality training and simulation market is set for strong growth over the next ten years as a combination of increasing demand for oil &amp; gas, the retirement of the baby boomer generation, improving technologies, and increasing safety concerns help virtual reality technologies become more widespread. Visiongain calculates the oil &amp; gas virtual reality training and simulation market - defined as spending on hardware, software and maintenance of virtual reality technologies - to be worth $2.24bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 09 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Next-Generation Antibody Therapies: Pipeline and Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/712/Next-Generation-Antibody-Therapies-Pipeline-and-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/712/Next-Generation-Antibody-Therapies-Pipeline-and-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What are the prospects for emerging antibody technologies? Visiongain's report shows you potential revenues to 2021, discussing R&amp;D trends and opportunities.
A new generation of therapeutic antibody is coming. Discover revenue predictions for emerging antibody technologies at total world and submarket levels to 2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 08 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Biodegradable Plastic Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/710/The-Biodegradable-Plastic-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/710/The-Biodegradable-Plastic-Packaging-Market-2011-2021</guid>
		<category>plastics</category>
		<description>The Biodegradable Plastic Packaging Market 2011-2021 report examines one of the most dynamic sectors of the global packaging industry at a time when the market is experiencing a significant shift. Our market study analyses the substantial regional variations in the global market, describes technological changes and trends, and incorporates a wealth of data. Although 2009 was a difficult year for packaging markets in many parts of the world, this report discusses the market in detail, explaining how and why the market will evolve over the forecast period 2011-2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 07 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Biodegradable Plastic Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/711/The-Biodegradable-Plastic-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/711/The-Biodegradable-Plastic-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>The Biodegradable Plastic Packaging Market 2011-2021 report examines one of the most dynamic sectors of the global packaging industry at a time when the market is experiencing a significant shift. Our market study analyses the substantial regional variations in the global market, describes technological changes and trends, and incorporates a wealth of data. Although 2009 was a difficult year for packaging markets in many parts of the world, this report discusses the market in detail, explaining how and why the market will evolve over the forecast period 2011-2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 07 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Gas to Liquids Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/709/The-Gas-to-Liquids-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/709/The-Gas-to-Liquids-Market-2011-2021</guid>
		<category>energy</category>
		<description>The Gas to Liquids Market 2011-2021 analyses this dynamic growth market over the next 10 years. A combination of high oil prices, oversupply of natural gas, increasing global energy demands, and improving extraction technologies is creating a renewed interest in the gas to liquids market. Over the forecast period there is likely to be strong growth in the gas to liquids market as a number of countries look to utilise their natural gas resources by establishing or expanding their gas to liquids industries. Our research shows that global spending on gas to liquids technology R&amp;D, along with construction of new and upgraded infrastructure will total $5.75bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 02 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Augmented Reality Report: Creating New Market Paradigm for Smartphones &amp; Tablets 2011-2016</title>
		<link>http://www.visiongain.com/Report/707/Mobile-Augmented-Reality-Report-Creating-New-Market-Paradigm-for-Smartphones-Tablets-2011-2016</link>
		<guid>http://www.visiongain.com/Report/707/Mobile-Augmented-Reality-Report-Creating-New-Market-Paradigm-for-Smartphones-Tablets-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>At what point will mobile phones not only affect the way consumers communicate, but also the way they look upon the world? Mobile augmented reality (MAR) - the overlay of virtual information and images on a live, real world view - promises to do exactly that. Visiongain research concludes that MAR will expand exponentially in the five year forecast period (2011-2016) following the widespread popularity of one or a handful of killer MAR applications, expected in late 2012 or early 2013.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 01 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Small-Molecule Targeted Cancer Therapies: World Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/708/Small-Molecule-Targeted-Cancer-Therapies-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/708/Small-Molecule-Targeted-Cancer-Therapies-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What does the future hold for small-molecule cancer treatments? Find revenue predictions at overall world market, product and national levels to 2021. Where are the 10 leading drugs heading? Find out how products such as Glivec/Gleevec, Revlimid, Alimta, Taxotere, Velcade and Tarceva can perform to 2021. See potential revenues and other trends.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 01 Nov 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Border Security Market 2011-2021: UAVs, UGVs &amp; Perimeter Surveillance Systems</title>
		<link>http://www.visiongain.com/Report/706/The-Border-Security-Market-2011-2021-UAVs-UGVs-Perimeter-Surveillance-Systems</link>
		<guid>http://www.visiongain.com/Report/706/The-Border-Security-Market-2011-2021-UAVs-UGVs-Perimeter-Surveillance-Systems</guid>
		<category>defence</category>
		<description>Border security systems are sought by governments the world over who continue to be concerned with monitoring and recording the flow of goods and persons across international boundaries. Although the expansion of international agreements in Europe and Eurasia is reducing the number of secured international borders, continued threats from international terrorism, cross-border crime and illegal immigration maintain border security as a top priority in more developed states, and increasingly in developing states. Visiongain has determined that the value of the border security market in 2011 will reach $17bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 28 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oilfield Chemicals Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/705/The-Oilfield-Chemicals-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/705/The-Oilfield-Chemicals-Market-2011-2021</guid>
		<category>energy</category>
		<description>The market for oilfield chemicals is gaining strength as oil recovery from existing fields faces challenges of peak oil and enhanced chemical recovery is required to achieve maximum output. It is also becoming increasingly difficult to recover oil and gas from new fields, most of which lie in remote and hostile environments where extraction relies solely on drilling fluids. Visiongain calculates that global expenditure in the oilfield chemicals market will total $17.65bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 24 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Electro Optical Infrared (EO/IR) Systems Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/704/The-Military-Electro-Optical-Infrared-(EO-IR)-Systems-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/704/The-Military-Electro-Optical-Infrared-(EO-IR)-Systems-Market-2011-2021</guid>
		<category>defence</category>
		<description>Military EO/IR systems are commonplace within modern and advanced militaries around the world, enabling war-fighters on the ground to achieve battlefield advantage through the use of infrared imaging, night vision capabilities, and range finding tools. In addition, the growth of unmanned aerial systems (UAS), and the development of interoperable and real time data processing and transference, has meant that intelligence, surveillance, and reconnaissance (ISR) is aided by EO/IR products and systems.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 21 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Unconventional Gas Market 2011-2021: Shale Gas, Tight Gas, CBM &amp; Methane Hydrate</title>
		<link>http://www.visiongain.com/Report/703/The-Unconventional-Gas-Market-2011-2021-Shale-Gas-Tight-Gas-CBM-Methane-Hydrate</link>
		<guid>http://www.visiongain.com/Report/703/The-Unconventional-Gas-Market-2011-2021-Shale-Gas-Tight-Gas-CBM-Methane-Hydrate</guid>
		<category>energy</category>
		<description>Unconventional gas exploration and production has grown rapidly in recent years. This has been partly due to technological advances in drilling as well as hydraulic fracturing and partly due to the benefits of using natural gas instead of other fuels for power generation. Furthermore, unconventional gas resources are found in almost every continent and they are more widely available than was previously estimated. Visiongain calculates the global unconventional gas market, defined as spending on exploration and production of unconventional gas, to be worth $75.2bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 20 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Steel Market Analysis, Financials &amp; Forecasting 2011-2021</title>
		<link>http://www.visiongain.com/Report/702/The-Steel-Market-Analysis-Financials-Forecasting-2011-2021</link>
		<guid>http://www.visiongain.com/Report/702/The-Steel-Market-Analysis-Financials-Forecasting-2011-2021</guid>
		<category>metals</category>
		<description>Since the industrial revolution, steel has been the essential material used in the maintenance and expansion of the global economy. But shortages of iron ore and coking coal coupled with a high oil price have meant that the steel industry today faces significant challenges. With the rise of China, the steel market - and all commodity markets - has experienced a reawakening like never before. China's rapid industrialisation and frantic urbanisation, coupled with extensive industrial development in the other BRIC nations, has meant a reinvigoration of the steel industry and a renewed interest in steel, iron ore and coking coal by the investing community</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 19 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Epigenetic Therapies and Technologies: World Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/701/Epigenetic-Therapies-and-Technologies-World-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/701/Epigenetic-Therapies-and-Technologies-World-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>What are the prospects for epigenetic products and technologies? Visiongain's report shows you potential revenues to 2021, discussing trends and opportunities. Where is the epigenetics market heading? Find revenue predictions for epigenetic applications at total world, submarket, product and national levels to 2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 17 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Video &amp; TV on Smartphones: Market Drivers and Challenges Report 2011-2016</title>
		<link>http://www.visiongain.com/Report/698/Mobile-Video-TV-on-Smartphones-Market-Drivers-and-Challenges-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/698/Mobile-Video-TV-on-Smartphones-Market-Drivers-and-Challenges-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>29% of smartphones users access mobile video services. Visiongain expects that by 2016 at least 40% of smartphone customers will use mobile video. In addition, upcoming LTE technology will allow for significantly higher capacity at a lower cost per bit, leading to improved commercial viability of video services. This report quantifies mobile TV and video market, analyses the market drivers and the key market players and their strategies.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 12 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Tin Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/699/The-Tin-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/699/The-Tin-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>Having achieved a solid base in the mature markets where consumption of tin packaged products is high, packaging companies are now gaining footholds in the lucrative emerging markets. Enhancements in consumer living standards and preferences, coupled with impulse purchases and convenience, have been the key propelling factors for market expansion. The tin packaging market has been buoyed by the trend for ready-to-eat and economical food, with manufacturers quick to meet increasingly sophisticated demands from the consumer. Increasingly tin packaging market leaders are producing a plethora of products to meet these growing demands, such as single-serve, aesthetically pleasing, convenient, re-sealable, sustainable packaging. Visiongain calculates the global tin packaging market to be worth $31.79bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 12 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Ground Reconnaissance, Surveillance, Target Acquisition (RSTA) Systems Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/700/The-Military-Ground-Reconnaissance-Surveillance-Target-Acquisition-(RSTA)-Systems-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/700/The-Military-Ground-Reconnaissance-Surveillance-Target-Acquisition-(RSTA)-Systems-Market-2011-2021</guid>
		<category>defence</category>
		<description>Reconnaissance, surveillance and target acquisition (RSTA) systems are absolutely critical to the full spectrum of land-based military operations. Equipment relevant to the global RSTA systems market ranges from personal gear such as night vision goggles (NVG) and thermal weapon sights (TWS) to counter-fire radar systems and vehicle-mounted long-range reconnaissance and surveillance sensors. We examine the commercial prospects for companies involved in supplying these types of RSTA systems or looking to break into this expanding marketplace. Visiongain's analysis has concluded that global government spending on RSTA systems will total $3.36bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 12 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Location Based Services 2011-2016: Monetising Opportunities and Challenges</title>
		<link>http://www.visiongain.com/Report/697/Location-Based-Services-2011-2016-Monetising-Opportunities-and-Challenges</link>
		<guid>http://www.visiongain.com/Report/697/Location-Based-Services-2011-2016-Monetising-Opportunities-and-Challenges</guid>
		<category>telecoms &amp; IT</category>
		<description>Have location based services already reached their full potential? Visiongain doesn't believe so. With some extraordinary successes already achieved with apps like Foursquare and Gowalla, the possible applications for location based services are still in their infancy. On the verge of LTE the LBS landscape is poised for explosion. This report reveals the opportunities that lie between 2011 and 2016 for all market entrants.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 11 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Device Management Report 2011-2016  </title>
		<link>http://www.visiongain.com/Report/696/Mobile-Device-Management-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/696/Mobile-Device-Management-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>MDM (Mobile Device Management) solution can reduce calls to customer service by 15- 20% and lower OpEx in customer care and marketing leading to higher profit margins. Are you taking advantage of the latest MDM solutions available on the market? Do you want to capitalise on the strengths of some the best-integrated MDM solution out there? Our report will guide you in formulating emergent strategies for device management in your organisation. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 10 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The UAV Payload and Subsystems Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/694/The-UAV-Payload-and-Subsystems-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/694/The-UAV-Payload-and-Subsystems-Market-2011-2021</guid>
		<category>defence</category>
		<description>The global surge in unmanned aerial vehicle (UAV) use in recent years has led to leaps in development and spending on sensors, radars, cameras, signals intelligence (SIGINT), detection, communications and attack capabilities included in their payloads. Companies engaged in manufacturing payloads for their own UAVs or for upgrades of deployed aircraft are finding a ready market across a growing number of states. Visiongain calculates that the global UAV payload market - including weaponry, electro-optical/infrared (EO/IR), radars and lasers, intelligence sensors, communication devices, navigation sensors and detection sensors - will reach $2.9bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 06 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Vaccine Manufacturing Technology and Services: World Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/695/Vaccine-Manufacturing-Technology-and-Services-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/695/Vaccine-Manufacturing-Technology-and-Services-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What does the future hold for the vaccine manufacturing industry and market? Visiongain's report shows you potential revenues and trends to 2021. Discover activities shaping the vaccines market and the outsourcing of vaccine manufacturing for human healthcare. Vaccine manufacturing will become more important this decade. Our study discusses activities of GSK, Sanofi, Merck &amp; Co., Novartis, Pfizer and others. See how changes in the pharma industry affect production, outsourcing and contract service providers (CMOs). </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 06 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Neuromodulation Devices: World Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/693/Neuromodulation-Devices-World-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/693/Neuromodulation-Devices-World-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>Our latest pharma report - Neuromodulation Devices: World Market Prospects 2011-2021 - offers a comprehensive view of the global neuromodulation devices market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict the global value of the neuromodulation devices market in 2011 to be worth $3.05bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 05 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Airborne ISR Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/692/The-Airborne-ISR-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/692/The-Airborne-ISR-Market-2011-2021</guid>
		<category>defence</category>
		<description>Airborne intelligence, surveillance and reconnaissance (ISR) assets are essential components of military operations where information superiority and battlefield awareness provide significant advantages to forces that can deploy them. Defence budgets are being cut in many parts of the world although there is also growth in others regions. While airborne ISR has seen its share of funding cuts, the sector has largely continued to enjoy financial backing from many governments as these assets are seen as critical force multipliers. Visiongain calculates the global airborne ISR market, including new acquisitions and upgrades, to be worth $17.3bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 03 Oct 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Pharma Contract Sales Organisation (CSO) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/691/World-Pharma-Contract-Sales-Organisation-(CSO)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/691/World-Pharma-Contract-Sales-Organisation-(CSO)-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the pharma contract sales market perform from 2011? Visiongain's report shows you potential revenues and trends to 2021, discussing opportunities and prospects. Our report gives you forecasts to 2021 for the world market and leading countries. Outsourced pharma sales activities will expand from 2011 to 2021. See how emerging technologies are changing drug promotion and sales, and how service providers contribute value to pharmaceutical sales operations.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 30 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Gas Processing Infrastructure Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/690/The-Gas-Processing-Infrastructure-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/690/The-Gas-Processing-Infrastructure-Market-2011-2021</guid>
		<category>energy</category>
		<description>According to the World Energy Council (WEC), global demand for natural gas is likely to increase by 44% between 2007 and 2035 as a combination of an increasing global population, economic growth, significant natural gas reserves and a desire to produce cleaner energy, help to drive growth in the natural gas industry. This will create substantial opportunities for companies involved in the gas processing infrastructure market, as new facilities will need to be constructed and existing facilities upgraded to process increasing quantities of gas. Visiongain calculates the global gas processing infrastructure market will reach $12.15bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 28 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Parkinson's Disease: World Drug Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/689/Parkinson's-Disease-World-Drug-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/689/Parkinson's-Disease-World-Drug-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for the treatment of Parkinson's disease? Visiongain's report shows you potential drug revenues to 2021. Find out how the drugs Stalevo/Comtess, Sifrol, Azilect and Requip can perform to 2021, seeing potential revenues. We cover revenues for dopaminergic agents, dopamine agonists, COMT inhibitors, MAO inhibitors and other drugs for Parkinson's disease.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 26 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Aluminium Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/688/The-Aluminium-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/688/The-Aluminium-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>The Aluminium Packaging Market 2011-2021 report examines the scope of growth available in the dynamic packaging industry through items such as lightweight packaging, aluminium containers, foils and aluminium beverage cans. The report discusses the developments related to the changing demographics of the world population, due to developing economies, rising incomes, improving GDPs leading to rising demand in several markets, infrastructure and development works, increased use of pharmaceuticals and chemicals, and consumption of packaged food &amp; beverages.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 23 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Advanced Oil &amp; Gas Exploration Technologies Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/687/The-Advanced-Oil-Gas-Exploration-Technologies-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/687/The-Advanced-Oil-Gas-Exploration-Technologies-Market-2011-2021</guid>
		<category>energy</category>
		<description>The Advanced Oil &amp; Gas Exploration Technologies Market 2011-2021 report analyses how this vitally important market will develop over the next ten years. The report quantifies the market in terms of global size and breaks the market down into sub-markets and seven regional markets, with forecasts and analysis provided for each market from 2011-2021. The report also examines the major drivers and restraints influencing the market over the next decade and explains the major technologies utilised, analysing which regions will drive growth for each technology. Our research shows that global spending in 2011 on advanced oil &amp; gas exploration technologies will total $10.17bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 22 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Electronic Warfare (EW) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/686/The-Electronic-Warfare-(EW)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/686/The-Electronic-Warfare-(EW)-Market-2011-2021</guid>
		<category>defence</category>
		<description>The growth of electronic warfare (EW) over recent years has been a reflection of advancing technology, combined with increasing demand due to operational deployment overseas. The major factor, however, expected to impact the EW market over the course of the next decade is the state of public finances, and as a consequence the size of military budgets. Defence ministries are under severe pressure to limit their spending outlays. This has implications for the EW market in that despite being somewhat immune to large defence spending cuts, due to the utility of such advanced systems, limited military procurement and upgrade contracts across a multitude of platforms will act as a restraint on the EW market. Nevertheless, Visiongain has determined that the value of the electronic warfare market in 2011 will reach $8.89bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 21 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Advertising 2011-2016: Industry Outlook Report</title>
		<link>http://www.visiongain.com/Report/683/Mobile-Advertising-2011-2016-Industry-Outlook-Report</link>
		<guid>http://www.visiongain.com/Report/683/Mobile-Advertising-2011-2016-Industry-Outlook-Report</guid>
		<category>telecoms &amp; IT</category>
		<description>Are mobiles becoming an essential platform for advertisers? Our new report offers research into the new trends in advertising and their increasing focus on mobiles. The industry is currently exploring different options: from SMS marketing to branded apps, through to mobile video and augmented reality. This expanding market is presenting a number of lucrative opportunities which are not yet being exploited to their full potential.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 19 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Biofuels Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/684/The-Biofuels-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/684/The-Biofuels-Market-2011-2021</guid>
		<category>renewable energy</category>
		<description>Biofuels is a thriving global industry which offers huge potentials for investment. During 2010-2011, the biofuels market gained increased interest as the price of oil increased rapidly. Many developed countries, such as the US and countries in the European Union, reconsidered their energy policy and significantly decreased their imports of oil. On the other side, policy makers were promoting production and consumption of biofuels, through a series of tax credits and incentives. Even though the production of biofuels is still mainly concentrated in US, Europe and South America, 2010-2011 was marked by the more diversified picture with regions such as Asia, Africa and the Middle East increasing their biofuels production. Visiongain calculates that the global expenditure on biofuels in 2011 will total $46.63bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 19 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Therapeutic Monoclonal Antibodies: World Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/685/Therapeutic-Monoclonal-Antibodies-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/685/Therapeutic-Monoclonal-Antibodies-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the market for monoclonal antibody (mAb) therapies perform from 2011? How will competition affect the mAb industry and market? Which national markets have the greatest potential for growth? Discover mAb treatment revenues at total world, submarket, product and national levels. The monoclonal antibody drug market has potential to expand. See how treatments such as Avastin, Herceptin, MabThera, Remicade, Humira, Tysabri and Lucentis can perform to 2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 19 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Interventional Cardiology Devices: World Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/682/Interventional-Cardiology-Devices-World-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/682/Interventional-Cardiology-Devices-World-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>Our latest pharma report - Interventional Cardiology Devices: World Market Prospects 2011-2021 - offers a comprehensive view of the global interventional cardiology devices market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. Visiongain analyses predict the global value of the interventional cardiology devices market in 2011 to be worth $10.6bn. Growth in this market will be driven by new technology such as, bioabsorbable stents, drug-eluting balloons and optical coherence tomography.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 16 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Generic Drugs: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/681/Generic-Drugs-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/681/Generic-Drugs-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>How will the market for generic drugs perform from 2011? Visiongain's report shows you potential revenues to 2021. The world generics market has great potential to expand. Discover generic drug market revenues at total world and national levels. Which national markets have the greatest potential? See how generics markets in the US, Japan, leading EU countries, India, China, Turkey, Brazil, Mexico, South Korea and the Russian Federation can perform to 2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 13 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile VoIP Report 2011-2016: Opportunities and Challenges</title>
		<link>http://www.visiongain.com/Report/680/Mobile-VoIP-Report-2011-2016-Opportunities-and-Challenges</link>
		<guid>http://www.visiongain.com/Report/680/Mobile-VoIP-Report-2011-2016-Opportunities-and-Challenges</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain predicts that by 2016, mobile VoIP applications will generate annual revenues of $36 billion, driven by more than 180 million users worldwide. Across the world, operators are beginning to embrace the technology as consumer demand for cost effective communication services rises. There has been a steady increase in the number of successful partnership between VoIP vendors and mobile operators to deploy mobile VoIP services. This report quantifies mobile VoIP market, analyses the market drivers and the key market players and their strategies.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 09 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Rheumatoid Arthritis: World Drug Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/679/Rheumatoid-Arthritis-World-Drug-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/679/Rheumatoid-Arthritis-World-Drug-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the market for rheumatoid arthritis treatments perform from 2011? Visiongain's report shows you potential revenues to 2021, discussing opportunities and prospects. Discover rheumatoid arthritis drug revenues at total world, submarket, product and national levels.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 07 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Smartphone Report: Gaming, Digital Music Distribution and Entertainment Opportunities 2011-2016</title>
		<link>http://www.visiongain.com/Report/678/Smartphone-Report-Gaming-Digital-Music-Distribution-and-Entertainment-Opportunities-2011-2016</link>
		<guid>http://www.visiongain.com/Report/678/Smartphone-Report-Gaming-Digital-Music-Distribution-and-Entertainment-Opportunities-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Is the Smartphone capable of swallowing the market for both handheld consoles and personal music players? Our research show that with declining iPod sales and an explosion in downloads of Smartphone game apps; the answer is yes. This report details the opportunities arising from this unique situation and also traces the future revenue generating potential of the Smartphone, as a one stop entertainment device.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 06 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Arctic Oil &amp; Gas Exploration &amp; Production (E&amp;P) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/677/The-Arctic-Oil-Gas-Exploration-Production-(E-P)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/677/The-Arctic-Oil-Gas-Exploration-Production-(E-P)-Market-2011-2021</guid>
		<category>energy</category>
		<description>The Arctic remains one of the final frontier areas for oil and gas exploration. Strong oil prices, more advanced offshore equipment and receding sea ice are leading to a growing interest in the Arctic. The Arctic contains a number of basins supporting positive geology for hydrocarbon occurrence, and with the Arctic onshore industry already having provided significant discoveries, the Arctic offshore will provide opportunities for future E&amp;P growth. Visiongain has calculated the Arctic oil &amp; gas E&amp;P market to be worth $11.93bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 02 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Drilling Technologies Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/676/The-Oil-Gas-Drilling-Technologies-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/676/The-Oil-Gas-Drilling-Technologies-Market-2011-2021</guid>
		<category>energy</category>
		<description>Although oil &amp; gas drilling has been taking place for over 100 years, the technological advances in recent years along with increasing extraction of unconventional oil &amp; gas resources has revived interest and investment in the drilling industry over the past few years. The technologies are more and more integrated to enable faster and more accurate drilling in deepwater and ultra-deepwater and help secure oil &amp; gas wells in the most demanding and challenging environments around the globe. Visiongain calculates the global oil &amp; gas drilling technologies market defined as, spending on new drilling equipment, infrastructure and upgrading of existing facilities to be worth $70.1bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 01 Sep 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmacovigilance and Related Developments 2011-2021</title>
		<link>http://www.visiongain.com/Report/674/Pharmacovigilance-and-Related-Developments-2011-2021</link>
		<guid>http://www.visiongain.com/Report/674/Pharmacovigilance-and-Related-Developments-2011-2021</guid>
		<category>pharma</category>
		<description>What does the future hold for pharmacovigilance? Visiongain's new report shows you prospects to 2021, discussing opportunities and developments. Find data you need.
Assess events, opportunities and activities shaping pharmacovigilance to 2021: regulations, technologies and services.
How will changes affect pharmacovigilance? What are drug producers and service providers doing? What regulations and technologies influence that field?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 22 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Companion Diagnostics: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/675/Companion-Diagnostics-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/675/Companion-Diagnostics-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>Our latest pharma report - Companion Diagnostics: World Market Outlook 2011-2021 - offers a comprehensive view of the global companion diagnostics market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict the global value of the companion diagnostics market in 2011 to be worth $1.57bn. A number of specialty drugs will be associated with a companion diagnostic test by 2021, increasing the global market for companion diagnostics.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 22 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil Shale Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/673/The-Oil-Shale-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/673/The-Oil-Shale-Market-2011-2021</guid>
		<category>energy</category>
		<description>Oil shale is not a newly discovered energy source; it has been utilised around the world in various places and at various times for more than 150 years. But the high costs of oil shale extraction, together with the ready availability of conventional oil reserves, made the process uneconomic for most of the 20th century. However, a combination of high oil prices, improved extraction technologies, and increasing energy demands have reignited interest in the oil shale industry over the past few years, and a number of countries are currently seeking to establish major domestic oil shale markets. Visiongain calculates the global oil shale market, defined as, spending on new infrastructure and upgrading of existing oil shale facilities plus spending on R&amp;D, to be worth $2.88bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 19 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Unmanned Ground Vehicles (UGV) Market 2011-2021: Military Robots for EOD &amp; Counter-IED</title>
		<link>http://www.visiongain.com/Report/672/The-Unmanned-Ground-Vehicles-(UGV)-Market-2011-2021-Military-Robots-for-EOD-Counter-IED</link>
		<guid>http://www.visiongain.com/Report/672/The-Unmanned-Ground-Vehicles-(UGV)-Market-2011-2021-Military-Robots-for-EOD-Counter-IED</guid>
		<category>defence</category>
		<description>Visiongain's latest defence report - The Unmanned Ground Vehicles (UGV) Market 2011-2021: Military Robots for EOD &amp; Counter-IED - assesses the business opportunities presented by this critical unmanned systems marketplace. Our study examines the 12 leading national markets for unmanned ground vehicles (UGV) by sales, as well as assessing the wide range of factors that are driving sales growth around the world. Visiongain's analysis has concluded that worldwide government spending on UGVs will total $702m in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 18 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Airport Passenger Screening Systems Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/666/The-Airport-Passenger-Screening-Systems-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/666/The-Airport-Passenger-Screening-Systems-Market-2011-2021</guid>
		<category>aviation</category>
		<description>The impetus for large-scale growth of the airport passenger screening systems market remains buoyed by rapid expansion of airport infrastructure to accommodate the projected substantial growth in global air traffic. Evolving security needs post 9/11, both within the leading U.S aviation security market and throughout the world, will ensure long-term viability for the market of airport passenger screening systems. Visiongain calculates that the global airport passenger screening systems market will reach $10bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 16 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Device Security 2011-2016: Opportunities and Challenges</title>
		<link>http://www.visiongain.com/Report/665/Mobile-Device-Security-2011-2016-Opportunities-and-Challenges</link>
		<guid>http://www.visiongain.com/Report/665/Mobile-Device-Security-2011-2016-Opportunities-and-Challenges</guid>
		<category>telecoms &amp; IT</category>
		<description>2011 is witnessing an explosion of new threats targeting mobile devices. Data and ID theft, SMS fraud, rogue apps and covert espionage are infecting smartphones at an unprecedented rate. Malware such as Trojans, worms, spyware and spam are spreading across mobile platforms, already highly capable of stealing data, corrupting functions and usurping control. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 15 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Social Networking 2011-2016</title>
		<link>http://www.visiongain.com/Report/661/Mobile-Social-Networking-2011-2016</link>
		<guid>http://www.visiongain.com/Report/661/Mobile-Social-Networking-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>The frequency of mobile social networking grew 10% between the three-month period ended January 2011 and the three-month period ended April 2011. 28% of US mobile subscribers accessed a social networking site via mobile phone in April 2011, compared to 25% in January 2011. Such is the scale of the Mobile Social Networking success story that by 2016, visiongain forecasts that one in every 12 people on Earth will regularly use social networking services using a mobile device.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 11 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/663/Pharmaceutical-Contract-Manufacturing-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/663/Pharmaceutical-Contract-Manufacturing-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>The pharmaceutical manufacturing market refers to the outsourcing of pharmaceutical product manufacturing to contract manufacturing organisations (CMOs) by pharmaceutical companies.  Major pharmaceutical companies use CMOs principally to achieve efficiencies in cost, capacity, and time-to-market, or to obtain a specific expertise not available in-house. In the past, outsourcing manufacturing was a tactical decision for pharmaceutical companies - they outsourced to fill short-term lack of capacity or personnel. However, in the past decade, there has been a move towards more strategic outsourcing. Companies now look to outsource manufacturing so that they can focus on their core competencies, freeing up personnel and capital that have otherwise been invested in running manufacturing facilities.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 11 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Payment: Operator Strategies, Opportunities and Challenges Report 2011</title>
		<link>http://www.visiongain.com/Report/660/Mobile-Payment-Operator-Strategies-Opportunities-and-Challenges-Report-2011</link>
		<guid>http://www.visiongain.com/Report/660/Mobile-Payment-Operator-Strategies-Opportunities-and-Challenges-Report-2011</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile Payment market is entering into a rapid growth stage. Across the world, customers are embracing the technology as operators move from trials and testing phase towards commercial deployments. There has been a steady increase in the number of transactions for payment of digital and physical goods via mobiles. Our research suggests that global m-payment volumes are expected to reach $556 billion by 2016. This report quantifies mobile payments market, analyses the operator business models, key market players and their strategies.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 10 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Industrial &amp; Bulk Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/659/The-Industrial-Bulk-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/659/The-Industrial-Bulk-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>The Industrial &amp; Bulk Packaging Market 2011-2021 examines the scope of growth available in this dynamic packaging industry. The report discusses the developments related to rising incomes, improving GDPs leading to rising demand from several industries, infrastructure and development works, increased use of pharmaceuticals and chemicals, and other industrial developments. The industrial &amp; bulk packaging industry is also driven by reformation in laws and regulations, growth in recyclable eco-friendly material, and food and safety issues. Visiongain's has concluded that the global value of the industrial &amp; bulk packaging market will reach $134.9bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 09 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Asthma and COPD Therapies: World Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/658/Asthma-and-COPD-Therapies-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/658/Asthma-and-COPD-Therapies-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the market for asthma and COPD treatments perform from 2011? Discover potential asthma and COPD drug revenues at total world, company, product and national levels. How will competition affect the asthma and COPD treatment market? We show you how drugs such as Seretide/Advair, Singulair, Spiriva, Symbicort, Combivent and Pulmicort can perform to 2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 08 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil Sands Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/657/The-Oil-Sands-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/657/The-Oil-Sands-Market-2011-2021</guid>
		<category>energy</category>
		<description>Global demand for energy is rising at a rapid pace as population growth and economic prosperity is enabling consumers in developing and emerging markets to shift their lifestyle towards increasingly energy consuming products. Risks of oil supply disruptions from Middle Eastern and North African countries are apparent; hence the price of crude oil and petroleum products are expected to remain high over the next few years, making alternative sources such as oil sands economically viable. Therefore most advanced nations capable of investing in alternative supplies are making considerable investments. As a result visiongain calculates capital expenditure in the oil sands market will reach $24.9bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 05 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Electric Power Generation Infrastructure Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/656/The-Electric-Power-Generation-Infrastructure-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/656/The-Electric-Power-Generation-Infrastructure-Market-2011-2021</guid>
		<category>energy</category>
		<description>Visiongain's latest report - The Electric Power Generation Infrastructure Market 2011-2021 - comprehensively examines this vital and dynamic market sector. Although the global recession reduced electricity demand in OECD nations, recovering economies and powerful growth from emerging markets are creating an atmosphere for strong growth in electricity generation. Visiongain calculates the global capital expenditure on electric power generation infrastructure will reach $403.7bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 04 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>M2M 2011: Opportunities and Challenges with Connected Devices</title>
		<link>http://www.visiongain.com/Report/655/M2M-2011-Opportunities-and-Challenges-with-Connected-Devices</link>
		<guid>http://www.visiongain.com/Report/655/M2M-2011-Opportunities-and-Challenges-with-Connected-Devices</guid>
		<category>telecoms &amp; IT</category>
		<description>M2M will allow operators to expand their portfolio of offerings and therefore create new value added services and revenue streams in an increasingly saturated market place. M2M has potential applications in virtually limitless number of industries, with successful current uses documented in the report, in the automotive, e-health and energy sectors. This report proposes business models for successful adoption of M2M by operators.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 02 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Unmanned Aerial Vehicles (UAV) Market 2011-2021: Technologies for ISR and Counter-Insurgency</title>
		<link>http://www.visiongain.com/Report/653/The-Unmanned-Aerial-Vehicles-(UAV)-Market-2011-2021-Technologies-for-ISR-and-Counter-Insurgency</link>
		<guid>http://www.visiongain.com/Report/653/The-Unmanned-Aerial-Vehicles-(UAV)-Market-2011-2021-Technologies-for-ISR-and-Counter-Insurgency</guid>
		<category>defence</category>
		<description>Despite defence spending cuts announced recently, armed forces continue to prioritise spending on unmanned aerial vehicles. UAVs have continually proved themselves in Iraq and Afghanistan and their relative low-cost compared to manned platforms makes them highly attractive alternatives in a climate of restrained or even declining defence budgets. In fact, in some cases UAV spending is substituting spending on manned platforms. Based on visiongain's research, global spending on UAVs will reach $7.8bn in 2011. This will fluctuate in the forecast period of 2011-2021, with value remaining high over the forecast period.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 01 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Simulation and Virtual Training Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/654/The-Military-Simulation-and-Virtual-Training-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/654/The-Military-Simulation-and-Virtual-Training-Market-2011-2021</guid>
		<category>defence</category>
		<description>The military simulation and virtual training market is forecast by Visiongain to experience considerable expansion over the next ten years, with militaries worldwide ready to utilise simulation technology in order to achieve two key objectives: To cut costs and to provide first class training for troops. Visiongain has determined that the value of the military simulation and virtual training market in 2011 will reach $8.75bn, and expects that the market will witness growth in multiple sectors over the coming years. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 01 Aug 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Translational Regenerative Medicine: Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/652/Translational-Regenerative-Medicine-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/652/Translational-Regenerative-Medicine-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for regenerative medicine? Our new report shows you potential revenues to 2021, discussing opportunities and market prospects. Our study identifies three main areas: tissue engineering, stem cell therapy and gene therapy.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 27 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Managed Services in LTE Era Report 2011-2016</title>
		<link>http://www.visiongain.com/Report/651/Managed-Services-in-LTE-Era-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/651/Managed-Services-in-LTE-Era-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Managed Services is having a transformative affect on the wireless value chain in general and operators in particular. The managed services market was around $55 billion in 2010, we believe the market is poised to reach $86 billion by 2016.Global trends that are driving managed services include the explosive growth of data services and advent of LTE networks. Our research suggests that increasing number of operators want to capitalise on the plethora of tangible and intangible benefits offered by managed services. This report details all the latest developments in this sector along with the strategies that will help the operators to maximise their gains. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 26 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Homeland Security Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/649/The-Homeland-Security-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/649/The-Homeland-Security-Market-2011-2021</guid>
		<category>defence</category>
		<description>Homeland security (HLS) is a substantial expanding market that offers a vast number of opportunities for private sector entities. Despite sharp budget cuts and fiscal austerity measures implemented across advanced economies, visiongain calculates that the value of the HLS industry reached as much as US$194.3bn in 2011. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 25 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Inflammatory Bowel Diseases: World Drug Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/650/Inflammatory-Bowel-Diseases-World-Drug-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/650/Inflammatory-Bowel-Diseases-World-Drug-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the market for inflammatory bowel disease (IBD) treatments perform from 2011? Our new report shows you potential pharmaceutical revenues to 2021, discussing opportunities and market prospects.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 25 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Commercial Aircraft Maintenance, Repair and Overhaul (MRO) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/648/The-Commercial-Aircraft-Maintenance-Repair-and-Overhaul-(MRO)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/648/The-Commercial-Aircraft-Maintenance-Repair-and-Overhaul-(MRO)-Market-2011-2021</guid>
		<category>aviation</category>
		<description>The Commercial Aircraft Maintenance, Repair and Overhaul (MRO) Market 2011-2021, is Visiongain's latest aviation report. The report offers a comprehensive view of the global commercial aircraft MRO market. In 2011, with 21,494 commercial aircraft forecast to be in service, Visiongain has determined that the commercial aircraft MRO market in 2011 to be worth $50.2bn. The global fleet of commercial aircraft is expected to reach nearly 30,000 units by 2021, increasing the global demand for commercial aircraft MRO.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 21 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Drug Discovery Outsourcing: World Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/647/Drug-Discovery-Outsourcing-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/647/Drug-Discovery-Outsourcing-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the drug discovery outsourcing market develop this decade? Assess the activities shaping drug discovery outsourcing worldwide. How will changes in focus for pharmaceutical R&amp;D affect drug discovery outsourcing and contract research organisations? Which preclinical activities, technologies and national markets will provide the best opportunities from 2011 to 2021? </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Hydropower Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/646/The-Hydropower-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/646/The-Hydropower-Market-2011-2021</guid>
		<category>energy</category>
		<description>The world is currently facing two potentially contradictory developments: that of increasing global energy supply to meet a growing demand for energy; and that of tackling global warming by lowering emissions of carbon dioxide. This situation creates an opportunity for hydropower, which is a low-carbon energy source, capable of supplying substantial quantities of power throughout the world. Visiongain calculates the global hydropower market, defined as spending on new hydropower projects plus spending on upgrades and expansions, to be worth $56.51bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 13 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Hydropower Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/664/The-Hydropower-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/664/The-Hydropower-Market-2011-2021</guid>
		<category>renewable energy</category>
		<description>The world is currently facing two potentially contradictory developments: that of increasing global energy supply to meet a growing demand for energy; and that of tackling global warming by lowering emissions of carbon dioxide. This situation creates an opportunity for hydropower, which is a low-carbon energy source, capable of supplying substantial quantities of power throughout the world. Visiongain calculates the global hydropower market, defined as spending on new hydropower projects plus spending on upgrades and expansions, to be worth $56.51bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 13 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Floating Production Storage and Offloading (FPSO) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/644/The-Floating-Production-Storage-and-Offloading-(FPSO)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/644/The-Floating-Production-Storage-and-Offloading-(FPSO)-Market-2011-2021</guid>
		<category>energy</category>
		<description>The Floating Production Storage and Offloading (FPSO) Market 2011-2021 investigates this prosperous area of the energy industry. The report assesses this growing sector, which is central to the future of global oil output. The report focuses on the developments in the industry, with analysis of all major FPSO vessels across the largest 16 FPSO national markets. Visiongain research assesses that the global capital expenditure on FPSO in 2011 will reach $6.8bn. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 12 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Huawei Report 2011: Securing New Markets and Gaining Competitive Advantage in the LTE Domain</title>
		<link>http://www.visiongain.com/Report/645/Huawei-Report-2011-Securing-New-Markets-and-Gaining-Competitive-Advantage-in-the-LTE-Domain</link>
		<guid>http://www.visiongain.com/Report/645/Huawei-Report-2011-Securing-New-Markets-and-Gaining-Competitive-Advantage-in-the-LTE-Domain</guid>
		<category>telecoms &amp; IT</category>
		<description>Is Huawei emerging as a dominant force in the LTE market? Visiongain research shows that Huawei's rivals such as Ericsson, NSN and Alcatel Lucent have the greatest to lose if they do not address the competitive threats from Huawei and formulate emergent strategies in the infrastructure and professional services market. The LTE network infrastructure market alone is forecast to grow rapidly to be worth $68 billion by 2016, with just a handful of key vendors fighting for market share. Visiongain's new report quantifies these market changes and analyses the impacts of these variations</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 12 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Cloud 2011: Moving into the Realm of an Essential IT Strategy</title>
		<link>http://www.visiongain.com/Report/643/Cloud-2011-Moving-into-the-Realm-of-an-Essential-IT-Strategy</link>
		<guid>http://www.visiongain.com/Report/643/Cloud-2011-Moving-into-the-Realm-of-an-Essential-IT-Strategy</guid>
		<category>telecoms &amp; IT</category>
		<description>Cloud computing has been the subject of intense debate in the past three years, with arguments vying for the technology and hailing it as the next phase in enterprise IT management while challengers state it is only a new name for existing computing models. More recently however, a number of catalysts such as the increasing smartphone adoption and the current economic climate have pushed cloud computing to the forefront of business and consumer interest.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 11 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/642/Macular-Degeneration-(AMD)-and-Diabetic-Retinopathy-(DR)-World-Drug-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/642/Macular-Degeneration-(AMD)-and-Diabetic-Retinopathy-(DR)-World-Drug-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for the treatment of macular degeneration (AMD) and diabetic retinopathy (DR)? Our new report shows you potential revenues to 2021, discussing commercial opportunities and prospects. Discover potential revenues at total world, submarket, product and national levels.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 08 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharma Clinical Trial Services: World Market 2011-2021 </title>
		<link>http://www.visiongain.com/Report/641/Pharma-Clinical-Trial-Services-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/641/Pharma-Clinical-Trial-Services-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the clinical trial services industry perform from 2011 onwards? Our new report shows you potential revenues and trends to 2021, discussing opportunities and prospects. How will changes in focus for pharmaceutical R&amp;D affect clinical outsourcing and CROs? Which research areas and national markets will provide the best opportunities to 2021? </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 04 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Video Surveillance Systems Market 2011-2021: Full Motion Video for ISR</title>
		<link>http://www.visiongain.com/Report/640/The-Military-Video-Surveillance-Systems-Market-2011-2021-Full-Motion-Video-for-ISR</link>
		<guid>http://www.visiongain.com/Report/640/The-Military-Video-Surveillance-Systems-Market-2011-2021-Full-Motion-Video-for-ISR</guid>
		<category>defence</category>
		<description>Visiongain's latest defence report - The Military Video Surveillance Systems Market 2011-2021: Full Motion Video for ISR - assesses the business opportunities presented by this critical marketplace driving the growth in intelligence, surveillance and reconnaissance (ISR). Our study examines the 15 leading national markets for military video surveillance systems by sales, as well as assessing the wide range of factors that are driving sales growth around the world. Visiongain's analysis has concluded that worldwide government spending on military video surveillance systems will reach $8.09bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 01 Jul 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Solar Power Photovoltaic (PV) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/637/The-Solar-Power-Photovoltaic-(PV)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/637/The-Solar-Power-Photovoltaic-(PV)-Market-2011-2021</guid>
		<category>energy</category>
		<description>Global demand for energy is rising at a rapid pace as population growth and economic prosperity is enabling developing and emerging markets to buy increasing amounts of energy consuming products. The nuclear catastrophe in Japan has shifted the focus of economies around the globe and raised demand for alternatively sourced electricity. Meanwhile, risks of oil supply disruptions from Middle East and North African countries are at an all time high; hence the price of crude oil and related products are expected to remain high over the next few years</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 30 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Sustainable &amp; Green Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/638/The-Sustainable-Green-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/638/The-Sustainable-Green-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>The Sustainable &amp; Green Packaging Market 2011-2021 is Visiongain's brand new materials report which analyses the industry trends prevailing in the global sustainable &amp; green packaging market and anticipates the progression in the market over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the sustainable &amp; green packaging market will reach $107.7bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 30 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Mobile Roaming 2011: Operator Strategies, Opportunities and Challenges in the 3G and LTE Era</title>
		<link>http://www.visiongain.com/Report/639/Global-Mobile-Roaming-2011-Operator-Strategies-Opportunities-and-Challenges-in-the-3G-and-LTE-Era</link>
		<guid>http://www.visiongain.com/Report/639/Global-Mobile-Roaming-2011-Operator-Strategies-Opportunities-and-Challenges-in-the-3G-and-LTE-Era</guid>
		<category>telecoms &amp; IT</category>
		<description>LTE is set to transform Roaming- but what impact will it have? With LTE services rolling out around the globe in 2011, operators and affiliates must prepare themselves for the transformative effect this will have on the telecoms industry, particularly the roaming sector. The enterprise roaming segment has long provided a reliable price inelastic revenue stream but this stream can be widened to include all subscribers and increase revenues in a saturated market. International regulatory bodies are taking action in regards to roaming costs and we believe this is the right time to capitalise with smart and effective pricing strategies.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 30 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Solar Power Photovoltaic (PV) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/671/The-Solar-Power-Photovoltaic-(PV)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/671/The-Solar-Power-Photovoltaic-(PV)-Market-2011-2021</guid>
		<category>renewable energy</category>
		<description>Global demand for energy is rising at a rapid pace as population growth and economic prosperity is enabling developing and emerging markets to buy increasing amounts of energy consuming products. The nuclear catastrophe in Japan has shifted the focus of economies around the globe and raised demand for alternatively sourced electricity. Meanwhile, risks of oil supply disruptions from Middle East and North African countries are at an all time high; hence the price of crude oil and related products are expected to remain high over the next few years</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 30 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Natural Gas and LNG Storage Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/635/The-Natural-Gas-and-LNG-Storage-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/635/The-Natural-Gas-and-LNG-Storage-Market-2011-2021</guid>
		<category>energy</category>
		<description>Natural gas is becoming an increasingly favourable energy source due to its comparative low cost and clean-burning attributes, as well as its growing accessibility through pipeline and LNG trade. Both mature and fast growing economies are looking to natural gas to reduce carbon dioxide emissions and diversify away from unpredictably priced oil, driving global demand. Based on our research and analysis of current and planned projects, visiongain has calculated the natural gas and LNG storage market to be worth $18.57bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 28 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Metal Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/636/The-Metal-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/636/The-Metal-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>The Metal Packaging Market 2011-2021 is our brand new materials report investigating one of the key industries behind numerous consumer markets. Our detailed study explores the potential of emerging markets to strengthen overall metal packaging demand, as a result of rising GDPs and corresponding developments in activities relating to packaging. Countries continue to invest in metal industries and growing demand is expected for metal packaging, allowing for healthy market development.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 27 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/633/Lyophilisation-for-Pharmaceuticals-Technology-and-Services-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/633/Lyophilisation-for-Pharmaceuticals-Technology-and-Services-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for lyophilisation technology? Our new report shows you potential revenues to 2021. Our report covers lyophilisation (cryodesiccation or freeze drying) in pharmaceutical applications: technologies, products and services. You will assess events, opportunities and activities shaping the lyophilisation industry and market from 2011 to 2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 27 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Metal Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/634/The-Metal-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/634/The-Metal-Packaging-Market-2011-2021</guid>
		<category>metals</category>
		<description>The Metal Packaging Market 2011-2021 is our brand new materials report investigating one of the key industries behind numerous consumer markets. Our detailed study explores the potential of emerging markets to strengthen overall metal packaging demand, as a result of rising GDPs and corresponding developments in activities relating to packaging. Countries continue to invest in metal industries and growing demand is expected for metal packaging, allowing for healthy market development.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 27 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biomarkers: Technological and Commercial Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/632/Biomarkers-Technological-and-Commercial-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/632/Biomarkers-Technological-and-Commercial-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for biomarkers in pharma and diagnostics? In our study you will find discussions of genomic and proteomic approaches to biomarker discovery, including metabolomics and microarray platforms. You will see how biomarker technologies are changing pharma and diagnostics.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 22 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pre-Filled Syringes: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/631/Pre-Filled-Syringes-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/631/Pre-Filled-Syringes-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>How will the pre-filled syringes market develop this decade?  prospects. Our report covers pre-filled syringes in therapeutic applications: devices and drugs. You will find potential revenues for pre-filled syringe technologies at total world, submarket and national levels to 2021. What technologies and applications will expand that market?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 21 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Russian Defence Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/630/The-Russian-Defence-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/630/The-Russian-Defence-Market-2011-2021</guid>
		<category>defence</category>
		<description>The Russian defence market is set to expand considerably over the next decade, with the Russian authorities seeking to modernise and improve the capabilities of the Russian armed forces, and to cement Russia's place as a leading military nation.
Visiongain has determined that the value of the Russian defence market in 2010 was $47.10bn, and despite evident challenges existing within the market, Visiongain expects the Russian defence market to witness growth in multiple areas. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 20 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>In Vitro Diagnostics: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/629/In-Vitro-Diagnostics-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/629/In-Vitro-Diagnostics-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>How will the in vitro diagnostics (IVD) market develop this decade? Our report shows you potential revenues to 2021, discussing opportunities and prospects. Through our research and analysis we aim to save you time and help in your decisions.

Our new study shows you potential revenues to 2021 for in vitro diagnostics at total world, submarket and national levels. What technologies and applications will expand that market? What effects will changes have? You will find predictions and answers.
</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 13 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil Refinery Catalyst Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/628/The-Oil-Refinery-Catalyst-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/628/The-Oil-Refinery-Catalyst-Market-2011-2021</guid>
		<category>energy</category>
		<description>Visiongain's latest energy report comprehensively examines this evolving market for oil refinery catalysts, which have been at the forefront of transformations to crude oil refining over recent years. Growing demand for petroleum fuels and olefins used in the plastics sector is expected to lead to refining capacity expansions, particularly in non-OECD states. This, along with demand for highly purified and high octane petroleum products and fuels, will ensure the oil refinery catalyst market is home to rising revenues over the coming ten years. Visiongain calculates that the global oil refinery catalyst market will reach $3.18bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Vaccines Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/627/World-Vaccines-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/627/World-Vaccines-Market-2011-2021</guid>
		<category>pharma</category>
		<description>Do you want to know how the vaccines industry and market will develop from 2011? Our new report shows you potential revenues to 2021, discussing opportunities and prospects. You will find revenue predictions at total world, submarket, product, company and national levels. You will see how products such as Prevnar, Pandemrix, Fluzone, Proquad/MMR-II/Varivax, Infanrix/Pediarix and Gardasil can perform to 2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 07 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Electric Power Transmission and Distribution (T&amp;D) Equipment Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/626/The-Electric-Power-Transmission-and-Distribution-(T-D)-Equipment-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/626/The-Electric-Power-Transmission-and-Distribution-(T-D)-Equipment-Market-2011-2021</guid>
		<category>energy</category>
		<description>The Electric Power Transmission &amp; Distribution (T&amp;D) Equipment Market 2011-2021 is visiongain's latest energy report which assesses the changes occurring in an industry essential for economic development and growth. The study examines the leading 20 national markets and delivers insightful recommendations and forecasts. Visiongain's research evaluates the level of capital expenditure in the electric power T&amp;D equipment market, showing that the market will be worth $128.9bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 03 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Electric Power Transmission and Distribution (T&amp;D) Equipment Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/742/The-Electric-Power-Transmission-and-Distribution-(T-D)-Equipment-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/742/The-Electric-Power-Transmission-and-Distribution-(T-D)-Equipment-Market-2011-2021</guid>
		<category>utilities</category>
		<description>The Electric Power Transmission &amp; Distribution (T&amp;D) Equipment Market 2011-2021 is visiongain's latest energy report which assesses the changes occurring in an industry essential for economic development and growth. The study examines the leading 20 national markets and delivers insightful recommendations and forecasts. Visiongain's research evaluates the level of capital expenditure in the electric power T&amp;D equipment market, showing that the market will be worth $128.9bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 03 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Google in Mobile 2011: Building a Sustainable Competitive Advantage</title>
		<link>http://www.visiongain.com/Report/624/Google-in-Mobile-2011-Building-a-Sustainable-Competitive-Advantage</link>
		<guid>http://www.visiongain.com/Report/624/Google-in-Mobile-2011-Building-a-Sustainable-Competitive-Advantage</guid>
		<category>telecoms &amp; IT</category>
		<description>Google has been dominating desktop internet search and advertising for almost a decade now. It has deployed an aggressive strategy which is swiftly occupying the mobile space. Google is dominating the global mobile search market with a market share of 97% for mobile searches worldwide. Optimising its core expertise, Google has managed to anticipate the mobile demand and is constantly optimising its services to anticipate future trends. Visiongain estimates Google's mobile search advertising revenues to reach $2.85 billion by 2016.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 02 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Commercial Aircraft Leasing Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/625/The-Commercial-Aircraft-Leasing-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/625/The-Commercial-Aircraft-Leasing-Market-2011-2021</guid>
		<category>aviation</category>
		<description>The Commercial Aircraft Leasing Market 2011-2021, is our new aviation report which provides a comprehensive analysis of the global commercial aircraft leasing market, on both the supply-side and demand-side. While the performance of the global economy remains sluggish, and the outlook remains uncertain, the commercial aircraft leasing market will continue to expand, allowing for growth during 2011 and beyond. Visiongain calculates that leased commercial aircraft will steadily increase their market share of the total active commercial fleet. Visiongain calculates that the commercial aircraft leasing market currently constitutes 6,864 aircraft globally and has a market value of $233bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 02 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Clean Coal Technologies (CCT) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/623/The-Clean-Coal-Technologies-(CCT)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/623/The-Clean-Coal-Technologies-(CCT)-Market-2011-2021</guid>
		<category>energy</category>
		<description>Over the next few years many countries around the world are hoping to take advantage of coal's relative low cost and abundance as an energy source. Yet, at the same time, increasing fears over global warming and coal's impact on the environment and human health have led to calls for coal to be replaced by cleaner energy sources. Taken together, these factors create an opportunity for clean coal technologies, which aim to reduce the harmful by-products of burning coal. The market is likely to see substantial spending over the next decade as a number of national governments and private companies seek to invest in this growing market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 01 Jun 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Deepwater &amp; Ultra Deepwater Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/622/The-Deepwater-Ultra-Deepwater-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/622/The-Deepwater-Ultra-Deepwater-Market-2011-2021</guid>
		<category>energy</category>
		<description>Global demand for energy is rising at a rapid pace as population growth and economic prosperity is enabling consumers in developing and emerging markets to shift their lifestyle to increasingly energy consuming products. The nuclear catastrophe in Japan has raised the threat level for economies around the globe and increased demand for gas. Meanwhile, risks of oil supply disruptions from Middle East and North African countries are at an all time high; hence the price of crude oil is expected to remain high over the next few years. Therefore all nations capable of investing in deepwater exploration and development are taking the steps to secure a reliable supply of energy from deepwater reserves.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 31 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Saudi Arabian Defence Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/621/The-Saudi-Arabian-Defence-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/621/The-Saudi-Arabian-Defence-Market-2011-2021</guid>
		<category>defence</category>
		<description>This report, The Saudi Arabian Defence Market 2011-2021, finds a robust market in the Kingdom of Saudi Arabia, a critically important country that is the world's leading oil exporter and which also has one of the most powerful armed forces in the Middle East. Saudi Arabia had a total defence budget of $43bn in 2010. Visiongain assesses that of that figure, $11.1bn was acquisitions spending for purchasing new or upgraded military equipment. It is expected that Saudi Arabia will provide robust demand for defence acquisitions over the next decade.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 27 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Femtocell Report 2011-2016: Analysing Operator Savings and Investments</title>
		<link>http://www.visiongain.com/Report/619/Femtocell-Report-2011-2016-Analysing-Operator-Savings-and-Investments</link>
		<guid>http://www.visiongain.com/Report/619/Femtocell-Report-2011-2016-Analysing-Operator-Savings-and-Investments</guid>
		<category>telecoms &amp; IT</category>
		<description>Femtocells have entered into the growth stage of their lifecycle in 2011. With a range of benefits for enterprise and residential subscribers, Femtocells technology is poised to increase data ARPU for operators across the globe. Using Femtocells, operators can also embark on the value discipline of customer intimacy thereby reducing the churn rates.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 24 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Smartphones in Enterprises Report 2011-2016</title>
		<link>http://www.visiongain.com/Report/620/Smartphones-in-Enterprises-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/620/Smartphones-in-Enterprises-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Are smartphones becoming an essential tool in business, or are the consumer devices not yet correctly positioned to provide all the functionality that enterprise mobility requires? This report covers the global enterprise smartphone market with opportunities across all major geographical markets and vertical sectors. With analysis of the major players in the enterprise smartphone ecosystem, Smartphones in Enterprises Report 2011-2016 is a definitive guide to this complex marketplace.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 24 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Missiles Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/618/The-Missiles-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/618/The-Missiles-Market-2011-2021</guid>
		<category>defence</category>
		<description>The global missile market - which visiongain calculates was worth $10.27bn in 2010 alone - is currently in a state of flux as development continues to move beyond established markets in the US and Europe. A number of emerging markets are now able to forgo joint development with established missile manufacturers and have managed to build advanced capabilities. Simultaneously, a growing number of these countries will be investing billions of dollars into missile programmes over the next 10 years and are looking to procure increasingly sophisticated technology or collaborate on new ranges of missiles.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 20 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Food &amp; Drink Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/617/The-Food-Drink-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/617/The-Food-Drink-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>Visiongain's brand new materials report analyses one of the key sectors of the dynamic packaging industry. The report investigates the developing trends in food &amp; drink packaging and anticipates the progression in the global market over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the food &amp; drink packaging market will reach $316.7bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Single-Use Bioreactors for Pharma: World Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/616/Single-Use-Bioreactors-for-Pharma-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/616/Single-Use-Bioreactors-for-Pharma-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the market for single-use bioreactors develop this decade? Our study shows you revenue prospects for disposable bioreactor technology at total world, submarket and national levels to 2021. You will discover commercial prospects, including those for hardware, disposable bags, accessories and specialist products and services.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 18 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>LTE Ecosystem Report 2011-2016</title>
		<link>http://www.visiongain.com/Report/614/LTE-Ecosystem-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/614/LTE-Ecosystem-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>LTE technology has entered into the growth stage of its lifecycle in 2011. With players in the LTE ecosystem embarking on a strategy of innovation and product leadership, the market looks poised for new developments that will revolutionise the mobile broadband. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 17 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The UAV Flight Training &amp; Simulation Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/615/The-UAV-Flight-Training-Simulation-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/615/The-UAV-Flight-Training-Simulation-Market-2011-2021</guid>
		<category>defence</category>
		<description>Visiongain's latest defence report assesses the business opportunities presented by one of the most important parts of the wider unmanned systems marketplace. Our study examines the 10 leading national markets for unmanned aerial vehicle (UAV) flight training and simulation products and services by sales, as well as assessing the factors that are driving sales growth around the world. The analysis and forecasting have been underpinned by consultation with experts at MacDonald, Dettwiler and Associates Ltd (MDA); SELEX Galileo; and Simlat Ltd. Visiongain's analysis has concluded that worldwide government spending on UAV flight training and simulation will reach $375m in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 17 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Fast Moving Consumer Goods (FMCG) Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/613/The-Fast-Moving-Consumer-Goods-(FMCG)-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/613/The-Fast-Moving-Consumer-Goods-(FMCG)-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>The Fast Moving Consumer Goods (FMCG) Packaging Market 2011-2021 is our brand new materials report. FMCG packaging is one of the key industries driving our modern civilisation. The report analyses the evolving industry trends within the global FMCG packaging industry and anticipates the progression in the market over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the FMCG packaging market will reach $456bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 11 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Indian Defence Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/611/The-Indian-Defence-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/611/The-Indian-Defence-Market-2011-2021</guid>
		<category>defence</category>
		<description>Enabled by substantial economic growth over the past decade, and driven forward by a national policy of military renewal and development, the Indian defence market has been propelled to the forefront of the world stage in relation to global military markets. The rise of Indian defence spending and capabilities reflects India's position not only within the confines of Asia, but throughout the entire world, as the shifting dynamics of geopolitical power tilt its way. Visiongain has determined that the value of the Indian defence market in 2011 amounted to $36.42bn and forecasts the Indian defence market in detail from 2011-2021. The forecasts and analysis are underpinned by extensive expert consultation with Larsen &amp; Toubro and Lockheed Martin Indian Private Ltd.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 10 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Stem Cell Technologies: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/612/Stem-Cell-Technologies-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/612/Stem-Cell-Technologies-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>How will the stem cells market develop this decade? Our new report shows you that emerging industry and market's revenue potential from 2011 to 2021. This report covers stem cells in therapeutic applications: technologies, products and services. You will assess events, opportunities and activities shaping that industry. Our new study shows you revenue prospects for stem cells at total world, submarket and product levels to 2021. What activities will expand that market from 2011 to 2021?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 10 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/610/Acute-Coronary-Syndrome-(ACS)-Drug-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/610/Acute-Coronary-Syndrome-(ACS)-Drug-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for the pharmacological treatment of acute coronary syndrome? Our new report shows you its revenue potential from 2011 to 2021. Our study covers ACS treatments, including those for unstable angina (UA) and acute myocardial infarction (AMI). You will see commercial prospects for platelet aggregation inhibitors, anticoagulant treatments, fibrinolytic agents and their subgroups to 2021. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 06 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile User Interface 2011-2016: Designing Compelling UI in iPhone and Android Era</title>
		<link>http://www.visiongain.com/Report/608/Mobile-User-Interface-2011-2016-Designing-Compelling-UI-in-iPhone-and-Android-Era</link>
		<guid>http://www.visiongain.com/Report/608/Mobile-User-Interface-2011-2016-Designing-Compelling-UI-in-iPhone-and-Android-Era</guid>
		<category>telecoms &amp; IT</category>
		<description>User experience is driving growth in the smartphone and tablet market. For this reason, UI design has become the crucial factor in product differentiation between market players. This means that innovation and original concepts in UI are conferring important competitive advantages to those players that are investing in UI development.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 03 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/609/Genomic-Sequencing-Technologies-for-Medicine-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/609/Genomic-Sequencing-Technologies-for-Medicine-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>How will the genomic sequencing market develop this decade? This report covers technology to support genomics, with an emphasis on pharma R&amp;D. Our new study shows you revenue prospects for genomic technologies at total world, submarket, company and national levels to 2021. Third-generation sequencing platforms can increase throughput and lower costs.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 03 May 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Pain Relieving Drug Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/606/World-Pain-Relieving-Drug-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/606/World-Pain-Relieving-Drug-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What are the prospects for the pain treatment market from 2011? Our new report shows you its revenue potential from 2011 to 2021. Our report gives you revenue forecasts to 2021 for pain-relieving drugs. You will discover market predictions at total world, submarket, product and national levels.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 27 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Liquefied Natural Gas (LNG) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/607/The-Liquefied-Natural-Gas-(LNG)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/607/The-Liquefied-Natural-Gas-(LNG)-Market-2011-2021</guid>
		<category>energy</category>
		<description>Our latest energy report - The Liquefied Natural Gas (LNG) Market 2011-2021 - examines this rapidly evolving area of the energy industry with detailed analysis of global and regional LNG terminal investment. The report examines this sector analytically and includes a SWOT analysis and original interviews with experts in the industry which underpin the forecasting and analysis. Visiongain calculates that the global liquefied natural gas (LNG) infrastructure market will reach $27.5bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 27 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Shale Gas Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/605/The-Shale-Gas-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/605/The-Shale-Gas-Market-2011-2021</guid>
		<category>energy</category>
		<description>The US shale gas market has seen great success over the last ten years following the coupling of hydraulic fracturing methods with horizontal drilling. The growing volume of domestically produced natural gas from shale sources in North America has driven other areas of the world into investigating their own shale gas producing potential. This has created a shale gas market with considerable opportunity for profound growth. Our latest energy report The Shale Gas Market 2011-2021 examines this vital sector and its prospects over the next decade. Based on our research, Visiongain has calculated the global shale gas market to be worth $26.66bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 18 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Multiple Myeloma Drug Treatment Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/603/World-Multiple-Myeloma-Drug-Treatment-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/603/World-Multiple-Myeloma-Drug-Treatment-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What are the prospects for the multiple myeloma treatment market from 2011? Our new report shows you its revenue potential from 2011 to 2021. Our report gives you revenue forecasts to 2021 for myeloma drugs. You will discover market predictions at total world, product and national levels.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Energy Storage Technologies (EST) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/604/The-Energy-Storage-Technologies-(EST)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/604/The-Energy-Storage-Technologies-(EST)-Market-2011-2021</guid>
		<category>energy</category>
		<description>The increasing volatility in the world's electricity grids, driven by the growing global demand for electrical products and the rising penetration levels of intermittent renewable energy sources, has created an arena for energy storage technologies to thrive. This latest visiongain energy report examines the vital EST sector and its prospects over the next decade. Based on our research and analysis of company activity, Visiongain has calculated the global energy storage technologies (EST) market for utility applications to reach $666m in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Energy Storage Technologies (EST) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/670/The-Energy-Storage-Technologies-(EST)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/670/The-Energy-Storage-Technologies-(EST)-Market-2011-2021</guid>
		<category>renewable energy</category>
		<description>The increasing volatility in the world's electricity grids, driven by the growing global demand for electrical products and the rising penetration levels of intermittent renewable energy sources, has created an arena for energy storage technologies to thrive. This latest visiongain energy report examines the vital EST sector and its prospects over the next decade. Based on our research and analysis of company activity, Visiongain has calculated the global energy storage technologies (EST) market for utility applications to reach $666m in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil Refineries Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/602/The-Oil-Refineries-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/602/The-Oil-Refineries-Market-2011-2021</guid>
		<category>energy</category>
		<description>The oil refineries market is currently undergoing a significant reorientation, with demand moving away from the traditional strongholds of Europe and North America to other regions of the world. This transformation, which began before the recent economic recession, but was accelerated by its effects, both creates a number of opportunities and poses a number of threats to companies involved in the industry. Visiongain calculates that spending on upgrades, new acquisitions and maintenance of oil refineries across the world will total $40bn in 2011. Our market analysis and forecasts have been further underpinned by informed interviews from both Hyperion Resources and Valero Energy Corporation.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 14 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021</title>
		<link>http://www.visiongain.com/Report/598/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2011-2021</link>
		<guid>http://www.visiongain.com/Report/598/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2011-2021</guid>
		<category>pharma</category>
		<description>What are the commercial prospects for pharmaceutical anti-counterfeiting technology? Our new report shows you that industry and market's revenue potential from 2011 to 2021. Our report shows you revenue prospects for pharma anti-counterfeiting technologies at total world, submarket and national levels to 2021. We discuss the anti-counterfeiting activities of companies such as Pfizer, J&amp;J, GSK, Sanofi-Aventis, Novartis and AstraZeneca. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 11 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Enhanced Oil Recovery (EOR) Technologies Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/599/The-Enhanced-Oil-Recovery-(EOR)-Technologies-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/599/The-Enhanced-Oil-Recovery-(EOR)-Technologies-Market-2011-2021</guid>
		<category>energy</category>
		<description>The Enhanced Oil Recovery (EOR) Technologies Market 2011-2021 assesses this vital and growing industry which is central to the future of global oil output. The report focuses on the developments in the industry, with analysis of all major EOR projects in 20 leading countries with analysis and forecasts underpinned by consultation with expert opinion from Oil Chem Technologies and other leading companies. Visiongain's research evaluates the level of capital expenditure in the EOR Technologies market will be worth $20.9bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 11 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Glass Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/600/The-Glass-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/600/The-Glass-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>Visiongain's brand new materials report examines the scope of growth available in the dynamic glass packaging industry through items such as lightweight glass bottles, borosilicate glass tubing, glass vials and ampoules, and designer and colourful glass bottles and containers. The report analyses industry trends prevailing in the global glass packaging and anticipates the progression in the market. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the glass packaging market will reach $33.1bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 11 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biosimilars and Follow-On Biologics: World Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/601/Biosimilars-and-Follow-On-Biologics-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/601/Biosimilars-and-Follow-On-Biologics-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>How will the biosimilars and follow-on biologics market develop this decade? Our new report shows you that emerging industry and market's revenue potential from 2011 to 2021. This report covers drugs in the biosimilar medicinal product and follow-on protein product field. You will assess events, opportunities and activities shaping that industry.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 11 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Armoured Vehicle Upgrade &amp; Retrofit Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/597/The-Armoured-Vehicle-Upgrade-Retrofit-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/597/The-Armoured-Vehicle-Upgrade-Retrofit-Market-2011-2021</guid>
		<category>defence</category>
		<description>The Armoured Vehicle Upgrade &amp; Retrofit Market 2011-2021 examines the market for refurbishment and enhancement of existing armoured vehicles. The report reviews leading armoured vehicle re-fit programmes and examines the prospects and outlook for government spending on armoured vehicle upgrades and retrofits. It reviews major programmes related to the upgrade of main battle tanks, medium armoured vehicles, medium mine-resistant vehicles and light protected vehicles. The report reviews the state of the market in 2010 and projects future prospects for the market in the forecast period of 2011-2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 07 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Wholesale and Distribution Industry: World Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/595/Pharmaceutical-Wholesale-and-Distribution-Industry-World-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/595/Pharmaceutical-Wholesale-and-Distribution-Industry-World-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>How will the pharma wholesale and distribution industry perform from 2011 onwards? What effects will healthcare budget cuts have on pharmaceutical wholesalers? Which national markets will provide the best opportunities from 2011 to 2021? How common will direct-to-pharmacy distribution become? Our work provides answers you need.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 01 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Armoured Vehicles Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/596/The-Armoured-Vehicles-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/596/The-Armoured-Vehicles-Market-2011-2021</guid>
		<category>defence</category>
		<description>This report, The Armoured Vehicles Market 2011-2021, finds many countries in the midst of acquisition or upgrade programmes to replace or refurbish large fleets of armoured vehicles. However, reduced defence budgets were announced by many countries in 2010 which have had an impact on some armoured vehicle programmes, although there are other nations that are actually set to increase defence spending. Armoured vehicles of various types have been found to be critical whether in conventional battles or in counter-insurgency-type conflicts, and thus programmes related to these are expected to see considerable funding in coming years.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 01 Apr 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Application Ecosystem 2011-2016</title>
		<link>http://www.visiongain.com/Report/593/Mobile-Application-Ecosystem-2011-2016</link>
		<guid>http://www.visiongain.com/Report/593/Mobile-Application-Ecosystem-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Our market focused research shows that the mobile apps market is worth $3.9 billion in 2011. But how will the market evolve over the next five years? This report contains detailed App market forecasts and development models based on our thorough research.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 31 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Smart Grid Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/594/The-Smart-Grid-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/594/The-Smart-Grid-Market-2011-2021</guid>
		<category>energy</category>
		<description>Until recently the electricity industry has been slow in realising the benefits of automation technologies, ICT and telecommunication advances. But now a slow revolution in the market derives the evolution of a 'smart' electricity grid. Within the next decade the composition of electricity generation will be changing and there is a greater need for smart grid on transmission lines. Further downstream, the distributors and households will see changes in the structure of the market that will impact the way they shop around for electricity. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 31 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Smart Grid Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/741/The-Smart-Grid-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/741/The-Smart-Grid-Market-2011-2021</guid>
		<category>utilities</category>
		<description>Until recently the electricity industry has been slow in realising the benefits of automation technologies, ICT and telecommunication advances. But now a slow revolution in the market derives the evolution of a 'smart' electricity grid. Within the next decade the composition of electricity generation will be changing and there is a greater need for smart grid on transmission lines. Further downstream, the distributors and households will see changes in the structure of the market that will impact the way they shop around for electricity. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 31 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Communications &amp; COTS Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/591/The-Military-Communications-COTS-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/591/The-Military-Communications-COTS-Market-2011-2021</guid>
		<category>defence</category>
		<description>Despite pressure on defence spending worldwide, military communications look set to remain central to defence procurement and investment in the coming years. Military communications are a vital part of all armed forces, and have grown in scope as technology has continued to advance. Maintaining superior communications capability is paramount for both conventional and limited warfare operations, with an increased demand for real time information and interconnected troops. Visiongain has determined that the size of the global military communications market in 2010 amounted to $15.91bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 30 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Monetising NFC: Challenges and Opportunities Report 2011-2016</title>
		<link>http://www.visiongain.com/Report/592/Monetising-NFC-Challenges-and-Opportunities-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/592/Monetising-NFC-Challenges-and-Opportunities-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>NFC technology has entered into growth stage of its lifecycle in 2011. With players in the NFC ecosystem embarking on a strategy of innovation and product leadership, the market looks poised for groundbreaking developments that will change the way we envision smartphones.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 30 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>RNAi for Therapeutic Applications: Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/590/RNAi-for-Therapeutic-Applications-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/590/RNAi-for-Therapeutic-Applications-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>How will the RNA interference (RNAi) therapies market develop this decade? Our new report shows you that emerging market's revenue potential from 2011 to 2021. Our new study shows you revenue prospects for RNAi technologies at total world, geographical and product levels. We discuss RNAi applications for cancer, respiratory disorders, eye disorders and other diseases.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 29 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Aviation Security Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/589/The-Aviation-Security-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/589/The-Aviation-Security-Market-2011-2021</guid>
		<category>aviation</category>
		<description>The Aviation Security Market 2011-2021, is Visiongain's brand new aviation report which offers a comprehensive view of the global aviation security market, on both the supply- and demand-side. While the performance of the global economy remains sluggish, and the outlook remains uncertain, aviation security spending will demonstrate resilience, allowing for strong growth prospects during 2010 and beyond. Visiongain calculates that the global aviation security market will reach $20bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 22 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Healthcare Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/587/The-Healthcare-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/587/The-Healthcare-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>Healthcare packaging is one the key industries driving our civilisation. The report analyses industry trends occurring in the global healthcare packaging industry and anticipates the progression in the market over the next decade. The report also surveys recent market trends among major companies and reveals where the healthcare packaging market will experience growth, exploring the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the healthcare packaging market will reach $87.3bn in 2011. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 21 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Body Armour &amp; Personal Protective Gear Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/588/The-Military-Body-Armour-Personal-Protective-Gear-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/588/The-Military-Body-Armour-Personal-Protective-Gear-Market-2011-2021</guid>
		<category>defence</category>
		<description>Our latest defence report - The Military Body Armour &amp; Personal Protective Gear Market 2011-2021 - assesses the business opportunities presented by one of the key defence marketplaces. Our study examines the 12 leading national markets for military body armour and personal protective gear by sales, as well as assessing the factors that are driving sales growth around the world. Our analysis has concluded that worldwide government spending on military body armour and personal protective gear will reach $1.19bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 21 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Ophthalmic Drugs: World Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/586/Ophthalmic-Drugs-World-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/586/Ophthalmic-Drugs-World-Market-2011-2021</guid>
		<category>pharma</category>
		<description>Where will the highest revenue growth occur in the ophthalmic drug market? Our new report shows you the eye disorder treatment market's potential from 2011 to 2021. 
You will discover revenue prospects for eye disorder drugs at total world, sub-market, product and national levels. We cover drugs for glaucoma, retinal disorders, dry eye, ocular allergy, inflammation and infection. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 18 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Diabetes Drug Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/585/World-Diabetes-Drug-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/585/World-Diabetes-Drug-Market-2011-2021</guid>
		<category>pharma</category>
		<description>Where will revenue growth occur in the diabetes treatment market? Our new report shows you the potential that drug market offers from 2011 to 2021, explaining the opportunities there. You will discover revenue prospects for diabetes treatments at total world, sub-market, product and national levels. We show potential revenues for human insulins and analogues, as well as other diabetes treatments. You will discover revenue prospects for Novo Nordisk, GSK, Takeda, sanofi-aventis, Eli Lilly, Merck and other companies from 2011 onwards.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 11 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Mobile Offshore Drilling Units (MODU) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/584/The-Mobile-Offshore-Drilling-Units-(MODU)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/584/The-Mobile-Offshore-Drilling-Units-(MODU)-Market-2011-2021</guid>
		<category>energy</category>
		<description>Visiongain's latest report The Mobile Offshore Drilling Units (MODU) Market 2011-2021 comprehensively examines one of the most critical segments of the offshore E&amp;P sector. The report provides in-depth analysis and forecasts of the global MODU market, sub-market sectors and the regional markets over the coming ten years. Our thorough research determines global expenditure on MODU construction, leasing, maintenance &amp; upgrades to stand at $48.65bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 10 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Next Generation OSS: Creating New Realities 2011-2016</title>
		<link>http://www.visiongain.com/Report/582/Next-Generation-OSS-Creating-New-Realities-2011-2016</link>
		<guid>http://www.visiongain.com/Report/582/Next-Generation-OSS-Creating-New-Realities-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Next generation OSS (Operation Support Subsystem) is not a standalone solution but is a tightly integrated set of sub functions that together allow operators to maintain and manage their networks effectively and efficiently. These subsystems in turn are integrated with BSS functions, allowing operators to embrace the value discipline of customer intimacy, drive the business from a customer centric perspective and map customer activity to revenues.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 09 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Exploration &amp; Production (E&amp;P) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/583/The-Oil-Gas-Exploration-Production-(E-P)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/583/The-Oil-Gas-Exploration-Production-(E-P)-Market-2011-2021</guid>
		<category>energy</category>
		<description>Soaring oil prices and a perpetually increasing global demand for energy are creating a ripe environment for the oil &amp; gas exploration &amp; production E&amp;P industry to increase its spending. Historically the E&amp;P market has experienced relative underinvestment, but as growing global energy demand puts pressure on supply capacity, new capital will be needed to find more oil &amp; gas, and to boost production. With the oil price once again at a high price, oil company revenues are increasing and the rewards of investing in E&amp;P are lucrative. Through our thorough research and analysis of company expenditure, major projects and expert insight into the market, visiongain has calculated the oil &amp; gas exploration &amp; production market to be worth $434.3bn in 2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 09 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Warships &amp; Naval Vessels Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/580/The-Warships-Naval-Vessels-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/580/The-Warships-Naval-Vessels-Market-2011-2021</guid>
		<category>defence</category>
		<description>Our new defence report The Warships &amp; Naval Vessels Market 2011-2021 reviews major programmes related to combatant vessels, non-combatant vessels and submarines. The report examines the market for new vessels, refurbishment of old vessels and research and development of future naval platforms. The report reviews leading naval procurement and re-fit programmes and examines the prospects and outlook for government spending on warships and naval vessels. Visiongain calculates that in 2011 the global market for warships and naval vessels will amount to $75.4bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 03 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Statins: World Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/581/Statins-World-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/581/Statins-World-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>What does the future hold for the statins industry and market? Our new report shows how the patent expiry of Lipitor and others will affect statin drug revenues from 2011 onwards. 
In 2009 the world statins market generated over $27bn in revenues. We show the organisations, products and activities that will shape the statins industry and market this decade. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 03 Mar 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Leading Anti-Cancer Drugs: World Market Prospects 2011-2021</title>
		<link>http://www.visiongain.com/Report/578/Leading-Anti-Cancer-Drugs-World-Market-Prospects-2011-2021</link>
		<guid>http://www.visiongain.com/Report/578/Leading-Anti-Cancer-Drugs-World-Market-Prospects-2011-2021</guid>
		<category>pharma</category>
		<description>What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. Anti-cancer drug sales exceeded $50bn worldwide in 2009, with impressive growth. Our report shows you where cancer therapies are heading from 2011 to 2021 - technology, competition and revenues.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 25 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Pipelines Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/579/The-Oil-Gas-Pipelines-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/579/The-Oil-Gas-Pipelines-Market-2011-2021</guid>
		<category>energy</category>
		<description>Visiongain's new energy report The Oil &amp; Gas Pipeline Markets 2011-2021 analyses all aspects of the oil &amp; gas pipelines industry, which is crucial for the distribution and transport of oil &amp; gas. The report analyses developments in the industry over the last year, detailing over 85 major pipelines in 30 countries. Visiongain's detailed research calculates that global capital expenditure on oil &amp; gas pipelines will reach $57.5bn in 2011 and the report projects the future developments within the industry over the forecast period 2011-2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 25 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Carrier Ethernet Report 2011-2016</title>
		<link>http://www.visiongain.com/Report/576/Carrier-Ethernet-Report-2011-2016</link>
		<guid>http://www.visiongain.com/Report/576/Carrier-Ethernet-Report-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Carrier Ethernet is currently in the growth stage of its lifecycle and as one of the few sectors of the telecoms industry that saw positive growth during the recession it is clear the Ethernet services, products, solutions and equipment are set to see substantial grow between 2011 and 2016 with revenues in the US growing at CAGR 28%.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 24 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Billing Evolution 2011-2016</title>
		<link>http://www.visiongain.com/Report/577/Mobile-Billing-Evolution-2011-2016</link>
		<guid>http://www.visiongain.com/Report/577/Mobile-Billing-Evolution-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Our latest report Mobile Billing Evolution 2011-2016 offers a comprehensive analysis of the global billing markets with regional breakdown. It also analyses the leading vendors and service providers who are using new mobile billing solutions to increase their market dominance.
Visiongain research shows that current market worth of the global mobile telecoms billing market is $6.75 billion in Q1 2011, but that strong, sustained growth in this market over the five years to 2016 will see the market transformed.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 24 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Anti-Obesity Drug Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/575/World-Anti-Obesity-Drug-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/575/World-Anti-Obesity-Drug-Market-2011-2021</guid>
		<category>pharma</category>
		<description>What will this decade hold for the challenged anti-obesity drug industry and market? Our new report gives you revenue forecasts at world, product and national level. How will the regulatory and marketing difficulties facing anti-obesity drugs affect companies and their revenues? In our report you will see prospects for obesity drug research, development, launches and marketing from 2011 onwards. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 21 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Active, Intelligent and Smart Food &amp; Drink Packaging Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/574/The-Active-Intelligent-and-Smart-Food-Drink-Packaging-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/574/The-Active-Intelligent-and-Smart-Food-Drink-Packaging-Market-2011-2021</guid>
		<category>packaging</category>
		<description>This brand new materials report analyses the evolving industry trends occurring in the active, intelligent and smart food &amp; drink packaging and anticipates the progression in the market over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the active, intelligent and smart food &amp; drink packaging market will reach $11.7bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 18 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Biological Drugs Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/573/World-Biological-Drugs-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/573/World-Biological-Drugs-Market-2011-2021</guid>
		<category>pharma</category>
		<description>Do you want to find market prospects for products and companies in the biological drugs industry? Our new report shows you biopharma revenue forecasts for 2011 to 2021. What revenues will biopharmaceutical markets achieve from 2011 to 2021? What gains can leading companies achieve? What sales trends will national markets - developed and developing - show?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 09 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Influenza Vaccines Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/572/World-Influenza-Vaccines-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/572/World-Influenza-Vaccines-Market-2011-2021</guid>
		<category>pharma</category>
		<description>Are you looking for influenza vaccine market data - answers to benefit your work? Our new report shows you revenue prospects for the manufacture and sale of influenza vaccines from 2009 to 2021. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 07 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Infrastructure Security Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/571/The-Oil-Gas-Infrastructure-Security-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/571/The-Oil-Gas-Infrastructure-Security-Market-2011-2021</guid>
		<category>energy</category>
		<description>Visiongain's brand new energy report The Oil &amp; Gas Infrastructure Security Market 2011-2021 provides in-depth analysis of a sector critical to the stability of the global economy. The report forecasts the global market, sub-market sectors and the top 10 national markets over the coming ten years. Our thorough research determines global expenditure on oil &amp; gas infrastructure security to stand at $27.2bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 04 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Helicopter Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/570/The-Military-Helicopter-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/570/The-Military-Helicopter-Market-2011-2021</guid>
		<category>defence</category>
		<description>The military helicopter market is a critically important sector of the defence industry. While not totally immune to defence budget cuts, military helicopters have proven to be largely resilient even as many countries are reviewing overall defence spending. Military helicopters also figure prominently in the modernisation programmes of countries that do have fast-growing economies to support increased defence spending. This visiongain defence report will be valuable to those involved in the military helicopter market or who wish to take part in it in the future.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 01 Feb 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The CBRN Defence Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/569/The-CBRN-Defence-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/569/The-CBRN-Defence-Market-2011-2021</guid>
		<category>defence</category>
		<description>Our latest defence report - The CBRN Defence Market 2011-2021 - assesses the continually growing business opportunities presented by one of the most significant markets in the global defence and security world. Our study examines the 12 leading national markets for chemical, biological, radiological and nuclear (CBRN) defence products and services by sales, as well as assessing the factors that are driving sales growth around the world. Our analysis has concluded that worldwide government spending on CBRN defence products and services will reach $8.38bn in 2011.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 31 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Plastic Packaging Market 2011-2021: Rigid and Flexible (Converted)</title>
		<link>http://www.visiongain.com/Report/566/The-Plastic-Packaging-Market-2011-2021-Rigid-and-Flexible-(Converted)</link>
		<guid>http://www.visiongain.com/Report/566/The-Plastic-Packaging-Market-2011-2021-Rigid-and-Flexible-(Converted)</guid>
		<category>plastics</category>
		<description>The Plastic Packaging Market 2011-2021: Rigid and Flexible (Converted) is our brand new report investigating the materials industry. The report analyses industry and consumer trends prevailing in the global plastic packaging industry and forecasts their market impact over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, revealing the market's strengths and weaknesses with targeted forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 28 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Plastic Packaging Market 2011-2021: Rigid and Flexible (Converted)</title>
		<link>http://www.visiongain.com/Report/567/The-Plastic-Packaging-Market-2011-2021-Rigid-and-Flexible-(Converted)</link>
		<guid>http://www.visiongain.com/Report/567/The-Plastic-Packaging-Market-2011-2021-Rigid-and-Flexible-(Converted)</guid>
		<category>packaging</category>
		<description>The Plastic Packaging Market 2011-2021: Rigid and Flexible (Converted) is our brand new report investigating the materials industry. The report analyses industry and consumer trends prevailing in the global plastic packaging industry and forecasts their market impact over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, revealing the market's strengths and weaknesses with targeted forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 28 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Floating Liquefied Natural Gas (FLNG) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/568/The-Floating-Liquefied-Natural-Gas-(FLNG)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/568/The-Floating-Liquefied-Natural-Gas-(FLNG)-Market-2011-2021</guid>
		<category>energy</category>
		<description>Visiongain's latest report, The Floating Liquefied Natural Gas (FLNG) Market 2011-2021, takes a thorough look into this rapidly emerging sector considering potential market drivers and restraints over the next ten years. Visiongain has calculated the 2010 global FLNG market to be worth $492m as it struggled through the restrained spending of the post-recessionary period. This new report explains how the market will develop into a multi-billion dollar sector, revealing developments through global, regional and country specific forecasts and analysis. Prospects for both floating regasification and liquefaction are analysed over the ten year forecast period.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 28 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The C2/C4ISR Systems Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/565/The-C2-C4ISR-Systems-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/565/The-C2-C4ISR-Systems-Market-2011-2021</guid>
		<category>defence</category>
		<description>The C2/C4ISR Systems Market 2011-2021 is our brand new defence report. It reviews major programmes related to C2/C4ISR systems (command and control/command, control, communications, computers, intelligence, surveillance and reconnaissance) C2/C4ISR. Visiongain calculates that in 2011 the global market for C2/C4ISR systems will amount to $70.3bn which constitutes 5% of global defence spending.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 21 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Augmented Reality 2011-2016</title>
		<link>http://www.visiongain.com/Report/564/Mobile-Augmented-Reality-2011-2016</link>
		<guid>http://www.visiongain.com/Report/564/Mobile-Augmented-Reality-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile Augmented Reality in 2011 is a market sector on the verge of commercial boom. While the proposed technology has been in discussion for many years, previous attempts at realising the potential of this interactive data-rich environment have been hindered by the technological advancement of the smartphone market and by narrowband mobile Internet.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 20 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Cell-Based Assays: World Market Prospects 2011-2026</title>
		<link>http://www.visiongain.com/Report/562/Cell-Based-Assays-World-Market-Prospects-2011-2026</link>
		<guid>http://www.visiongain.com/Report/562/Cell-Based-Assays-World-Market-Prospects-2011-2026</guid>
		<category>pharma</category>
		<description>Are you looking for pharmaceutical R&amp;D market data - answers to save you time and effort, aiding decisions? Our new report shows you spending trends and revenue prospects for cell-based assays in pharma. We give market data for 2009 to 2026. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 19 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Broadband 2011-2016</title>
		<link>http://www.visiongain.com/Report/563/Mobile-Broadband-2011-2016</link>
		<guid>http://www.visiongain.com/Report/563/Mobile-Broadband-2011-2016</guid>
		<category>telecoms &amp; IT</category>
		<description>This is an up to date and concise report on Mobile Broadband with statistics dating from 2008 up to 2011, and projections and forecasts up to 2016. The report deals with the current popularity and demand of the technology as well as giving a breakdown of reasons why it is popular now, and reasons it will be popular in the immediate future.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 19 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Cyberwarfare Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/561/The-Cyberwarfare-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/561/The-Cyberwarfare-Market-2011-2021</guid>
		<category>defence</category>
		<description>Cyberwarfare is the current single greatest emerging threat to national security. In 2010, nations worldwide placed cyberwar at the forefront of their defence planning, and provision of government cyber solutions is the single greatest growth market in the defence and security sector. Based on Visiongain's research, global spending in 2011 on cyberwarfare will reach $12.5bn. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 17 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Field Machinery Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/560/The-Oil-Gas-Field-Machinery-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/560/The-Oil-Gas-Field-Machinery-Market-2011-2021</guid>
		<category>energy</category>
		<description>Our new energy report, The Oil &amp; Gas Field Machinery Market 2011-2021, evaluates a prosperous sector crucial to the global supply of energy. The report analyses and forecasts the growth of the market over the next ten years, highlighting the countries and subsectors with strong growth prospects within the market. Our thorough research determines global expenditure on oil &amp;gas field machinery to be $120.6bn in 2011. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 13 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Antibacterial Drugs: Commercial Prospects 2011-2026</title>
		<link>http://www.visiongain.com/Report/559/Antibacterial-Drugs-Commercial-Prospects-2011-2026</link>
		<guid>http://www.visiongain.com/Report/559/Antibacterial-Drugs-Commercial-Prospects-2011-2026</guid>
		<category>pharma</category>
		<description>What revenues will the world antibacterial drug market yield from 2011 to 2026? What will be the revenue prospects for leading antibacterial products? What will be the sales trends for leading national markets, developed and developing?
Our report answers those questions and others. You will find original sales forecasts for 2010 to 2026.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 12 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Aluminium Market Analysis, Financials and Forecasting 2011-2016</title>
		<link>http://www.visiongain.com/Report/558/The-Aluminium-Market-Analysis-Financials-and-Forecasting-2011-2016</link>
		<guid>http://www.visiongain.com/Report/558/The-Aluminium-Market-Analysis-Financials-and-Forecasting-2011-2016</guid>
		<category>metals</category>
		<description>Our latest materials report The Aluminium Market Analysis, Financials and Forecasting 2011-2016 analyses this dynamic commodity and reveals prevailing trends and anticipates the progression in the global aluminium industry over the next five years. The report also surveys recent market trends among major companies and reveals where and why the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the aluminium industry will reach $99.9bn in 2011 and will shortly break the $100bn barrier.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 10 Jan 2011 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Carbon Capture and Storage/Sequestration (CCS) Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/557/The-Carbon-Capture-and-Storage-Sequestration-(CCS)-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/557/The-Carbon-Capture-and-Storage-Sequestration-(CCS)-Market-2011-2021</guid>
		<category>energy</category>
		<description>Our brand new energy report outlines trends in the Carbon Capture and Storage / Sequestration (CCS) industry and anticipates the direction of the market over the next decade, outlining the strengths and weaknesses of different markets with targeted sales forecasts. Based on our research, global spending in 2010 on new CCS infrastructure will total $11.9bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 17 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Unified Communications Market 2010-2015</title>
		<link>http://www.visiongain.com/Report/556/The-Unified-Communications-Market-2010-2015</link>
		<guid>http://www.visiongain.com/Report/556/The-Unified-Communications-Market-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Unified Communications (UC) is the total integration of real-time communication services such as instant messaging (chat), presence information, telephony (including IP telephony), video conferencing, call control and speech recognition with non-real-time communication services such as unified messaging (integrated voicemail, e-mail, SMS and fax). UC has been one of the most hyped ICT developments of the last few years, due to newly enabling technologies such as a maturing smartphone market and increased mobile broadband coverage, but will sector revenues live up to this hype?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 14 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>CNS Clinical Trials: World Market Prospects 2011-2026</title>
		<link>http://www.visiongain.com/Report/555/CNS-Clinical-Trials-World-Market-Prospects-2011-2026</link>
		<guid>http://www.visiongain.com/Report/555/CNS-Clinical-Trials-World-Market-Prospects-2011-2026</guid>
		<category>pharma</category>
		<description>How will the CNS clinical trials sector develop from 2010, and where can you find the greatest opportunities there? Our new report shows you prospects for revenue growth worldwide, with contract research providers and sponsors of CNS clinical trials analysed. Investment in R&amp;D for central nervous system disorders comes second only to that of oncology. We show how you could make gains in the CNS sector, especially for treating neurological disorders. You can assess the potential of the industry and market now.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 13 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile 2.0 2010-2015</title>
		<link>http://www.visiongain.com/Report/554/Mobile-2-0-2010-2015</link>
		<guid>http://www.visiongain.com/Report/554/Mobile-2-0-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Social media and Mobile apps are two of the most talked about phenomena of recent times, and yet they are only a small part of what makes up Mobile 2.0. The landscape of wireless communications is changing rapidly and so are the ways in which we communicate with each other. Mobile 2.0 is at the heart of this change. This report offers an insight into what constitutes Mobile 2.0 today and what it will lead to in the future.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Remotely Operated Vehicles (ROV) and Autonomous Underwater Vehicles (AUV) in the Energy Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/553/Remotely-Operated-Vehicles-(ROV)-and-Autonomous-Underwater-Vehicles-(AUV)-in-the-Energy-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/553/Remotely-Operated-Vehicles-(ROV)-and-Autonomous-Underwater-Vehicles-(AUV)-in-the-Energy-Market-2011-2021</guid>
		<category>energy</category>
		<description>Our latest energy report - Remotely Operated Vehicles (ROV) and Autonomous Underwater Vehicles (AUV) in the Energy Market 2011-2021 - examines in depth one of the most powerful and exciting areas in the offshore oil and gas industry; an industry which is seeing a profound movement towards deep sea development. ROVs and AUVs are a vital component of subsea work, especially where great depths and extreme environments create challenging conditions. Based on our research, the global ROV and AUV market in the energy sector was worth $1.27bn in 2010. We analyse, quantify and forecast the expected growth in the global and regional ROV and AUV markets over the period 2011-2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 07 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Shutdown, Turnaround and Outage (STO) Services Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/552/The-Oil-Gas-Shutdown-Turnaround-and-Outage-(STO)-Services-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/552/The-Oil-Gas-Shutdown-Turnaround-and-Outage-(STO)-Services-Market-2011-2021</guid>
		<category>energy</category>
		<description>This brand new energy report from Visiongain analyses the increasingly critical shutdown, turnaround and outage (STO) services market in depth, with key trends discussed and market forecasts from 2011-2021. Based on our research, global spending in 2011 on oil &amp; gas STO services will total $13.17bn. We analyse, quantify and forecast the expected spending in the global STO services market over the period 2011-2021. These forecasts are underpinned by Visiongain's oil &amp; gas price forecasts and analysis of oil &amp; gas demand.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 06 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>US Pharmaceutical Market Outlook 2011-2021</title>
		<link>http://www.visiongain.com/Report/551/US-Pharmaceutical-Market-Outlook-2011-2021</link>
		<guid>http://www.visiongain.com/Report/551/US-Pharmaceutical-Market-Outlook-2011-2021</guid>
		<category>pharma</category>
		<description>Do you want to know the effects of the Obama government's legislation for US healthcare? Insurance coverage will be extended, expanding the pharma market. But at what price to the pharmaceutical industry in rebates and other costs? Will the healthcare reforms underwrite another decade of growth in the US pharma market, or has it reached its limits?
US Pharmaceutical Market Outlook 2011-2021 answers those questions with a deep, wide-ranging survey of the market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 03 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Soldier Modernisation Market 2011-2021</title>
		<link>http://www.visiongain.com/Report/550/The-Soldier-Modernisation-Market-2011-2021</link>
		<guid>http://www.visiongain.com/Report/550/The-Soldier-Modernisation-Market-2011-2021</guid>
		<category>defence</category>
		<description>The Soldier Modernisation Market 2011-2021 is our new defence report. It reviews major programmes related to all aspects of soldier modernisation - examining the market for command, control, communications, computers and intelligence (C4I), lethality, sustainability, survivability and mobility equipment and technology.
The Soldier Modernisation Market 2011-2021 reviews leading soldier modernisation programmes and examines the prospects and outlook for government spending on such projects. The report reviews the state of the market in 2010 and projects future prospects for the market in the forecast period of 2011-2021.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 02 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Border Security Market 2010-2020: UAVs, UGVs &amp; Perimeter Surveillance Systems</title>
		<link>http://www.visiongain.com/Report/549/The-Border-Security-Market-2010-2020-UAVs-UGVs-Perimeter-Surveillance-Systems</link>
		<guid>http://www.visiongain.com/Report/549/The-Border-Security-Market-2010-2020-UAVs-UGVs-Perimeter-Surveillance-Systems</guid>
		<category>defence</category>
		<description>Our latest defence report - The Border Security Market 2010-2020: UAVs, UGVs &amp; Perimeter Surveillance Systems - assesses the business opportunities presented by one of the most exciting emerging markets within the global defence and security marketplace. Our study examines the regional markets and submarkets for border security products and services, as well as assessing the factors that are driving sales growth around the world. Our analysis has concluded that worldwide spending on border security products and services will reach $15.8bn in 2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 01 Dec 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>IMS 2010 Report: Critical Success Factors</title>
		<link>http://www.visiongain.com/Report/548/IMS-2010-Report-Critical-Success-Factors</link>
		<guid>http://www.visiongain.com/Report/548/IMS-2010-Report-Critical-Success-Factors</guid>
		<category>telecoms &amp; IT</category>
		<description>IMS (The IP Multimedia Subsystem) is the cornerstone technology for next generation networks. It offers a robust infrastructure for developing and deploying multiple network services and data from a common core across different access networks and for evolving from circuit-switched networks towards all IP networks.IMS remains the technology of choice for fixed and hybrid operators whose legacy network resources are near or full depreciation.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 30 Nov 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Stability Testing: Commercial Prospects 2011-2025</title>
		<link>http://www.visiongain.com/Report/547/Pharmaceutical-Stability-Testing-Commercial-Prospects-2011-2025</link>
		<guid>http://www.visiongain.com/Report/547/Pharmaceutical-Stability-Testing-Commercial-Prospects-2011-2025</guid>
		<category>pharma</category>
		<description>Pharmaceutical stability testing (PST) is an important component of drug development and manufacturing. This market constitutes one of the fastest growing sectors in the pharmaceutical and biotech sectors, with estimated revenues of $0.95bn (for technology and services) in 2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 24 Nov 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Electro Optical Infrared (EO/IR) Systems Market 2010-2020: Airborne, Ground and Naval</title>
		<link>http://www.visiongain.com/Report/546/The-Military-Electro-Optical-Infrared-(EO-IR)-Systems-Market-2010-2020-Airborne-Ground-and-Naval</link>
		<guid>http://www.visiongain.com/Report/546/The-Military-Electro-Optical-Infrared-(EO-IR)-Systems-Market-2010-2020-Airborne-Ground-and-Naval</guid>
		<category>defence</category>
		<description>This analytical defence report defines the current state of the military electro-optical infrared (EO/IR) systems market and discusses its potential for growth from 2010 onwards, with market forecasting at the global and national levels. Based on our research, global government spending in 2010 on military electro-optical infrared (EO/IR) systems will total $6.9bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 19 Nov 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Customer Segmentation &amp; Intelligence 2010-2015</title>
		<link>http://www.visiongain.com/Report/545/Customer-Segmentation-Intelligence-2010-2015</link>
		<guid>http://www.visiongain.com/Report/545/Customer-Segmentation-Intelligence-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>The recent financial downturn had a major impact on the telecommunications industry. With churn rates on the rise and ARPU figures on the decline what do operators and manufacturers need to do to maximise revenues and retain subscribers?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 17 Nov 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Cloud Computing 2010-2015</title>
		<link>http://www.visiongain.com/Report/544/Cloud-Computing-2010-2015</link>
		<guid>http://www.visiongain.com/Report/544/Cloud-Computing-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Cloud computing is in a period of realisation from speculation and hype to widespread adoption by the ICT community.
Visiongain's new report studies the wide ranging questions frequently asked by the IT and communications industries and examines the disciplines required to implement enterprise and commercial cloud computing solutions. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 12 Nov 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Dermatological Drugs: World Market 2011-2026</title>
		<link>http://www.visiongain.com/Report/543/Dermatological-Drugs-World-Market-2011-2026</link>
		<guid>http://www.visiongain.com/Report/543/Dermatological-Drugs-World-Market-2011-2026</guid>
		<category>pharma</category>
		<description>Dermatological drugs form an important segment of the global pharma market, with sales of over $25bn in 2009. New drugs with improved safety and efficacy can gain significant market shares in the future, our study reveals.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 10 Nov 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oilfield Chemicals Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/542/The-Oilfield-Chemicals-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/542/The-Oilfield-Chemicals-Market-2010-2020</guid>
		<category>energy</category>
		<description>The Oilfield Chemicals Market 2010-2020 is our latest energy report which examines the flourishing market for oilfield chemicals which allow increasingly difficult oil reserves to be extracted more efficiently and economically. The report explores trends in the market for oilfield chemicals and anticipates the direction of the market over the next decade, outlining the strengths and weaknesses of different markets with targeted sales forecasts. Based on our research, global spending in 2010 on oilfield chemicals will total $16.8bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 09 Nov 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Neurodegenerative Diseases: World Drug Market 2011-2026</title>
		<link>http://www.visiongain.com/Report/541/Neurodegenerative-Diseases-World-Drug-Market-2011-2026</link>
		<guid>http://www.visiongain.com/Report/541/Neurodegenerative-Diseases-World-Drug-Market-2011-2026</guid>
		<category>pharma</category>
		<description>Would you like to know how the industry and market for neurodegenerative drug treatments will develop? There will be trends to watch from 2010 onwards, especially areas of revenue growth. You can have our new report now, staying ahead, saving time and aiding your decisions.
The number of patients may quadruple worldwide by 2050. Yet, there remain significant unmet needs in all sectors of the neurodegenerative treatments market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 02 Nov 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Drilling Products and Services Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/538/The-Oil-Gas-Drilling-Products-and-Services-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/538/The-Oil-Gas-Drilling-Products-and-Services-Market-2010-2020</guid>
		<category>energy</category>
		<description>Our latest energy report, The Oil &amp; Gas Drilling Products and Services Market 2010-2020 analyses the dynamic and constantly evolving oil &amp; gas drilling products and services sector and anticipates the direction of the market over the next decade, outlining the key trends with targeted global and regional sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 25 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Radar Systems Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/539/The-Military-Radar-Systems-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/539/The-Military-Radar-Systems-Market-2010-2020</guid>
		<category>defence</category>
		<description>Our brand new defence report, The Military Radar Systems Market 2010-2020 examines the market for radar systems across all of the services - Airborne, Ground-Based, Naval and Space-Based. The report reviews leading radar programmes and examines the prospects and outlook for national government spending on radar systems. The report reviews the state of the market in 2009 and projects the future prospects for the market over the forecast period of 2010-2020 revealing opportunities for companies engaged in the production of radar systems. Visiongain calculates that in 2010 the global market for military radar systems will amount to $9,248m.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 25 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Paper Packaging Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/540/The-Paper-Packaging-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/540/The-Paper-Packaging-Market-2010-2020</guid>
		<category>packaging</category>
		<description>Visiongain's new materials report, The Paper Packaging Market 2010-2020 examines the industry trends prevailing in the global paper packaging industry and forecasts the development in the market over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the paper packaging market will be $228.3bn in 2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Paper Packaging Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/537/The-Paper-Packaging-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/537/The-Paper-Packaging-Market-2010-2020</guid>
		<category>paper</category>
		<description>Visiongain's new materials report, The Paper Packaging Market 2010-2020 examines the industry trends prevailing in the global paper packaging industry and forecasts the development in the market over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts. Visiongain's analysis has concluded that the global value of the paper packaging market will be $228.3bn in 2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Chinese Pharmaceutical Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/536/Chinese-Pharmaceutical-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/536/Chinese-Pharmaceutical-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Our new report will show you how the Chinese pharma market will develop from 2010. We provide forecasts for the main therapeutic areas in the Chinese prescription drug market, as well as giving coverage of OTC medicines. You will find revenues for generic and original-branded medicines from 2009 to 2025. Our report also discusses companies in the sector - domestic and foreign - assessing their prospects.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 14 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Counter-IED Market 2010-2020: Systems and Technologies for Force Protection</title>
		<link>http://www.visiongain.com/Report/534/The-Counter-IED-Market-2010-2020-Systems-and-Technologies-for-Force-Protection</link>
		<guid>http://www.visiongain.com/Report/534/The-Counter-IED-Market-2010-2020-Systems-and-Technologies-for-Force-Protection</guid>
		<category>defence</category>
		<description>Improvised explosive devices (IED) have been brutally effective weapons for insurgents in Iraq and Afghanistan, and increasingly, in other parts of the world. IEDs have been blamed for thousands of deaths of military personnel and also civilians. The US and its allies have responded to the IED threat by spending billions of dollars on vehicles, equipment, personnel and training for counter-IED and explosive ordnance disposal (EOD) missions. This has provided very strong demand in recent years in the counter-IED systems market. Based on visiongain's research, global spending on counter-IED systems amounted to $7.7bn in 2009.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 13 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Prepaid Mobile Market 2010-2015</title>
		<link>http://www.visiongain.com/Report/535/The-Prepaid-Mobile-Market-2010-2015</link>
		<guid>http://www.visiongain.com/Report/535/The-Prepaid-Mobile-Market-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>The recent financial downturn had a major impact on the telecommunications industry, but in no sector was it more profound than in prepaid mobile. With subscriber figures on the rise, what do operators and manufacturers need to do to maximise revenues and retain subscribers?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 13 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military GPS/GNSS Devices Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/533/The-Military-GPS-GNSS-Devices-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/533/The-Military-GPS-GNSS-Devices-Market-2010-2020</guid>
		<category>defence</category>
		<description>This new analytical defence report - The Military GPS/GNSS Devices Market 2010-2020 - assesses the business opportunities presented by one of the most exciting markets in the global defence marketplace. Our study examines the leading national markets for military global positioning system (GPS)/global navigation satellite system (GNSS) devices, as well as assessing the factors that are driving sales growth around the world. Our analysis has concluded that worldwide spending on military GPS/GNSS devices will reach $1.14bn in 2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 12 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Medical Devices: Industry and Market Prospects 2010-2025</title>
		<link>http://www.visiongain.com/Report/532/Medical-Devices-Industry-and-Market-Prospects-2010-2025</link>
		<guid>http://www.visiongain.com/Report/532/Medical-Devices-Industry-and-Market-Prospects-2010-2025</guid>
		<category>pharma</category>
		<description>How will the medical devices sector develop from 2010, and where can you find opportunities? We show you prospects for technological development and revenue growth. You can have our new report today, staying ahead.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 11 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Aircraft Avionics Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/531/The-Military-Aircraft-Avionics-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/531/The-Military-Aircraft-Avionics-Market-2010-2020</guid>
		<category>defence</category>
		<description>Our latest defence report - The Military Aircraft Avionics Market 2010-2020 - reveals the full range of opportunities presented by one of the defence industry's most important markets. Our market study examines leading users of military aircraft avionics systems, and explores the operational requirements which are driving global growth in this sector. We assess the commercial prospects and outlook for companies offering military aircraft avionics systems. Based on our research, global government spending in 2010 on military aircraft avionics systems, across all platforms, will total $12.9bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 07 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Biofuels Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/529/The-Biofuels-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/529/The-Biofuels-Market-2010-2020</guid>
		<category>energy</category>
		<description>The Biofuels Market 2010-2020 is our brand new renewable energy report which outlines trends in the flourishing biofuels industry and anticipates the direction of the market over the next decade, outlining the strengths and weaknesses of different markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 06 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Windows Phone 7: Microsoft's Smartphone Challenge Report 2010</title>
		<link>http://www.visiongain.com/Report/530/Windows-Phone-7-Microsoft's-Smartphone-Challenge-Report-2010</link>
		<guid>http://www.visiongain.com/Report/530/Windows-Phone-7-Microsoft's-Smartphone-Challenge-Report-2010</guid>
		<category>telecoms &amp; IT</category>
		<description>Microsoft is poised to launch its much awaited Mobile OS "Windows Phone 7" during the holiday season of 2010. The company has started over with a rigorous effort to re-invent itself as a consumer-driven mobile OS and application provider.
Amidst these developments, Visiongain brings the latest exclusive report focusing on the re-emergence of Microsoft as a key player in the smartphone market in 2011 and beyond.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 06 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Biofuels Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/667/The-Biofuels-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/667/The-Biofuels-Market-2010-2020</guid>
		<category>renewable energy</category>
		<description>The Biofuels Market 2010-2020 is our brand new renewable energy report which outlines trends in the flourishing biofuels industry and anticipates the direction of the market over the next decade, outlining the strengths and weaknesses of different markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 06 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Drug Delivery Technologies: Commercial Prospects 2010-2025 </title>
		<link>http://www.visiongain.com/Report/528/Drug-Delivery-Technologies-Commercial-Prospects-2010-2025</link>
		<guid>http://www.visiongain.com/Report/528/Drug-Delivery-Technologies-Commercial-Prospects-2010-2025</guid>
		<category>pharma</category>
		<description>How will the drug delivery sector develop from 2010, and where will you find the greatest opportunities? How will technology suppliers and drug companies benefit? We show you opportunities for revenue growth for suppliers and users of drug delivery technologies. You can have our report today, staying ahead.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 05 Oct 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Vaccines Manufacturing Technology and Services: Commercial Prospects 2010-2025 </title>
		<link>http://www.visiongain.com/Report/527/Vaccines-Manufacturing-Technology-and-Services-Commercial-Prospects-2010-2025</link>
		<guid>http://www.visiongain.com/Report/527/Vaccines-Manufacturing-Technology-and-Services-Commercial-Prospects-2010-2025</guid>
		<category>pharma</category>
		<description>Our new report will show you how the industry and market for vaccines manufacturing will develop. You can indentify where the greatest opportunities will lie for human-use vaccines. There will be trends to watch from 2010 onwards, with areas of revenue growth. You can have our report today, staying ahead. Which vaccines manufacturing segments will grow fastest from 2010? What are the commercial trends to watch? How will leading companies perform? We aim to save you time and benefit your work.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 28 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Copper Market Analysis, Financials and Forecasting 2010-2020</title>
		<link>http://www.visiongain.com/Report/526/The-Copper-Market-Analysis-Financials-and-Forecasting-2010-2020</link>
		<guid>http://www.visiongain.com/Report/526/The-Copper-Market-Analysis-Financials-and-Forecasting-2010-2020</guid>
		<category>metals</category>
		<description>The Copper Market Analysis, Financials and Forecasting 2010-2020 is our brand new materials report. Copper is one the key commodities driving our civilisation and is a vital component in every electronic product and our global electrical infrastructure. The report analyses industry trends prevailing in the global copper industry and anticipates the progression in the market over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 24 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Backhaul Strategies for LTE 2010-2015</title>
		<link>http://www.visiongain.com/Report/525/Backhaul-Strategies-for-LTE-2010-2015</link>
		<guid>http://www.visiongain.com/Report/525/Backhaul-Strategies-for-LTE-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain's latest exclusive report on LTE Backhaul examines how the radical increase in demand for rich media content and bandwidth hungry applications has been the main driver in the development of a high capacity, low latency mobile broadband system such as LTE.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 23 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Antithrombotic/Anticoagulant Drugs: World Market Prospects 2010-2025</title>
		<link>http://www.visiongain.com/Report/524/Antithrombotic-Anticoagulant-Drugs-World-Market-Prospects-2010-2025</link>
		<guid>http://www.visiongain.com/Report/524/Antithrombotic-Anticoagulant-Drugs-World-Market-Prospects-2010-2025</guid>
		<category>pharma</category>
		<description>Our new report will show you how the market for antithrombotic and anticoagulant drugs will develop. You can indentify where the greatest opportunities will lie. There will be trends to watch from 2010 onwards, especially product launches and areas of revenue growth. You can have our report today, staying ahead.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 17 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Generic Drug Market Outlook 2010-2025</title>
		<link>http://www.visiongain.com/Report/522/World-Generic-Drug-Market-Outlook-2010-2025</link>
		<guid>http://www.visiongain.com/Report/522/World-Generic-Drug-Market-Outlook-2010-2025</guid>
		<category>pharma</category>
		<description>Our new report will show you revenue prospects for the generic drug market from 2010 onwards. Where will the best growth prospects lie, and which companies will be the biggest winners? We provide revenue trends for 2010 to 2025 and discussions to meet your needs. You can have that report today, staying ahead.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 14 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Electronic Warfare (EW) Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/523/The-Electronic-Warfare-(EW)-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/523/The-Electronic-Warfare-(EW)-Market-2010-2020</guid>
		<category>defence</category>
		<description>Electronic warfare (EW) is a flourishing and dynamic market that is the subject of this unique Visiongain defence report. The evident utility of electronic warfare on the modern battlefield in jamming radars, decoying missiles and gathering electronic intelligence means that militaries are keen to upgrade, or acquire, electronic warfare capabilities. Thorough analysis of government spending, policy and procurement programmes are carried out, with an in-depth examination of the market potential from 2010-2020. Based on Visiongain's research, global government spending in 2010 on electronic warfare will reach $7.72bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 14 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Advanced Oil &amp; Gas Exploration Technologies Market, 2010-2020</title>
		<link>http://www.visiongain.com/Report/520/The-Advanced-Oil-Gas-Exploration-Technologies-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/520/The-Advanced-Oil-Gas-Exploration-Technologies-Market-2010-2020</guid>
		<category>energy</category>
		<description>Our brand new energy report, The Advanced Oil &amp; Gas Exploration Technologies Market, 2010-2020 outlines trends in the advanced exploration industry and anticipates the direction of the market as one of the key components of the upstream oil &amp; gas industry over the next decade, outlining the strengths and weaknesses of different markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmacovigilance and Other Pharma Regulatory Developments 2010-2020</title>
		<link>http://www.visiongain.com/Report/521/Pharmacovigilance-and-Other-Pharma-Regulatory-Developments-2010-2020</link>
		<guid>http://www.visiongain.com/Report/521/Pharmacovigilance-and-Other-Pharma-Regulatory-Developments-2010-2020</guid>
		<category>pharma</category>
		<description>What regulatory demands will pharma companies face from 2010 to 2020? Our new study will show you developments in pharma regulations - pre- and post-marketing - from 2010 onwards. How can regulatory developments help companies in the era of more-personalised medicine? You can have our report today, staying ahead.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Steel Market Analysis, Financials and Forecasting 2010-2020</title>
		<link>http://www.visiongain.com/Report/519/The-Steel-Market-Analysis-Financials-and-Forecasting-2010-2020</link>
		<guid>http://www.visiongain.com/Report/519/The-Steel-Market-Analysis-Financials-and-Forecasting-2010-2020</guid>
		<category>metals</category>
		<description>The Steel Market Analysis, Financials and Forecasting 2010-2020 is our brand new materials report. The report analyses industry trends prevailing in the global steel industry and anticipates the progression in the market over the next decade. The report also surveys recent market trends among major companies and reveals where the market will experience growth, laying out the market's strengths and weaknesses with targeted forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 06 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Smartphone Market 2010-2015</title>
		<link>http://www.visiongain.com/Report/518/The-Smartphone-Market-2010-2015</link>
		<guid>http://www.visiongain.com/Report/518/The-Smartphone-Market-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain's brand new exclusive report on the smartphone market focuses on the recent convergence of a number of factors that have led to a sharp increase in Smartphone adoption rates. The report charts those factors and also forecasts a boom that will see Feature phones replaced by their Smartphone counterparts and projects the profound impact this will have on global mobile communications.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 02 Sep 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Hydropower Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/517/The-Hydropower-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/517/The-Hydropower-Market-2010-2020</guid>
		<category>energy</category>
		<description>The Hydropower Market 2010-2020 is Visiongain's new renewable energy report outlining trends in an industry with a prominent history and an exciting future. The report looks at the direction of the hydropower market over the next decade, outlining the strengths and weaknesses of regional markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 27 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Hydropower Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/668/The-Hydropower-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/668/The-Hydropower-Market-2010-2020</guid>
		<category>renewable energy</category>
		<description>The Hydropower Market 2010-2020 is Visiongain's new renewable energy report outlining trends in an industry with a prominent history and an exciting future. The report looks at the direction of the hydropower market over the next decade, outlining the strengths and weaknesses of regional markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 27 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Contract Manufacturing: Industry and Market Prospects 2010-2025</title>
		<link>http://www.visiongain.com/Report/516/Pharmaceutical-Contract-Manufacturing-Industry-and-Market-Prospects-2010-2025</link>
		<guid>http://www.visiongain.com/Report/516/Pharmaceutical-Contract-Manufacturing-Industry-and-Market-Prospects-2010-2025</guid>
		<category>pharma</category>
		<description>How will the contract manufacturing sector adapt to the needs of pharma from 2010 onwards? Our new report will show you trends and prospects there. How will the sector and its customers face challenges and opportunities? We show commercial benefits for the pharma contract manufacturing sector and its customers, including revenue trends for 2010-2025. You can have that report today, staying ahead.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 26 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Floating Production Storage and Offloading (FPSO) Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/515/The-Floating-Production-Storage-and-Offloading-(FPSO)-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/515/The-Floating-Production-Storage-and-Offloading-(FPSO)-Market-2010-2020</guid>
		<category>energy</category>
		<description>The FPSO sector is a growing market with significant potential for growth and investment in the next ten years. This report outlines the major trends in the FPSO industry and provides a detailed analysis of the strengths and weaknesses of different regions. It provides an in-depth analysis of the market along with targeted regional sales forecast. Our research shows that global spending in 2010 on new FPSOs, company owned FPSOs, leased FPSOs and maintenance contracts will amount to $5.5bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 23 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Simulation and Virtual Training Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/514/The-Military-Simulation-and-Virtual-Training-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/514/The-Military-Simulation-and-Virtual-Training-Market-2010-2020</guid>
		<category>defence</category>
		<description>This authoritative Visiongain defence report analyses the rapidly growing military simulation and virtual training market, exploring in detail its potential from 2010-2020. Armed forces worldwide are rapidly embracing military simulation and virtual training as a critical tool for enhancing training capacity, increasing training capability and in the process reducing training costs compared to 'live' training. Based on Visiongain's research, global spending in 2009 on military simulation and virtual training reached $8.4bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 20 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biobanking for Medical R&amp;D: Technology and Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/513/Biobanking-for-Medical-R-D-Technology-and-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/513/Biobanking-for-Medical-R-D-Technology-and-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Biobanking for Medical R&amp;D: Technology and Market 2010-2025 reveals the opportunities and challenges the biobanking sector will face. These include consolidation and harmonisation of biobanking practices. Advances in genetic research, stem cell research and regenerative medicine increase the importance of biobanking, as well as its commercial potential.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Gaming on Smartphones 2010-2015</title>
		<link>http://www.visiongain.com/Report/512/Gaming-on-Smartphones-2010-2015</link>
		<guid>http://www.visiongain.com/Report/512/Gaming-on-Smartphones-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain's latest exclusive report examines how Smartphone adoption rates are on the rise, due to Apple's iPhone and the recent influx of app stores. Mobile Applications are at the heart of this new trend.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 18 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Airborne ISR Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/511/The-Airborne-ISR-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/511/The-Airborne-ISR-Market-2010-2020</guid>
		<category>defence</category>
		<description>Airborne intelligence, surveillance and reconnaissance (ISR) is key to military operations and armed forces worldwide have placed great emphasis on this capability. This new Visiongain defence report examines recent trends and forecasts future possibilities in this steadily growing and critically important defence sector. As such, countries are expected to continue making airborne ISR a priority. Based on Visiongain's research, global spending on airborne ISR amounted to about $17.7bn in 2009.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 17 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Unmanned Ground Vehicles (UGV) Market 2010-2020: Military Robots for EOD &amp; Counter-IED</title>
		<link>http://www.visiongain.com/Report/510/The-Unmanned-Ground-Vehicles-(UGV)-Market-2010-2020-Military-Robots-for-EOD-Counter-IED</link>
		<guid>http://www.visiongain.com/Report/510/The-Unmanned-Ground-Vehicles-(UGV)-Market-2010-2020-Military-Robots-for-EOD-Counter-IED</guid>
		<category>defence</category>
		<description>Our latest defence report - The Unmanned Ground Vehicles (UGV) Market 2010-2020: Military Robots for EOD &amp; Counter-IED - examines the range of business opportunities presented by one of the most exciting sectors in the global defence marketplace. Our study examines the leading national markets for UGVs, as well as assessing the factors that are driving sales growth around the world. Our analysis has concluded that worldwide spending on UGVs will reach $418m in 2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 05 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Location based advertising 2010-2015</title>
		<link>http://www.visiongain.com/Report/509/Location-based-advertising-2010-2015</link>
		<guid>http://www.visiongain.com/Report/509/Location-based-advertising-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain's latest exclusive report on location based advertising examines how the location-based services market has experienced huge growth over the past two years and how the potential for the next five years is immense in the LBA sector.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 04 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Therapeutic Monoclonal Antibodies: World Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/508/Therapeutic-Monoclonal-Antibodies-World-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/508/Therapeutic-Monoclonal-Antibodies-World-Market-2010-2025</guid>
		<category>pharma</category>
		<description>In 2009, the therapeutic monoclonal antibodies market generated total revenues of over $35bn worldwide. From 2010 onwards, this sector will benefit from new drugs and expanding indications for existing products, our latest study shows. New technologies will be an important driver of revenue growth. Intensive R&amp;D activity is producing a strong R&amp;D pipeline, filled with novel monoclonal antibodies, antibody fragments and antibody-drug conjugates. We expect significant opportunities for further commercial growth, as discussed in our latest report.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 03 Aug 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Homeland Security Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/506/The-Homeland-Security-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/506/The-Homeland-Security-Market-2010-2020</guid>
		<category>defence</category>
		<description>Homeland Security is a vast and dynamic market that is the subject of this extensive Visiongain defence report. Thorough analysis of government spending, policy and procurement programmes are carried out, with an in-depth examination of the market potential from 2010-2020. The ever-present and continually-evolving threats to homeland security necessitate a commensurate technologically-based effort to combat such activities as terrorism, cyber attack, piracy and natural disasters. Based on visiongain research, global government spending in 2010 on homeland security will reach $178.2bn. Over the forecast period of 2010-2020, the cumulative homeland security market will total nearly $2.7 trillion.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 27 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Prospects for Pharma Mergers, Acquisitions and Alliances 2010-2020</title>
		<link>http://www.visiongain.com/Report/502/Prospects-for-Pharma-Mergers-Acquisitions-and-Alliances-2010-2020</link>
		<guid>http://www.visiongain.com/Report/502/Prospects-for-Pharma-Mergers-Acquisitions-and-Alliances-2010-2020</guid>
		<category>pharma</category>
		<description>Last year was important for pharmaceutical mergers and acquisitions, with total deal values in 2009 reaching almost $150bn. Driving this activity were three 'mega-mergers' at the heart of the industry, as Pfizer took over Wyeth, Roche bought the remaining shares in Genentech, and Merck &amp; Co acquired Schering-Plough. Those historic deals signal the continued importance of mergers and acquisitions (M&amp;A) as a strategy among pharma companies, with associated benefits and challenges. The importance of consolidation and alliances will increase from 2010 onwards, as companies adapt to changing conditions within the industry and market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 23 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile ID Fraud 2010</title>
		<link>http://www.visiongain.com/Report/503/Mobile-ID-Fraud-2010</link>
		<guid>http://www.visiongain.com/Report/503/Mobile-ID-Fraud-2010</guid>
		<category>telecoms &amp; IT</category>
		<description>Identity theft and fraud has gained a foothold on the fixed internet as well as areas of hard copy information. Visiongain believes that this will migrate onto the mobile platform.
Key players in the mobile industry involved in mobile content, the mobile web and protecting mobile subscribers need to gain a thorough understanding of a crime that is continuously evolving and will migrate onto the mobile platform. The mobile phone has become intrinsically linked with the mobile web and as such has heightened the security risks associated with identity fraud.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 23 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Electric Power Transmission and Distribution (T&amp;D) Equipment Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/501/The-Electric-Power-Transmission-and-Distribution-(T-D)-Equipment-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/501/The-Electric-Power-Transmission-and-Distribution-(T-D)-Equipment-Market-2010-2020</guid>
		<category>energy</category>
		<description>Visiongain's brand new energy report - The Electric Power Transmission and Distribution (T&amp;D) Equipment Market 2010-2020 analyses the growth of the transmission and distribution (T&amp;D) industry which remains one of the most important sectors in the energy market.
The T&amp;D sector is a thriving market with significant potential for growth and investment over the next ten years. This report outlines the major trends in the T&amp;D industry and provides a detailed analysis of the strengths and weaknesses of the market in different regions.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 21 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Android and Apple Mobile Ecosystem 2010</title>
		<link>http://www.visiongain.com/Report/499/The-Android-and-Apple-Mobile-Ecosystem-2010</link>
		<guid>http://www.visiongain.com/Report/499/The-Android-and-Apple-Mobile-Ecosystem-2010</guid>
		<category>telecoms &amp; IT</category>
		<description>The latest visiongain report, The Android and Apple Mobile Ecosystem 2010, provides an insight into the development of the mobile ecosystem around the Android and the Apple mobile OS standards to date.
The report looks at the reasons behind the creation of the ecosystem, including the improved User Interface of the new generation of smartphones, the introduction of new high speed mobile networks and the emergence of bundled and flat rate pricing with handset subsidies - in return for long term Pay Monthly contracts - in developed markets.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 15 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global OTC Pharmaceutical Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/500/The-Global-OTC-Pharmaceutical-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/500/The-Global-OTC-Pharmaceutical-Market-2010-2025</guid>
		<category>pharma</category>
		<description>In 2009, the global over-the-counter (OTC) pharmaceutical market generated revenues of more than $60bn. Our analyses show that total OTC revenues will exceed $70bn by 2015. From 2010 onwards, Rx-to-OTC switching and the continuing importance of emerging healthcare markets will drive sales in this sector. Our forecasts reveal that the OTC pharma market will grow significantly from 2010 onwards. This report explains where future OTC switching and other developments will occur, providing you with the information that you need to understand the current OTC market and its future prospects.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 15 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Biodegradable Plastic Packaging Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/498/The-Global-Biodegradable-Plastic-Packaging-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/498/The-Global-Biodegradable-Plastic-Packaging-Market-2010-2020</guid>
		<category>plastics</category>
		<description>Our latest materials report - The Global Biodegradable Plastic Packaging Market 2010-2020 - analyses recent trends in the biodegradable plastic packaging industry and anticipates the development of the market over the next decade with global, regional and submarket forecasts. The report also surveys current trends and reveals the market’s strengths and weaknesses revealing areas that will experience growth and present new business opportunities.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 14 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Biodegradable Plastic Packaging Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/505/The-Global-Biodegradable-Plastic-Packaging-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/505/The-Global-Biodegradable-Plastic-Packaging-Market-2010-2020</guid>
		<category>packaging</category>
		<description>Our latest materials report - The Global Biodegradable Plastic Packaging Market 2010-2020 - analyses recent trends in the biodegradable plastic packaging industry and anticipates the development of the market over the next decade with global, regional and submarket forecasts. The report also surveys current trends and reveals the marketâ€™s strengths and weaknesses revealing areas that will experience growth and present new business opportunities.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 14 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Clinical Trials: World Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/497/Clinical-Trials-World-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/497/Clinical-Trials-World-Market-2010-2025</guid>
		<category>pharma</category>
		<description>The market for clinical trial services has been expanding rapidly, with impressive revenue growth and expansion of the sector in recent years. Our new study shows how that sector will develop from 2010 onwards, with benefits to the pharma industry and clinical service providers. Clinical research organisations (CROs) are playing increasingly important roles in drug development worldwide, from conducting phase I trials to post-marketing studies.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 12 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Smart Grid Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/496/The-Global-Smart-Grid-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/496/The-Global-Smart-Grid-Market-2010-2020</guid>
		<category>energy</category>
		<description>Our brand new energy report - The Global Smart Grid Market 2010-2020 - outlines trends in the revolutionary smart grid market which is a concept to optimise electrical grids with huge potential savings for utilities and consumers alike. The direction of the market over the next decade is detailed, outlining the strengths and weaknesses of different smart grid markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 08 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Social Networking and UGC 2010-2015</title>
		<link>http://www.visiongain.com/Report/494/Mobile-Social-Networking-and-UGC-2010-2015</link>
		<guid>http://www.visiongain.com/Report/494/Mobile-Social-Networking-and-UGC-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Social networking is the fastest growing Internet activity and has even exceeded that of email usage. Social networks such as Facebook and Twitter are some of the most frequently accessed websites in the world with Facebook alone accounting for 50% of the UK's entire mobile Internet traffic.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 06 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Product Lifecycle Management 2010-2020</title>
		<link>http://www.visiongain.com/Report/495/Pharmaceutical-Product-Lifecycle-Management-2010-2020</link>
		<guid>http://www.visiongain.com/Report/495/Pharmaceutical-Product-Lifecycle-Management-2010-2020</guid>
		<category>pharma</category>
		<description>The pharmaceutical industry currently faces marked challenges in its long-standing business model. Product lifecycle management (PLM) is being used to maximise the revenue-generating potential of pharmaceuticals, especially in their maturity, but also earlier on. In our new report - Pharmaceutical Product Lifecycle Management 2010-2020 - we examine the PLM strategies that pharmaceutical companies are using. Those measures range from reformulations, new combinations of drugs and expanded indication ranges, to the use of alliances, licensing, mergers and acquisitions.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 06 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Energy Storage Technologies (EST) Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/492/The-Energy-Storage-Technologies-(EST)-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/492/The-Energy-Storage-Technologies-(EST)-Market-2010-2020</guid>
		<category>energy</category>
		<description>Visiongain's new report, The Energy Storage Technologies (EST) Market 2010-2020 explores this burgeoning new market which has huge potential for participating companies.
In the report, the rapidly growing EST market is fully analysed, identifying key trends across the sector. The report provides the most informed projection for the direction of the market over the coming ten years, outlining the strengths and weaknesses of regional markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 01 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Macular Degeneration (AMD) and Diabetic Retinopathy Pharmaceutical Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/493/Macular-Degeneration-(AMD)-and-Diabetic-Retinopathy-Pharmaceutical-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/493/Macular-Degeneration-(AMD)-and-Diabetic-Retinopathy-Pharmaceutical-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Our new report examines current and future prospects for the age-related macular degeneration (AMD) and diabetic retinopathy (DR) pharmaceutical markets. The global market for AMD and DR drugs exceeded $2.5bn in 2009, with growth from previous years. We predict that the overall market will expand from 2010 onwards. The rising prevalence of AMD and DR is due to aging populations worldwide and other changes. In particular, the world is facing a "diabetes epidemic", with soaring numbers of people with diabetes and related complications, including diabetic retinopathy.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 01 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Energy Storage Technologies (EST) Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/669/The-Energy-Storage-Technologies-(EST)-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/669/The-Energy-Storage-Technologies-(EST)-Market-2010-2020</guid>
		<category>renewable energy</category>
		<description>Visiongain's new report, The Energy Storage Technologies (EST) Market 2010-2020 explores this burgeoning new market which has huge potential for participating companies.
In the report, the rapidly growing EST market is fully analysed, identifying key trends across the sector. The report provides the most informed projection for the direction of the market over the coming ten years, outlining the strengths and weaknesses of regional markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 01 Jul 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/490/Lyophilisation-for-Pharmaceuticals-Technology-and-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/490/Lyophilisation-for-Pharmaceuticals-Technology-and-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Lyophilisation (also known as freeze drying or cryodesiccation) is an operation used for the preparation of stable pharmaceutical products. The market for lyophilisation has enjoyed strong growth in recent years, driven by new products and drug classes, especially in biotechnology. In recent years, the number of such products has been growing steadily. It is predicted that half of the injectable drugs approved in the next five years will require lyophilisation. In our new report, we predict that the global lyophilisation market will grow steadily in revenue and unit sales from 2010 to 2025.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 28 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Rural Mobile Connectivity 2010-2015</title>
		<link>http://www.visiongain.com/Report/491/Rural-Mobile-Connectivity-2010-2015</link>
		<guid>http://www.visiongain.com/Report/491/Rural-Mobile-Connectivity-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Rural connectivity has long been an area of business that the MNOs have engaged wearily due to low population density and low RoI for infrastructure deployment. However, due to an uptake in mobile penetration in developing countries the rural connectivity market has rapidly become an important growth market for the industry.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 28 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Military Video Surveillance Systems Market 2010-2020: Full-Motion Video for ISR</title>
		<link>http://www.visiongain.com/Report/489/Military-Video-Surveillance-Systems-Market-2010-2020-Full-Motion-Video-for-ISR</link>
		<guid>http://www.visiongain.com/Report/489/Military-Video-Surveillance-Systems-Market-2010-2020-Full-Motion-Video-for-ISR</guid>
		<category>defence</category>
		<description>Visiongain's brand new defence report - Military Video Surveillance Systems Market 2010-2020: Full-Motion Video for ISR - assesses the exciting business opportunities presented by one of the most dynamic technological markets in the defence industry. Our in-depth study examines the leading national markets for military video surveillance systems, as well as assessing the factors that are driving sales growth around the world. Our analysis has concluded that worldwide spending on military video surveillance systems will reach $7.7bn in 2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 24 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025</title>
		<link>http://www.visiongain.com/Report/488/In-Vitro-Diagnostics-and-Theranostics-World-Market-Analysis-2010-2025</link>
		<guid>http://www.visiongain.com/Report/488/In-Vitro-Diagnostics-and-Theranostics-World-Market-Analysis-2010-2025</guid>
		<category>pharma</category>
		<description>Our new report examines the commercial prospects for in vitro diagnostics (IVD) in the global healthcare market. Those technological solutions are playing an important role in clinical practice and pharmaceutical R&amp;D - increasing safety, speeding up clinical development and facilitating regulatory acceptance. Molecular diagnostic technologies are leading healthcare towards the goal of personalised medicine, to the benefit of healthcare stakeholders. Molecular diagnostic tests receive support from pharmaceutical regulators, such as the FDA.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 22 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Unmanned Aerial Vehicles (UAV) Market 2010-2020: Technologies for ISR and Counter-Insurgency</title>
		<link>http://www.visiongain.com/Report/486/The-Unmanned-Aerial-Vehicles-(UAV)-Market-2010-2020-Technologies-for-ISR-and-Counter-Insurgency</link>
		<guid>http://www.visiongain.com/Report/486/The-Unmanned-Aerial-Vehicles-(UAV)-Market-2010-2020-Technologies-for-ISR-and-Counter-Insurgency</guid>
		<category>defence</category>
		<description>This unique Visiongain defence report analyses the evolving and dynamic market for unmanned aerial vehicles (UAV) exploring in detail its potential from 2010-2020. The report examines current programmes and future prospects for current and new entrants into the flourishing unmanned aerial vehicles (UAV) market. Armed forces worldwide are embracing unmanned aerial vehicles (UAVs) as critical tools for intelligence, surveillance and reconnaissance (ISR) and in some cases, also for strike missions in particular in counter-insurgency (COIN) operations. Based on Visiongain's research, global spending in 2009 on unmanned aerial vehicles (UAV) reached $5.1bn. Over the forecast period of 2010-2020, the cumulative UAV market will total nearly $71bn.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 21 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Developments in Pricing and Reimbursement in Leading Pharma Markets 2010-2020</title>
		<link>http://www.visiongain.com/Report/487/Developments-in-Pricing-and-Reimbursement-in-Leading-Pharma-Markets-2010-2020</link>
		<guid>http://www.visiongain.com/Report/487/Developments-in-Pricing-and-Reimbursement-in-Leading-Pharma-Markets-2010-2020</guid>
		<category>pharma</category>
		<description>The global economic crisis and rising healthcare costs have caused governments to take cautious approaches towards pricing and reimbursement (P&amp;R) for pharmaceuticals. Increasing drug prices and rising demand for the latest treatments - driven by aging, expanding populations and improving standards of living - have increased the burden on healthcare systems, public and private. Those events have particularly affected countries whose healthcare is mostly funded by the state. Developing nations are also finding it challenging to meet the increasing expectations for healthcare, despite rapid economic growth. Our new report covers pharma pricing and reimbursement in detail, showing the implications of P&amp;R developments on the pharma industry and market in leading countries.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 21 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025</title>
		<link>http://www.visiongain.com/Report/485/Monoclonal-Antibodies-in-Cancer-Therapy-World-Market-Prospects-2010-2025</link>
		<guid>http://www.visiongain.com/Report/485/Monoclonal-Antibodies-in-Cancer-Therapy-World-Market-Prospects-2010-2025</guid>
		<category>pharma</category>
		<description>In 2009, monoclonal antibodies for cancer therapy generated total revenues of over $18bn worldwide. From 2010, that sector will benefit from new drugs and expanding indications for existing products. Cancer incidence and prevalence are rising worldwide; studies reveal that incidence will rise by up to 40% by 2025. Worldwide, the treatment of cancer is a priority for healthcare providers, with high demand for efficacious and well-tolerated therapies. Where is the monoclonal antibody therapy market for cancer heading - technologically and commercially - from 2010 onwards? Our new report covers such questions, providing the information that you need.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 14 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The MDM Market 2010-2015</title>
		<link>http://www.visiongain.com/Report/484/The-MDM-Market-2010-2015</link>
		<guid>http://www.visiongain.com/Report/484/The-MDM-Market-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>The Mobile Device Management (MDM) market has gone through major changes and looks poised to enter into a rapid growth stage in the coming years. Many vendors now offer holistic MDM portfolio that rope in configuration and diagnostics, end-to-end security, software management, and policy management. These newer solutions offer opportunities to increase revenues, reduce OpEx and build strong brand image. Our brand new report focuses primarily on operator and device manufacturer centric MDM market and how these players are leveraging MDM to enable their strategies and business models.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 11 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Breast Cancer Drugs: World Market Prospects 2010-2025</title>
		<link>http://www.visiongain.com/Report/482/Breast-Cancer-Drugs-World-Market-Prospects-2010-2025</link>
		<guid>http://www.visiongain.com/Report/482/Breast-Cancer-Drugs-World-Market-Prospects-2010-2025</guid>
		<category>pharma</category>
		<description>The breast cancer treatments market generated pharmaceutical revenues of over $11bn worldwide in 2009. The incidence and prevalence of breast cancer have been rising worldwide, in line with ageing populations, lifestyle/environmental factors and improvements in diagnosis. Expanding patient populations worldwide offer significant commercial and therapeutic opportunities, which our new report forecasts and discusses. Governments and other healthcare providers are investing in health education, diagnosis and treatments for this serious - but controllable - disorder.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 09 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Payments in Mobile 2010-2015</title>
		<link>http://www.visiongain.com/Report/483/Payments-in-Mobile-2010-2015</link>
		<guid>http://www.visiongain.com/Report/483/Payments-in-Mobile-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>According to the GSMA there will be 1.7 Billion mobile phone users by the end of 2012 who do not possess a formal bank account. Mobile subscriber penetration worldwide will continue to increase with over 5.4 Billion handsets in circulation as of the end of 2015.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 09 Jun 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Anti-counterfeiting Strategies and Commercial Analysis 2010-2020</title>
		<link>http://www.visiongain.com/Report/481/Pharmaceutical-Anti-counterfeiting-Strategies-and-Commercial-Analysis-2010-2020</link>
		<guid>http://www.visiongain.com/Report/481/Pharmaceutical-Anti-counterfeiting-Strategies-and-Commercial-Analysis-2010-2020</guid>
		<category>pharma</category>
		<description>The pharmaceutical anti-counterfeiting market has been generating increasing revenues in recent years, with strong growth to come, as our new report explains and quantifies. Counterfeit drugs cost the pharmaceutical industry billions of dollars annually in lost revenues, with risk to patients and brands. Drug counterfeiting is increasing worldwide, with greater sophistication by counterfeiters and increased online drug purchasing. The rising prevalence of counterfeiting yields significant commercial opportunities for companies offering anti-counterfeiting solutions, as well as for their clients. Companies worldwide are investing in technologies to fight this threat to pharma stakeholders.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 28 May 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Quad Play 2010</title>
		<link>http://www.visiongain.com/Report/480/Quad-Play-2010</link>
		<guid>http://www.visiongain.com/Report/480/Quad-Play-2010</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain's latest report on the global 'Quad Play' and bundled services market analyses the worldwide consumer market by geographical region.
The report outlines the current technological advancements and offers predictions on future developments.
The report interprets the commercial implications of variations in the quad play business model across all critical world markets, outlining the major themes followed by both incumbent and incoming operators.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 27 May 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Mobile Offshore Drilling Units (MODU) Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/479/The-Mobile-Offshore-Drilling-Units-(MODU)-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/479/The-Mobile-Offshore-Drilling-Units-(MODU)-Market-2010-2020</guid>
		<category>energy</category>
		<description>The Mobile Offshore Drilling Units (MODU) Market 2010-2020 is our latest energy report. The report outlines the trends within the MODU industry and anticipates the direction of the market over the next decade, outlining the strengths and weaknesses of different regional markets with detailed leasing forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 26 May 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile TV Market: Analysis and Opportunities 2010-2015</title>
		<link>http://www.visiongain.com/Report/478/Mobile-TV-Market-Analysis-and-Opportunities-2010-2015</link>
		<guid>http://www.visiongain.com/Report/478/Mobile-TV-Market-Analysis-and-Opportunities-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain's latest report on the Mobile TV market reviews upcoming innovative technologies and existing applications &amp; standards related to the Mobile TV industry. The report also explains the commercial feasibility of the Mobile TV market's current infrastructure with recommendations for both network operators and broadcasters.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 24 May 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Missiles Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/476/The-Missiles-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/476/The-Missiles-Market-2010-2020</guid>
		<category>defence</category>
		<description>This new visiongain defence report examines current trends, future markets, programmes and future prospects for the missiles market. Missiles remain at the core of modern capabilities of military platforms from ships to aircraft and some vehicles. In some cases, this even extends to infantry. Visiongain calculates that the missiles market was worth $9.2bn in 2009. There will be steady growth in the missiles market. This report analyses and forecasts the global missiles market and also provides individual forecasts for the 20 leading national markets.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 19 May 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Stem Cells - The Hype and the Hope 2010-2025</title>
		<link>http://www.visiongain.com/Report/477/Stem-Cells-The-Hype-and-the-Hope-2010-2025</link>
		<guid>http://www.visiongain.com/Report/477/Stem-Cells-The-Hype-and-the-Hope-2010-2025</guid>
		<category>pharma</category>
		<description>In 2010, the stem cells market stands on the brink of technological and commercial breakthroughs, our new study explains. For the first time, pharmaceutical companies are beginning to invest significantly in the drive to create new treatments based on embryonic and adult stem cells. As this research gathers pace, with clinical trials commencing, the potential of stem cells in medicine may relatively soon be fulfilled. Results in animals indicate that stem cells may provide treatment options for a range of disorders and restorative applications including multiple sclerosis, diabetes, Parkinson's disease, Alzheimer's disease, spinal cord injury, blindness, immune system disorders and cardiovascular disease.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 19 May 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Email 2010-2015</title>
		<link>http://www.visiongain.com/Report/475/Mobile-Email-2010-2015</link>
		<guid>http://www.visiongain.com/Report/475/Mobile-Email-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Increasingly more mobile devices are offering mobile email services, as developments in handset technology are leading to improved mobile devices being available to a broader range of users. The days of mobile email being predominantly used by business users are disappearing; services are now being used by a range of subscribers, from teens to older users, as handsets are becoming more user friendly thus boosting mobile email.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 18 May 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025</title>
		<link>http://www.visiongain.com/Report/474/Biosimilars-and-Follow-On-Biologics-Global-Market-Outlook-2010-2025</link>
		<guid>http://www.visiongain.com/Report/474/Biosimilars-and-Follow-On-Biologics-Global-Market-Outlook-2010-2025</guid>
		<category>pharma</category>
		<description>In 2009, the biological (biologic) drug market generated over $125bn in revenues worldwide. There is great demand for lower-cost biological drugs. Commercial and regulatory developments will make biosimilars and follow-on biologics seize market share - our new report explains how. Many biologic patents will expire during our forecast period. There is mounting pressure from governments, insurers and patients' groups to reduce drug costs. Biologic drugs - noted as some of the most-expensive medicines - are prime targets. Developments facilitating biosimilars/follow-on biologics are gaining momentum, with commercial opportunities for the taking. The potential revenues are significant.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 05 May 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Liquefied Natural Gas (LNG) Market, 2010-2020</title>
		<link>http://www.visiongain.com/Report/473/The-Global-Liquefied-Natural-Gas-(LNG)-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/473/The-Global-Liquefied-Natural-Gas-(LNG)-Market-2010-2020</guid>
		<category>energy</category>
		<description>The Global Liquefied Natural Gas (LNG) Market, 2010-2020 is our new energy report. The report outlines trends in the LNG industry and anticipates the direction of the market over the next decade, outlining the strengths and weaknesses of different markets with targeted sales forecasts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 29 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Metal Packaging Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/472/The-Global-Metal-Packaging-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/472/The-Global-Metal-Packaging-Market-2010-2020</guid>
		<category>metals</category>
		<description>The Global Metal Packaging Market 2010-2020 is our brand new materials report. The report analyses recent trends in the metal packaging industry and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also surveys current trends and reveals the market’s strengths and weaknesses revealing areas that will experience growth and present new business opportunities.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 26 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Metal Packaging Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/504/The-Global-Metal-Packaging-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/504/The-Global-Metal-Packaging-Market-2010-2020</guid>
		<category>packaging</category>
		<description>The Global Metal Packaging Market 2010-2020 is our brand new materials report. The report analyses recent trends in the metal packaging industry and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also surveys current trends and reveals the marketâ€™s strengths and weaknesses revealing areas that will experience growth and present new business opportunities.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 26 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Service Delivery Platforms (SDP) Report 2010 - Analysis and Forecasts</title>
		<link>http://www.visiongain.com/Report/471/Service-Delivery-Platforms-(SDP)-Report-2010-Analysis-and-Forecasts</link>
		<guid>http://www.visiongain.com/Report/471/Service-Delivery-Platforms-(SDP)-Report-2010-Analysis-and-Forecasts</guid>
		<category>telecoms &amp; IT</category>
		<description>Using SDP, operators have the option to evolve as service retailers and wholesalers. However, migrating to SDP is not an easy proposition for operators, due to the infrastructure complexity and costs involved. This understanding is crucial is crucial for SDP development, not just from the technological perspective but also from the financial, marketing and operations perspectives.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 23 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025</title>
		<link>http://www.visiongain.com/Report/470/Pre-Filled-Syringes-and-Related-Systems-World-Market-Outlook-2010-2025</link>
		<guid>http://www.visiongain.com/Report/470/Pre-Filled-Syringes-and-Related-Systems-World-Market-Outlook-2010-2025</guid>
		<category>pharma</category>
		<description>The market for pre-filled syringes has achieved growth in recent years. In 2009, an estimated 2 billion pre-filled syringe units were sold and the market for that technology was estimated to be worth up to $2.5 billion. There is a trend towards pre-filled drug injection systems, away from vials/ampules, for both new and existing products. Examples are filled glass and plastic syringes, pens and low-volume auto-injection devices, including refills. That sector has shown growth of 10-15% in recent years, forming one of the fastest-expanding sectors in the pharmaceutical industry. In our new report, we predict that the pre-filled drug delivery market will grow steadily from 2010, as the number of products launched in pre-filled injectable forms increases.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 22 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Military Communications and COTS Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/469/Military-Communications-and-COTS-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/469/Military-Communications-and-COTS-Market-2010-2020</guid>
		<category>defence</category>
		<description>Our latest defence report - Military Communications and COTS Market 2010-2020 – assesses the exciting business opportunities presented by one of the most vitally important global defence markets. Military communications are increasingly essential to all military services and underpin all military operations. Our study examines the leading national markets for military communications products and services, as well as assessing the factors that are driving sales growth around the world.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 21 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Mobile VoIP Market Report 2010-2015</title>
		<link>http://www.visiongain.com/Report/468/The-Mobile-VoIP-Market-Report-2010-2015</link>
		<guid>http://www.visiongain.com/Report/468/The-Mobile-VoIP-Market-Report-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>The mobile market is growing, up 1.4% to €417 billion in 2010. The strongest growth is posted by data services such as mVoIP, both on fixed and mobile networks. Sales of internet connections and data services on fixed networks will grow in 2010 by 7% to almost €200 billion. Mobile data services – such as mVoIP are posting even stronger growth: up 16% to over €140 billion.
Our new telecoms report outlines how the mobile VoIP market will evolve further during the next five years, ensuring that you are in the know when it comes to important decisions within the mVoIP industry.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 15 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Maritime Security Market 2010-2020: Piracy, Shipping &amp; Seaports</title>
		<link>http://www.visiongain.com/Report/467/The-Maritime-Security-Market-2010-2020-Piracy-Shipping-Seaports</link>
		<guid>http://www.visiongain.com/Report/467/The-Maritime-Security-Market-2010-2020-Piracy-Shipping-Seaports</guid>
		<category>defence</category>
		<description>Our latest defence report - The Maritime Security Market 2010-2020: Piracy, Shipping &amp; Seaports - explores one of the homeland security market's most important sectors and reveals how this market will develop over the period 2010-2020.
Based on our research, global spending in 2010 on maritime security will total $15.4bn. We analyse, quantify and forecast the global and regional maritime security markets over the period 2010-2020. We also analyse and quantify separately the global and regional vessel security and seaport &amp; facility security markets over the period 2010-2020.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 12 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Osteoporosis &amp; Bone Metabolism Disorders: World Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/466/Osteoporosis-Bone-Metabolism-Disorders-World-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/466/Osteoporosis-Bone-Metabolism-Disorders-World-Market-2010-2025</guid>
		<category>pharma</category>
		<description>The bone metabolism treatments market generated pharmaceutical revenues of over $12 bn worldwide in 2009. The incidence and prevalence of bone metabolism disorders are on the rise worldwide, in line with an ageing population and improvements in diagnosis. The increasing number of older people offers significant commercial and therapeutic opportunities. The number of osteoporosis and other bone metabolism patients may exceed 400 million by 2020, reports suggest. Governments and other healthcare providers are investing in health education, diagnosis and treatments for those chronic, debilitating - but controllable - disorders, as our new report discusses.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 09 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Advergaming and Ad-Funded Gaming Report 2010-2015</title>
		<link>http://www.visiongain.com/Report/462/Mobile-Advergaming-and-Ad-Funded-Gaming-Report-2010-2015</link>
		<guid>http://www.visiongain.com/Report/462/Mobile-Advergaming-and-Ad-Funded-Gaming-Report-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Facebook games based around advertising now achieve over 1 million monthly active users, with many of these coming through mobile usage. Whether its referred to as advergaming, ad-funded gaming or casual games, the advergaming industry had revenues in excess of $3 billion on mobile, iPhone, social networks platforms. Targeted user information continues to emerge about who plays games, spurring interest on the part of advertising agencies who can use games to reach specific markets. Broadening of interest has meant that gamers are not just teenage males, but men through to 35 years and beyond as well as women between the ages of 35 and 55.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 06 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Pain Relieving Drug Market Analysis 2010-2025</title>
		<link>http://www.visiongain.com/Report/461/Global-Pain-Relieving-Drug-Market-Analysis-2010-2025</link>
		<guid>http://www.visiongain.com/Report/461/Global-Pain-Relieving-Drug-Market-Analysis-2010-2025</guid>
		<category>pharma</category>
		<description>In 2009, the global pain relieving drug market generated revenues over $50bn. From 2010, that sector will benefit from new drugs and reformulations of existing products. Cases of pain from many conditions are increasing rapidly. Worldwide, the treatment of pain is a priority for healthcare providers, with high demand for drugs. Where is the pain relieving drug market heading - technologically and commercially - from 2010 onwards?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 01 Apr 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Oil &amp; Gas Pipelines Market Analysis 2010-2020</title>
		<link>http://www.visiongain.com/Report/465/The-Oil-Gas-Pipelines-Market-Analysis-2010-2020</link>
		<guid>http://www.visiongain.com/Report/465/The-Oil-Gas-Pipelines-Market-Analysis-2010-2020</guid>
		<category>energy</category>
		<description>Our brand new energy report - The Oil &amp; Gas Pipelines Market 2010-2020 - explores one of the energy industry's most critical sectors and reveals how this market will evolve over the period 2010-2020. Media and public focus on pipeline sabotage by militants and leakage has brought oil and gas pipelines increasingly to the fore, with poor PR effects, and expensive, time-consuming costs. Nevertheless, despite supply requirements driving demand, the oil and gas pipelines market will have to contend with other restraints over the 2010-2020 forecast period - most notably, uncertainty over the state of the global economy. This analysis will inform you how to deal with this uncertainty.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 29 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Oil Refineries Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/464/The-Global-Oil-Refineries-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/464/The-Global-Oil-Refineries-Market-2010-2020</guid>
		<category>energy</category>
		<description>The Global Oil Refineries Market 2010-2020 is our brand new energy report. This unique one-off report analyses the latest trends in the oil refining industry and anticipates its progression in the market over the next decade. The report also surveys recent successes and failures among major companies and reveals where the market will experience growth, laying out the markets strengths and weaknesses with global and regional forecasts, so that you can make key decisions now.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 25 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Inflammatory Bowel Disease: World Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/460/Inflammatory-Bowel-Disease-World-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/460/Inflammatory-Bowel-Disease-World-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Our new report examines current and future prospects for the inflammatory bowel disease (IBD) drug market. The global market for IBD drugs exceeded $5bn in 2009, with strong growth from the previous year. We predict that the overall market for IBD drugs will expand from 2010 onwards. Main commercial drivers will be disease prevalence, improving diagnosis and wider access to treatments. Currently, IBD is under-diagnosed, especially in developing countries. As governments and other healthcare providers address chronic illnesses like IBD, this market will expand in many countries.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 23 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Armoured Vehicles Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/459/The-Armoured-Vehicles-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/459/The-Armoured-Vehicles-Market-2010-2020</guid>
		<category>defence</category>
		<description>This new unique industry defence report examines current programmes and future prospects for the armoured vehicles market. The current threat of Improvised Explosive Devices (IEDs) in operations in Afghanistan and Iraq is driving the market in particular for Mine Resistant Ambush Protected (MRAP) vehicles. However, armoured vehicles will remain the mainstay of land forces and provide steady demand over the forecast period of 2010-2020. Based on our research, global spending in 2010 on armoured vehicles will reach $10.3bn. We analyse, quantify and project growth in the expected acquisition and upgrade of armoured vehicles in the global market and 20 leading national markets over the forecast period of 2010-2020.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 18 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Vaccines Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/458/Global-Vaccines-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/458/Global-Vaccines-Market-2010-2025</guid>
		<category>pharma</category>
		<description>In 2009, the global market for vaccines achieved sales of over $10bn. Hundreds of millions of people are affected by infectious diseases that can be fought by vaccination. Despite controversy, vaccine use remains one of the greatest successes in the fight against disease - one with a long history. This market will achieve sustained growth over the next 15 years, our new study reveals. Increasingly, governments recognise the benefits of mass vaccination, with successive vaccines delivering healthcare solutions on a large scale, a trend set to continue.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 16 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The C2/C4ISR Market Analysis, Financials and Forecasting 2010-2020</title>
		<link>http://www.visiongain.com/Report/457/The-C2-C4ISR-Market-Analysis-Financials-and-Forecasting-2010-2020</link>
		<guid>http://www.visiongain.com/Report/457/The-C2-C4ISR-Market-Analysis-Financials-and-Forecasting-2010-2020</guid>
		<category>defence</category>
		<description>Our brand new defence report - The C2/C4ISR Market 2010-2020 - examines one of the defence industry's largest sectors and reveals how this market will evolve over the period 2010-2020.

Based on our research, global military spending on C2/C4ISR systems will total $63.6bn in 2010. This equates to nearly 5% of total global defence spending and therefore presents huge market opportunities for companies to exploit.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 15 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Network Sharing Report 2010-2015 - Developments, Analysis &amp; Forecasts</title>
		<link>http://www.visiongain.com/Report/456/Mobile-Network-Sharing-Report-2010-2015-Developments-Analysis-Forecasts</link>
		<guid>http://www.visiongain.com/Report/456/Mobile-Network-Sharing-Report-2010-2015-Developments-Analysis-Forecasts</guid>
		<category>telecoms &amp; IT</category>
		<description>Changes in data demand growth and availability of new technologies like LTE is having implications on the telecom industry's structure, competition and sources of competitive advantage. In addition, due to increasing competition, network operators are witnessing faltering profit margins. Service revenue growth is expected to be less than 1.2% up until 2014. In such harsh economic conditions, operators are now increasingly looking for innovative ways to increase operating profits, reduce their total cost of ownership and create shareholder value. In order to achieve the above objectives, many in the industry believe that operators should master the value discipline of "operational excellence" by embarking on a network sharing strategy.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 08 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Mobile Applications Market 2010-2015</title>
		<link>http://www.visiongain.com/Report/455/The-Mobile-Applications-Market-2010-2015</link>
		<guid>http://www.visiongain.com/Report/455/The-Mobile-Applications-Market-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>The mobile applications market is estimated to be worth around $25 billion by 2015. However, the economic meltdown has resulted in some big names within the applications and telecoms industry to shutdown recently and the fears of the aftermath of a recession are still on the clouds. Analysts have agreed on the fact that the recession slowed down the growth of the apps store and the apps industry. Had there been no recession in the last few years, it can be argued that the Mobile apps industry would have been propagated on a larger scale compared to the current situation.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 05 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Diabetes Market Analysis 2010-2025</title>
		<link>http://www.visiongain.com/Report/453/World-Diabetes-Market-Analysis-2010-2025</link>
		<guid>http://www.visiongain.com/Report/453/World-Diabetes-Market-Analysis-2010-2025</guid>
		<category>pharma</category>
		<description>In 2009, the diabetes treatment market generated worldwide sales of over $25 billion, with strong growth from the previous year. The incidence and prevalence of diabetes mellitus are on the rise worldwide, in line with lifestyle changes and ageing populations. In particular, the increasing prevalence of diabetes is closely linked with that of obesity, creating significant market opportunities in developed nations and some developing countries. The World Health Organization estimates the number of diabetics to exceed 350 million by 2030. Governments and other healthcare providers around the world are investing heavily in prevention and treatment of this serious - but controllable - disorder.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 03 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Multiple Sclerosis Drug Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/454/Global-Multiple-Sclerosis-Drug-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/454/Global-Multiple-Sclerosis-Drug-Market-2010-2025</guid>
		<category>pharma</category>
		<description>The multiple sclerosis (MS) treatments market is one of the largest for CNS disorders, with total pharmaceutical revenues of over $8bn in 2009. Revenues for MS treatments will rise significantly from 2010 to 2025, our new study reveals. Rising disease prevalence, expanding patient populations, technological advances and widening healthcare provision for MS will drive the market upwards. In Global Multiple Sclerosis Drug Market 2010-2025 we analyse and explain trends in this market, providing sales forecasts and other core analyses that you require. Our report explains why the market will expand, revealing where the most-exciting developments will lie.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 03 Mar 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>CBRN Defence Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/452/CBRN-Defence-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/452/CBRN-Defence-Market-2010-2020</guid>
		<category>defence</category>
		<description>Our latest defence report - CBRN Defence Market 2010-2020 - explores and analyses the substantial business opportunities presented by one of the most significant markets in the defence and homeland security sector. Our study examines the leading markets for chemical, biological, radiological and nuclear (CBRN) defence products and services, as well as assessing the factors that are driving sales growth around the world.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 26 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Apple iPhone and Mobile iTunes Report 2010</title>
		<link>http://www.visiongain.com/Report/451/Apple-iPhone-and-Mobile-iTunes-Report-2010</link>
		<guid>http://www.visiongain.com/Report/451/Apple-iPhone-and-Mobile-iTunes-Report-2010</guid>
		<category>telecoms &amp; IT</category>
		<description>The Apple iPhone has been a revelation since it was first launched in the US in June 2007. The first handset was met with great enthusiasm and excitement due to the reputation that Apple has developed. The iPhone has consequently heightened Apple's brand and this has continued as new and improved versions of the handset have been released. Operators have benefitted from increased data traffic from their iPhone-bundled subscriptions due to Apple’s success in producing a compelling user interface ideal for browsing and multimedia use.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 24 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2010-2025</title>
		<link>http://www.visiongain.com/Report/450/Pharmaceutical-Wholesale-and-Distribution-Industry-Outlook-and-Analysis-2010-2025</link>
		<guid>http://www.visiongain.com/Report/450/Pharmaceutical-Wholesale-and-Distribution-Industry-Outlook-and-Analysis-2010-2025</guid>
		<category>pharma</category>
		<description>The pharmaceutical wholesale and distribution sector is the vital link between pharmaceutical companies and pharmacies. Growing demand for drugs worldwide is driving that sector’s growth. However, many pressures and challenges have placed a premium on service and efficiency in pharma wholesale and distribution. What are the key issues involved? Who are the major players and how do their businesses operate? Where are the best opportunities to be found, and how could you unlock these? Our new report - Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2010-2025 - reveals where the most-exciting developments will lie from the present onwards. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 23 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Indian Cellular Market Report and Forecasts 2010-2015</title>
		<link>http://www.visiongain.com/Report/449/The-Indian-Cellular-Market-Report-and-Forecasts-2010-2015</link>
		<guid>http://www.visiongain.com/Report/449/The-Indian-Cellular-Market-Report-and-Forecasts-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>Such is the interest in the Indian telecom industry that companies from all over the world must do business in the country with a population of over a billion people. But crucial questions remain unanswered regarding competition and service improvments that are vital for the developent of the industry.
The much-awaited Mobile Number Portability (MNP) continues to deadlines, with the government now planning to launch MNP by the first week of May. How will this impact on churn rates throughout the country?
With Bharat Sanchar Nigam Ltd (BSNL) also launching 3G services in Bangalore to attempt to offer service differentiation, MNP's launch could result in greater switching between the mobile service providers.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 22 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Anti-Obesity Treatments Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/448/Global-Anti-Obesity-Treatments-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/448/Global-Anti-Obesity-Treatments-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Prevalence of obesity in the US and Europe has already reached high levels, with obesity being described as an epidemic and a "public health time-bomb". The developing world is also showing rising prevalence of obesity, now considered a serious - even life-threatening - disorder. In this report, we predict that the anti-obesity drug market will exhibit overall growth in worldwide revenues from 2010 to 2025, with new drugs entering the market during those years. Where will the best commercial prospects lie? Our new study provides the answers that you require.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 18 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Digital music distribution: markets, analysis and forecasts 2010</title>
		<link>http://www.visiongain.com/Report/444/Digital-music-distribution-markets-analysis-and-forecasts-2010</link>
		<guid>http://www.visiongain.com/Report/444/Digital-music-distribution-markets-analysis-and-forecasts-2010</guid>
		<category>telecoms &amp; IT</category>
		<description>According to a recent report on CNN, 'total revenue from U.S. music sales and licensing plunged' between the years 1999 and 2009. They said that 'at the end of last year, the music business was worth half of what it was ten years ago and the decline doesn't look like it will be slowing anytime soon'.
Many believe that the main reason for this decline is the increased popularity of digital music. The report quotes the former Head of Yahoo Music as saying 'The CD is still disappearing, and nothing is replacing it in entirety as a revenue generator. Digital downloads are not even going to replace what the CD business did for the industry." However, digital licensing revenue has reached toward $100 billion in 2009, and we expect it to grow even further in the next couple of years.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 08 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Antivirals Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/445/Global-Antivirals-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/445/Global-Antivirals-Market-2010-2025</guid>
		<category>pharma</category>
		<description>In 2009, the global market for antiviral drugs attained total sales of over $28bn. With hundreds of millions of people worldwide suffering from chronic or acute viral infections, there is enormous need for antiviral drugs. It is only in the past few decades that researchers have begun to find ways of combating viruses. Because viruses mutate rapidly and acquire drug-resistance, the antiviral pipeline needs to be continuously replenished with newer, better therapies, our new market study notes.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 08 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Statins: The World Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/446/Statins-The-World-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/446/Statins-The-World-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Statins are potent cholesterol-lowering drugs, making them important in the prevention of coronary heart disease. Consequently, statins constitute one of the most important sectors of the pharmaceutical industry, with total revenues exceeding $25 billion in 2009. Our new report - Statins: The World Market 2010-2025 - provides detailed sales predictions and supporting discussions for this important pharmaceutical sector.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 08 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Managed Services Report 2010 - Analysis and Developments</title>
		<link>http://www.visiongain.com/Report/447/Managed-Services-Report-2010-Analysis-and-Developments</link>
		<guid>http://www.visiongain.com/Report/447/Managed-Services-Report-2010-Analysis-and-Developments</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile Network Operators (MNO's) continue to look to reduce Capex and Opex costs through the adoption of Managed Services from a range of telecoms equipment vendors. Managed Services vendors are now offering a range of services, including the management of the MNO's network, RAN &amp; access infrastructure and network sharing.

The brand new Managed Services 2010 report provides a timely in-depth analysis of the Managed Services affecting the MNO - with unique hard-hitting case studies of mobile operators partnering with third party specialists and deploying Managed Services today.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 08 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Remotely Operated Vehicles (ROV) and Autonomous Underwater Vehicles (AUV) in the Energy Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/463/Remotely-Operated-Vehicles-(ROV)-and-Autonomous-Underwater-Vehicles-(AUV)-in-the-Energy-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/463/Remotely-Operated-Vehicles-(ROV)-and-Autonomous-Underwater-Vehicles-(AUV)-in-the-Energy-Market-2010-2020</guid>
		<category>energy</category>
		<description>Our brand new energy report - Remotely Operated Vehicles (ROV) and Autonomous Underwater Vehicles (AUV) in the Energy Market 2010-2020 - analyses why this market will exhibit robust growth despite the global economic uncertainty. The report explores the market's strengths and weaknesses with targeted forecasts highlighting areas of growth to exploit.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 08 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile payments: markets, analysis and forecast, 2010-2015</title>
		<link>http://www.visiongain.com/Report/443/Mobile-payments-markets-analysis-and-forecast-2010-2015</link>
		<guid>http://www.visiongain.com/Report/443/Mobile-payments-markets-analysis-and-forecast-2010-2015</guid>
		<category>telecoms &amp; IT</category>
		<description>A recent news report highlighted that many users trust their mobile more than their bank when it comes to handle money. Mobile payment, also called M-payment or mpayment, is at forefront of this technological innovation, development and establishing this element of trust and security. The improvement of security has seen the use of mobile funds transfer and transactions increase both in quantity of goods and services purchased, as well as value.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 01 Feb 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Oncology Market Leaders – Analyses and Outlook – 2010-2025</title>
		<link>http://www.visiongain.com/Report/441/Oncology-Market-Leaders-Analyses-and-Outlook-2010-2025</link>
		<guid>http://www.visiongain.com/Report/441/Oncology-Market-Leaders-Analyses-and-Outlook-2010-2025</guid>
		<category>pharma</category>
		<description>Cancer treatment is a global healthcare priority, one with rising therapeutic and commercial importance. Over 20 million new cases of cancer are predicted in 2025, compared with 12 million in 2008 (WHO). Furthermore, anti-cancer drug sales exceeded $50bn worldwide in 2009. The oncology drug market has grown impressively, driven by rising disease prevalence, expanding patient populations and technological advances, especially in biomolecular medicine. Current treatments are better-tolerated, more- effective and more-commercially-successful than ever before, our latest report shows.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 25 Jan 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Ophthalmic Pharmaceutical Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/442/World-Ophthalmic-Pharmaceutical-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/442/World-Ophthalmic-Pharmaceutical-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Ophthalmic drugs constitute a prominent segment of the global pharmaceutical market, with sales of over $14bn in 2009. Eye diseases are common worldwide, with expanding patient populations. The recent success of Lucentis highlighted the marked therapeutic and commercial potential of this sector. Which will be the ophthalmic blockbusters of the future? What are the most-promising R&amp;D pipeline developments there? What are the main drivers and restraints for the market? This new report provides answers - and other essential information - to help you understand the ophthalmic pharmaceutical industry and market from 2010 onwards.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 25 Jan 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Near Field Communications (2010-2015), the future of retail-payments from a technological and market perspective</title>
		<link>http://www.visiongain.com/Report/440/Near-Field-Communications-(2010-2015)-the-future-of-retail-payments-from-a-technological-and-market-perspective</link>
		<guid>http://www.visiongain.com/Report/440/Near-Field-Communications-(2010-2015)-the-future-of-retail-payments-from-a-technological-and-market-perspective</guid>
		<category>telecoms &amp; IT</category>
		<description>In assessing NFC from the commercial and technological perspectives, a comprehensive view of other contactless payment technologies has been taken into account. NFC has been compared against RFID, Bluetooth and other wireless technologies in terms of technological advantages NFC provides. In order to provide a comprehensive view of the domain of use for NFC technology, its feasible use in transportation, retail and couponing system has been analysed.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 18 Jan 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Smoking-Cessation Drug Market 2010-2025</title>
		<link>http://www.visiongain.com/Report/439/World-Smoking-Cessation-Drug-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/439/World-Smoking-Cessation-Drug-Market-2010-2025</guid>
		<category>pharma</category>
		<description>Smoking is a leading cause of preventable death worldwide. In 2009, total sales of smoking-cessation products surpassed $1.6bn (Rx products). The effects of smoking constitute a major burden on public healthcare systems, as well as lowering quality of life for many people. Currently-marketed smoking-cessation products arguably lack the desired levels of efficacy in practice, with the reputation of some suffering through noted side-effects. As a result, there are significant commercial opportunities for more-efficacious and better-tolerated smoking-cessation agents, especially in prescription form.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 13 Jan 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Cyberwarfare Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/438/Cyberwarfare-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/438/Cyberwarfare-Market-2010-2020</guid>
		<category>defence</category>
		<description>Our brand new defence report - Cyberwarfare Market 2010-2020 - assesses the considerable business opportunities exhibited by one of the defence industry’s fastest-growing markets. Our market study examines the leading cyber nations and analyses the range of factors that are driving strong global sales growth.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 11 Jan 2010 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Pharmaceutical Biotech Market 2010-2025 </title>
		<link>http://www.visiongain.com/Report/436/Global-Pharmaceutical-Biotech-Market-2010-2025</link>
		<guid>http://www.visiongain.com/Report/436/Global-Pharmaceutical-Biotech-Market-2010-2025</guid>
		<category>pharma</category>
		<description>The global pharmaceutical biotech market continues to experience high growth, with developers ranging from major pharmaceutical companies to specialist pharmaceutical firms. Significant R&amp;D efforts and innovative new treatments will lead to further expansion of the pharma biotech market. This new report - Global Pharmaceutical Biotech Market 2010-2025 - explains why that market will expand, revealing where the most exciting developments will lie.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 18 Dec 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Soldier Modernisation Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/437/The-Soldier-Modernisation-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/437/The-Soldier-Modernisation-Market-2010-2020</guid>
		<category>defence</category>
		<description>Our latest defence report - The Soldier Modernisation Market 2010-2020 - reveals the significant opportunities presented by one of the defence industry's most dynamic and growing markets. Our market study examines leading soldier modernisation programmes and systems, and explores the operational requirements which are creating global demand for soldier modernisation programmes. We assess the commercial prospects and outlook for companies offering soldier modernisation systems. This analytical report defines the current state of the soldier modernisation market and discusses its potential for growth from 2010 onwards, with market forecasting at the global and national levels. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 18 Dec 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Remittance 2010: Including trends in Mobile Banking</title>
		<link>http://www.visiongain.com/Report/435/Mobile-Remittance-2010-Including-trends-in-Mobile-Banking</link>
		<guid>http://www.visiongain.com/Report/435/Mobile-Remittance-2010-Including-trends-in-Mobile-Banking</guid>
		<category>telecoms &amp; IT</category>
		<description>The world's banking and financial retail infrastructure is characterised by two scenarios. One scenario is played out in some regions that have a saturated banking industry where the nature of business and society leaves no time for people to conduct transactions in a bank's premises. In other regions physical bank sites are few and far between. Mobile money transactions allows financial operations to be conducted under both scenarios.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 16 Dec 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Influenza Vaccine Market Outlook 2010-2020</title>
		<link>http://www.visiongain.com/Report/433/Influenza-Vaccine-Market-Outlook-2010-2020</link>
		<guid>http://www.visiongain.com/Report/433/Influenza-Vaccine-Market-Outlook-2010-2020</guid>
		<category>pharma</category>
		<description>
The influenza vaccines market is one of the fastest-growing sectors of the global pharmaceutical industry, generating multi-billion dollar revenues currently. The re-emergence of influenza as a pandemic threat this decade has stimulated this market area greatly, with vaccines coming back to the fore in healthcare worldwide. Our new pharma report - Influenza Vaccine Market Outlook 2010-2020 - explains how that market area will develop and where the main commercial opportunities will lie.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 14 Dec 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Helicopter Market 2010-2020</title>
		<link>http://www.visiongain.com/Report/434/The-Military-Helicopter-Market-2010-2020</link>
		<guid>http://www.visiongain.com/Report/434/The-Military-Helicopter-Market-2010-2020</guid>
		<category>defence</category>
		<description>Our brand new defence report - The Military Helicopter Market 2010-2020 - explores one of the defence industry’s most high profile sectors and reveals how this market will evolve over the period 2010-2020. The acute media and public focus on military operations in Iraq and Afghanistan has brought the role of helicopters increasingly to the fore. Nevertheless, despite these pressing operational requirements driving demand, the military helicopter market will have to contend with other restraints over the 2010-2020 forecast period - most notably, restrained defence budgets.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 14 Dec 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Broadband 2010-2015: A growing market requiring investment and sustainable support to fulfill burgeoning demand</title>
		<link>http://www.visiongain.com/Report/432/Mobile-Broadband-2010-2015-A-growing-market-requiring-investment-and-sustainable-support-to-fulfill-burgeoning-demand</link>
		<guid>http://www.visiongain.com/Report/432/Mobile-Broadband-2010-2015-A-growing-market-requiring-investment-and-sustainable-support-to-fulfill-burgeoning-demand</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile broadband looks set to overshadow fixed line broadband in terms of popularity. Despite the recession, demand for mobile broadband has remained on an upward curve. Can you afford to stand back and take no action, whilst others do? It is imperative that action is taken quickly and effectively in order to benefit from this thriving market before it's too late.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 10 Dec 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>LTE Roadmap 2010-2015 - Towards 4G: The next generation technology in waiting offering medium to long term high margin growth opportunities</title>
		<link>http://www.visiongain.com/Report/430/LTE-Roadmap-2010-2015-Towards-4G-The-next-generation-technology-in-waiting-offering-medium-to-long-term-high-margin-growth-opportunities</link>
		<guid>http://www.visiongain.com/Report/430/LTE-Roadmap-2010-2015-Towards-4G-The-next-generation-technology-in-waiting-offering-medium-to-long-term-high-margin-growth-opportunities</guid>
		<category>telecoms &amp; IT</category>
		<description>LTE is one of the most promising stepping stone technologies towards 4th generation mobile networks. Many wireless network operators believe that LTE offers the best value proposition to increase network capacity, improve QoS and significantly enhance data rates while reducing the TCO (total cost of ownership).</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 02 Dec 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Antibacterial Treatments Market 2010-2024</title>
		<link>http://www.visiongain.com/Report/431/The-World-Antibacterial-Treatments-Market-2010-2024</link>
		<guid>http://www.visiongain.com/Report/431/The-World-Antibacterial-Treatments-Market-2010-2024</guid>
		<category>pharma</category>
		<description>Our latest report examines the prospects for antibacterial treatments worldwide from 2009 to 2024, including detailed sales forecasts for leading products in that sector. The global anti-infectives market generated revenues of $79bn for the 12 months to the second-quarter of 2009, of which the antibacterial market accounted for $37bn. How will this market perform from 2010 onwards? Our original forecasts and qualitative analyses will show you how the antibacterial sector will fare, pointing out the most-exciting and fast-growing areas.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 02 Dec 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Dermatological Market Outlook 2010-2024</title>
		<link>http://www.visiongain.com/Report/429/The-World-Dermatological-Market-Outlook-2010-2024</link>
		<guid>http://www.visiongain.com/Report/429/The-World-Dermatological-Market-Outlook-2010-2024</guid>
		<category>pharma</category>
		<description>The dermatological drug market continues to be important and competitive globally. New treatments for skin disorders and increasing disease prevalence will lead to further expansion of that market area, we predict. There are potential gains in all the main aspects of pharma development: novel drugs, drug delivery innovation, generics and biotechnology. Our brand new report - The World Dermatological Market Outlook 2010-2024 - explains why that market will expand, revealing where the most-exciting developments will lie during our forecast period. And how you can benefit from this expansion.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 27 Nov 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Vodafone Insight 2009: Comparison of Relative Strengths vis-à-vis France Telecom, Telefonica and Hutchison Whampoa</title>
		<link>http://www.visiongain.com/Report/428/Vodafone-Insight-2009-Comparison-of-Relative-Strengths-vis-à-vis-France-Telecom-Telefonica-and-Hutchison-Whampoa</link>
		<guid>http://www.visiongain.com/Report/428/Vodafone-Insight-2009-Comparison-of-Relative-Strengths-vis-à-vis-France-Telecom-Telefonica-and-Hutchison-Whampoa</guid>
		<category>telecoms &amp; IT</category>
		<description>This report is the latest in an annual series of reports documenting Vodafone and its market position. In this report, Vodafone's position is comprehensively contrasted against 3 of its principal rivals on a global scale, namely Telefonica-O2, France Telecom/Orange and Hutchison Whampoa (mainly through its H3G Group and HTIL businesses).</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 26 Nov 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The US Pharmaceutical Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/427/The-US-Pharmaceutical-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/427/The-US-Pharmaceutical-Market-2009-2024</guid>
		<category>pharma</category>
		<description>The United States has by far the world's largest pharmaceutical market. In the twelve months to Q2 2009, the US accounted for 41% of world pharmaceutical sales. Its vast economy, high standard of living, minimal pricing controls and strong intellectual property rights help make it the world's most dominant pharma market. The US also has one of the most stringent regulatory environments in the world. This brand new report - US Pharmaceutical Market 2009-2024 - will provide you with extensive information about the US pharma market and industry to benefit your work.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 23 Nov 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Military Energy, Fuels and Power Sources Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/426/Military-Energy-Fuels-and-Power-Sources-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/426/Military-Energy-Fuels-and-Power-Sources-Market-2009-2019</guid>
		<category>defence</category>
		<description>Our new defence report - Military Energy, Fuels and Power Sources Market 2009-2019 - assesses the evolving opportunities presented by one of the defence industry's growing markets. Our market study examines the leading military consumers of energy, fuels and power sources and assesses the range of factors that are driving global sales growth.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 13 Nov 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Aircraft Avionics Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/423/The-Military-Aircraft-Avionics-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/423/The-Military-Aircraft-Avionics-Market-2009-2019</guid>
		<category>defence</category>
		<description>Our latest defence report – The Military Aircraft Avionics Market 2009-2019 – reveals the dynamic opportunities presented by one of the defence industry’s few growing markets. Our market study examines leading users of military aircraft avionics systems, and explores the operational requirements which are driving global growth in this sector. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 11 Nov 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Instant Messaging Report 2009-2014: Services in the Social Network and iPhone era</title>
		<link>http://www.visiongain.com/Report/424/Mobile-Instant-Messaging-Report-2009-2014-Services-in-the-Social-Network-and-iPhone-era</link>
		<guid>http://www.visiongain.com/Report/424/Mobile-Instant-Messaging-Report-2009-2014-Services-in-the-Social-Network-and-iPhone-era</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile operators across Europe and Asia have been looking to deploy customised but co-branded mobile IM (MIM) services since the end of 2006 in an effort to cement their position in the value chain. This renewed interest is being driven by perceived benefits such as increasing data ARPU, service differentiation, churn reduction and building customer loyalty. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 11 Nov 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Indian Pharmaceutical Market Outlook 2009-2024</title>
		<link>http://www.visiongain.com/Report/425/Indian-Pharmaceutical-Market-Outlook-2009-2024</link>
		<guid>http://www.visiongain.com/Report/425/Indian-Pharmaceutical-Market-Outlook-2009-2024</guid>
		<category>pharma</category>
		<description>The Indian pharmaceutical market is one of the fastest growing in the world. The rising Indian pharma market will achieve sales of close to $8 billion in 2009 and has enjoyed double-digit growth in the past five years, peaking at 25% in 2007. Will the Indian market continue to achieve high sales growth next decade?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 11 Nov 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Japanese Pharmaceutical Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/422/Japanese-Pharmaceutical-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/422/Japanese-Pharmaceutical-Market-2009-2024</guid>
		<category>pharma</category>
		<description>Japan is the second-largest pharmaceutical market in the world. As of the 12 months to Q1 2009, the Japanese pharmaceutical market accounted for nearly 10% of the world market, and generated total sales of $71.6bn. The Japanese government ensures that all citizens and workers have health insurance. Japan's healthcare expenditures have been increasing to keep up with the aging population, but the government is increasingly concerned that the expenses are unsustainable. What will happen in the Japanese pharmaceutical market next decade?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 22 Oct 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Smartphone Market 2009-2014: Consistent Window of Growth and Opportunity for the mobile sector</title>
		<link>http://www.visiongain.com/Report/421/The-Smartphone-Market-2009-2014-Consistent-Window-of-Growth-and-Opportunity-for-the-mobile-sector</link>
		<guid>http://www.visiongain.com/Report/421/The-Smartphone-Market-2009-2014-Consistent-Window-of-Growth-and-Opportunity-for-the-mobile-sector</guid>
		<category>telecoms &amp; IT</category>
		<description>Due to the arrival of a new generation of improved smartphones, with fuller sized screens, improved user interfaces, and advanced features such as GPS and accelerometers, the smartphone is becoming a key element in providing greater user access to the mobile internet and a plethora of services for communicating, content/document sharing and navigation. The smartphone has taken the mobile phone from a basic voice and text communications tool to a comprehensive web-connected platform for an ever-growing range of online and offline applications.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 21 Oct 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Analgesics Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/420/The-Global-Analgesics-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/420/The-Global-Analgesics-Market-2009-2024</guid>
		<category>pharma</category>
		<description>There remain many unmet therapeutic needs in the treatment of pain, as well as high demand for analgesic treatments worldwide. For several types of pain, including conditions such as diabetic neuropathy and sciatica, there are currently few treatments. Furthermore, the pain sector is associated with side effects. Novel compounds that demonstrate improved safety profiles - combined with high efficacies - have the potential to gain significant market shares from 2009 onwards.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 14 Oct 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>New Mobile Roaming Services &amp; Business Models 2009</title>
		<link>http://www.visiongain.com/Report/419/New-Mobile-Roaming-Services-Business-Models-2009</link>
		<guid>http://www.visiongain.com/Report/419/New-Mobile-Roaming-Services-Business-Models-2009</guid>
		<category>telecoms &amp; IT</category>
		<description>International mobile roaming is one of the most important services in the European mobile operator's portfolio. According to figures released by the GSM Association some 42 per cent of Europeans travel outside their home country. This is a higher proportion of travellers than any other major zone, while revenues from international roaming has accounted for up to 20 per cent of total mobile operator turnover in Europe. With the introduction of Pan European regulation the cost of roaming has become a highly visible target over time.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 12 Oct 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Precision-Guided Munitions Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/418/Precision-Guided-Munitions-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/418/Precision-Guided-Munitions-Market-2009-2019</guid>
		<category>defence</category>
		<description>This brand new report assesses the exciting opportunities presented by one of the defence industry's few growing markets in a climate of economic uncertainty. Our market study examines the leading military users of PGMs and details the requirements that are driving global sales growth. We examine the commercial prospects for companies involved in supplying weapons and components in the PGMs marketplace.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 29 Sep 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Neurodegenerative Diseases Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/417/World-Neurodegenerative-Diseases-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/417/World-Neurodegenerative-Diseases-Market-2009-2024</guid>
		<category>pharma</category>
		<description>The ageing of the baby-boom generation, combined with new and emerging treatments for neurodegenerative disorders - including multiple sclerosis, Alzheimer's disease and Parkinson's disease - will lead to further expansion of the neurodegenerative therapies market. Increasing disease prevalence and a robust pipeline make that sector dynamic and highly promising for pharmaceutical and biotechnology companies worldwide. Our new report - World Neurodegenerative Diseases Market 2009-2024 - explains why, revealing where the most-exciting developments will lie from the present onwards.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 18 Sep 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>User Interfaces 2009-2014: Enabling a compelling User Experience for the iPhone &amp; Web 2.0 era</title>
		<link>http://www.visiongain.com/Report/414/User-Interfaces-2009-2014-Enabling-a-compelling-User-Experience-for-the-iPhone-Web-2-0-era</link>
		<guid>http://www.visiongain.com/Report/414/User-Interfaces-2009-2014-Enabling-a-compelling-User-Experience-for-the-iPhone-Web-2-0-era</guid>
		<category>telecoms &amp; IT</category>
		<description>Within a short timeframe, the iPhone series of devices has helped fuel adoption of mobile applications and web access in North America and Europe unlike any device before. In the seven years prior to the launch, the paucity of user-friendly mobile web-focused devices proved a major obstacle to optimal growth in users and traffic. This 130+ page report analyses the market drivers and barriers affecting user interfaces, devices and applications.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 15 Sep 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Counter-IED Systems Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/415/The-Counter-IED-Systems-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/415/The-Counter-IED-Systems-Market-2009-2019</guid>
		<category>defence</category>
		<description>Improvised explosive devices (IEDs) are a significant threat in many conflict zones, most notably in Afghanistan and Iraq this decade. These makeshift bombs can be presented surreptitiously and used without warning, to devastating effect, especially against patrolling troops. The IED countermeasures market is an increasingly important defence sector that will exhibit growth over coming years, as this new defence report - The Counter-IED Systems Market 2009-2019 - shows. Our new study examines both commercial and technological aspects of the counter-IED sector analytically.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 15 Sep 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Airborne ISR Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/416/The-Global-Airborne-ISR-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/416/The-Global-Airborne-ISR-Market-2009-2019</guid>
		<category>defence</category>
		<description>Our latest defence report - The Global Airborne ISR Market 2009-2019 - covers the exciting opportunities presented by one of the defence industry's growing markets. Our market study examines leading users of airborne Intelligence, Surveillance and Reconnaissance (ISR) systems, and explores the operational requirements which are driving global growth in this sector. We assess the commercial prospects and outlook for companies offering airborne ISR systems. This analytical report defines the current state of the airborne ISR systems market and discusses its potential for growth from 2009 onwards, with market forecasting at the global and national levels.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 15 Sep 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Chinese Pharmaceutical Market Outlook 2009-2024</title>
		<link>http://www.visiongain.com/Report/412/Chinese-Pharmaceutical-Market-Outlook-2009-2024</link>
		<guid>http://www.visiongain.com/Report/412/Chinese-Pharmaceutical-Market-Outlook-2009-2024</guid>
		<category>pharma</category>
		<description>In November 2008, China announced a major economic stimulus package, including $124bn to be spent on healthcare. These changes will have a major impact on the Chinese pharmaceutical landscape over the next 15 years, as the stimulus increases the number of clinics in rural areas, dissociates pharmacies from hospitals and promises healthcare coverage to 100% of the population by 2020. This report analyses prospects for the pharma market and industry sector in China.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 27 Aug 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Google in Mobile 2009</title>
		<link>http://www.visiongain.com/Report/413/Google-in-Mobile-2009</link>
		<guid>http://www.visiongain.com/Report/413/Google-in-Mobile-2009</guid>
		<category>telecoms &amp; IT</category>
		<description>Having created, developed, grown and maintained the world's most popular internet search engine over the last decade, Google has turned its attentions to the mobile market. For the last few years, many of its web services and applications have been making their way to the mobile platform, as the take-up has increased at recession-defying rates for mobile web access and, most notably, for smartphones such as the iPhone and various BlackBerry models.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 27 Aug 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Generics Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/411/World-Generics-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/411/World-Generics-Market-2009-2024</guid>
		<category>pharma</category>
		<description>The generic pharmaceuticals sector has been expanding strongly in recent years as the need for cheaper medicines worldwide has increased. The next five years from 2009 will see more leading drugs going off patent, thus increasing opportunities for generics producers. Regulations favouring generic products give cause for optimism in the generics sector, while still leaving scope for novel branded drugs. We predict that total revenues in the generics market will continue to increase in the years ahead.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 26 Aug 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Military Simulation and Virtual Training Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/409/Military-Simulation-and-Virtual-Training-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/409/Military-Simulation-and-Virtual-Training-Market-2009-2019</guid>
		<category>defence</category>
		<description>Our latest defence report - Military Simulation and Virtual Training Market 2009-2019 - covers the exciting opportunities presented by one of the defence industry's growing markets. Our market study examines leading users of military simulation and virtual training, and outlines the requirements driving global growth. We assess the commercial prospects for companies offering military simulation products and services. This analytical report defines the current state of the military simulation and virtual training market and discusses its potential for growth from 2009 onwards, with market forecasting at the global and national levels.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 14 Aug 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Monoclonal Antibody Therapeutics 2009-2024</title>
		<link>http://www.visiongain.com/Report/408/Monoclonal-Antibody-Therapeutics-2009-2024</link>
		<guid>http://www.visiongain.com/Report/408/Monoclonal-Antibody-Therapeutics-2009-2024</guid>
		<category>pharma</category>
		<description>Monoclonal antibodies achieved total sales of nearly $32bn in 2008 and have grown rapidly to command over 30% of the global biologic drug market. We expect significant opportunities for further commercial growth from 2009 to 2024, as shown in our new report. New technologies will be an important growth driver. Intensive R&amp;D activity is producing an exciting antibody pipeline, filled with novel monoclonal antibodies, antibody fragments and antibody-drug conjugates.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 06 Aug 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military GPS/GNSS Devices Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/407/The-Military-GPS-GNSS-Devices-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/407/The-Military-GPS-GNSS-Devices-Market-2009-2019</guid>
		<category>defence</category>
		<description>Our latest defence report - The Military GPS/GNSS Devices Market 2009-2019 - examines one of the defence industry’s important emerging sectors. The Global Positioning System (GPS), with its US military origins, has led to a wide range of commercial products in recent years. We predict steady growth for the worldwide military GPS/GNSS devices market – you will see relevant forecasts in this report.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 28 Jul 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile LBA 2009-2014: how to generate revenue by advertising on mobile content, LBS and mobile search</title>
		<link>http://www.visiongain.com/Report/406/Mobile-LBA-2009-2014-how-to-generate-revenue-by-advertising-on-mobile-content-LBS-and-mobile-search</link>
		<guid>http://www.visiongain.com/Report/406/Mobile-LBA-2009-2014-how-to-generate-revenue-by-advertising-on-mobile-content-LBS-and-mobile-search</guid>
		<category>telecoms &amp; IT</category>
		<description>Location is a vital mobile tool. A whole of market opportunities for LBS and LBA have emerged in sectors such as Emergency Services; Emergency Alert Services; Home-Zone Billing; Fleet Management; Asset Management; Person Tracking; Pet Tracking; Traffic Congestion Reporting; Routing to Nearest Commercial Enterprise; Roadside Assistance; Navigation; City Sightseeing; Localised Advertising; Mobile Yellow Pages and Network Planning and Dynamic Network Control.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 27 Jul 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Emerging UMV and UGV Markets 2009-2019</title>
		<link>http://www.visiongain.com/Report/405/The-Emerging-UMV-and-UGV-Markets-2009-2019</link>
		<guid>http://www.visiongain.com/Report/405/The-Emerging-UMV-and-UGV-Markets-2009-2019</guid>
		<category>defence</category>
		<description>Our latest defence report - The Emerging UMV and UGV Markets 2009-2019 - examines one of the defence industry's most promising emerging markets. Our market study reviews leading unmanned maritime vehicle (UMV) and unmanned ground vehicle (UGV) programmes. Total governmental spending on research, development and procurement of UMV and UGV systems combined should reach $504 million worldwide in 2009.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 23 Jul 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Clinical Trials: World Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/403/Clinical-Trials-World-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/403/Clinical-Trials-World-Market-2009-2024</guid>
		<category>pharma</category>
		<description>The market for clinical trials has been expanding rapidly in recent years, with impressive revenue growth and important trends. One regional market expanded by 65% in 2008. From the perspectives of various pharma stakeholders, the expanding clinical research market represents opportunities for revenue growth and cost savings. Our latest report considers perspectives of pharma companies and CROs in particular. We comprehensively analyse the market's strengths, weaknesses and revenue trends from 2009 to 2024.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 22 Jul 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Mobile Web Browser Market 2009-2014: Challenges and opportunities in the Web 2.0, iPhone and Google Era</title>
		<link>http://www.visiongain.com/Report/404/The-Mobile-Web-Browser-Market-2009-2014-Challenges-and-opportunities-in-the-Web-2-0-iPhone-and-Google-Era</link>
		<guid>http://www.visiongain.com/Report/404/The-Mobile-Web-Browser-Market-2009-2014-Challenges-and-opportunities-in-the-Web-2-0-iPhone-and-Google-Era</guid>
		<category>telecoms &amp; IT</category>
		<description>Within a short timeframe, the iPhone series of devices has helped fuel mobile web adoption in North America and Europe unlike any device before. In the seven years prior to the launch, the paucity of user-friendly mobile web-focused devices proved a major obstacle to optimal growth in users and traffic.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 22 Jul 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/401/World-AMD-and-Diabetic-Retinopathy-Pharmaceutical-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/401/World-AMD-and-Diabetic-Retinopathy-Pharmaceutical-Market-2009-2024</guid>
		<category>pharma</category>
		<description>The global prevalences of AMD (age-related macular degeneration) and diabetic retinopathy are increasing due to rising numbers of older people worldwide. In addition, the world is facing a "diabetes epidemic", with rapidly-increasing numbers of people with diabetes and diabetic retinopathy. A clear market opportunity exists for pharmacological treatments for diabetic retinopathy, dry AMD and other retinal disorders. From 2009 to 2024, such treatments could repeat the commercial success that Lucentis achieved in the treatment of wet AMD.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 08 Jul 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Cardiovascular Drugs Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/399/Global-Cardiovascular-Drugs-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/399/Global-Cardiovascular-Drugs-Market-2009-2024</guid>
		<category>pharma</category>
		<description>Cardiovascular disorders are leading causes of death worldwide. Cardiovascular therapeutics form a central part of the global pharmaceutical market, with a wide range of treatments, including leading blockbusters. As the patient population grows and cardiovascular diseases become more prevalent, cardiovascular drugs have the potential for continued sales growth in both mature and emerging markets.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 30 Jun 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Advertising and Marketing 2009 - Market analysis and forecasts 2009-2014</title>
		<link>http://www.visiongain.com/Report/400/Mobile-Advertising-and-Marketing-2009-Market-analysis-and-forecasts-2009-2014</link>
		<guid>http://www.visiongain.com/Report/400/Mobile-Advertising-and-Marketing-2009-Market-analysis-and-forecasts-2009-2014</guid>
		<category>telecoms &amp; IT</category>
		<description>The global economy will recover but how soon, and what mobile advertising firms will be left when the upturn happens? As with any recession, advertising is hit strongly, but mobile advertising revenues correlate well with the beginning of Internet advertising so the potential still remain enormous and viable. As the global economy embarks on an inevitable recovery after its most serious setback in generations, new sectors are emerging stronger in terms of growth potential, with mobile advertising and marketing prominent among them.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 30 Jun 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Homeland Security 2009-2019</title>
		<link>http://www.visiongain.com/Report/397/Global-Homeland-Security-2009-2019</link>
		<guid>http://www.visiongain.com/Report/397/Global-Homeland-Security-2009-2019</guid>
		<category>defence</category>
		<description>Our new defence report - Global Homeland Security 2009-2019 - examines one of the defence industry's newest and most promising sectors. Governmental spending on products and services for homeland security should reach $141.6bn worldwide in 2009, our report shows. We expect that market to flourish from 2009 onwards, with high rewards for successful companies there. This report will show you the most promising areas and technologies for revenue growth, with detailed analyses.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 23 Jun 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Respiratory Disorders Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/398/World-Respiratory-Disorders-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/398/World-Respiratory-Disorders-Market-2009-2024</guid>
		<category>pharma</category>
		<description>Respiratory disorder therapies form an important and competitive part of the pharmaceutical market worldwide. There are wide ranges of drugs and therapeutic needs, both acute and chronic. Revenues are high currently, with good potential for sales increases. As the patient population grows and respiratory diseases become more prevalent, the market has the potential for continued growth in many countries and therapeutic areas. Our new pharma report will give you the analytical information that you need to understand current trends and likely future events in this market area.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 23 Jun 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Sleep Disorders Market Analysis 2009-2024</title>
		<link>http://www.visiongain.com/Report/396/World-Sleep-Disorders-Market-Analysis-2009-2024</link>
		<guid>http://www.visiongain.com/Report/396/World-Sleep-Disorders-Market-Analysis-2009-2024</guid>
		<category>pharma</category>
		<description>Sleep disorders affect hundreds of millions of people worldwide. It is a multi-billion dollar market for drug-based treatments with continuing potential for growth. This new report - World Sleep Disorders Market Analysis 2009-2024 - explains the commercial prospects for drugs to treat sleep disorders, an important, changing pharma market. The principal disorders are insomnia, narcolepsy, sleep apnea and restless leg syndrome, but there other potentially profitable market segments. Overall, sleep disorders are highly prevalent.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 18 Jun 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Geotagging - a new market opportunity from within the LBS and UGC markets, Analysis and Forecasts 2009-2014</title>
		<link>http://www.visiongain.com/Report/389/Mobile-Geotagging-a-new-market-opportunity-from-within-the-LBS-and-UGC-markets-Analysis-and-Forecasts-2009-2014</link>
		<guid>http://www.visiongain.com/Report/389/Mobile-Geotagging-a-new-market-opportunity-from-within-the-LBS-and-UGC-markets-Analysis-and-Forecasts-2009-2014</guid>
		<category>telecoms &amp; IT</category>
		<description>Identifying people, objects and data by their geographical location has always been crucial, though it has provided limited commercial value. However, the rapid evolution and commoditisation of the communication services technologies has led the way to the development of this activity as a business opportunity. One way to identify the data and objects by their physical location is by geotagging them - the process of adding geographical identification metadata to various media such as photographs, video, websites, RDF or RSS feeds and is a form of geospatial metadata.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 03 Jun 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>In Vitro Diagnostics Market Analysis 2009-2024</title>
		<link>http://www.visiongain.com/Report/392/In-Vitro-Diagnostics-Market-Analysis-2009-2024</link>
		<guid>http://www.visiongain.com/Report/392/In-Vitro-Diagnostics-Market-Analysis-2009-2024</guid>
		<category>pharma</category>
		<description>In vitro diagnostics constitute an important, growing healthcare industry and market, one that is increasingly biotechnological and closely aligned with pharma. In vitro diagnostic (IVD) tests provide essential information about physiological states, aiding diagnoses and choice of treatments. IVD's usefulness in drug development - especially via biomarkers - constitutes a major advance, and an expanding market opportunity. Our new report - In Vitro Diagnostics: Market Analysis 2009-2024 - analyses the global IVD market comprehensively.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 29 May 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global OTC Pharmaceutical Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/393/The-Global-OTC-Pharmaceutical-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/393/The-Global-OTC-Pharmaceutical-Market-2009-2024</guid>
		<category>pharma</category>
		<description>General economic trends worldwide will affect the over-the-counter (OTC) pharma market from 2009 onwards, with both market restraints and opportunities present. In this new report visiongain notes that Rx-to-OTC switching and the continuing importance of emerging pharma markets will drive OTC sales growth from 2009 onwards. Our forecasts reveal that the OTC pharma market will grow significantly next decade. This report explains where future OTC switching will occur, providing you with the information that you need to understand the current OTC market and its future prospects. The potential of this market remains significant, despite general economic uncertainty, visiongain asserts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 21 May 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Unmanned Aerial Vehicles (UAV) Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/387/The-Unmanned-Aerial-Vehicles-(UAV)-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/387/The-Unmanned-Aerial-Vehicles-(UAV)-Market-2009-2019</guid>
		<category>defence</category>
		<description>Our latest defence report examines one of the defence industry's most interesting and promising markets. Our market study reviews leading UAV programmes and products, with the prospects and outlook for providers of UAV systems and technologies. Those pilot-less aircraft are taking on important battlefield and security roles, becoming crucial to missions and other operations. Pending new rules, a significant civil UAV market is also poised to flourish. The high priority assigned to UAVs has made those products and systems relatively resistant to the global economic downturn, visiongain concludes. This report discusses that market in detail, explaining its characteristics and potential from 2009 onwards.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 20 May 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The IMS Report Market Forecast 2009-2014</title>
		<link>http://www.visiongain.com/Report/388/The-IMS-Report-Market-Forecast-2009-2014</link>
		<guid>http://www.visiongain.com/Report/388/The-IMS-Report-Market-Forecast-2009-2014</guid>
		<category>telecoms &amp; IT</category>
		<description>Virtually every major telecom industry player must now be dealing with IMS. News of planned IMS-compatible products and services are arriving with regularity. Are you one of those players? If you are testing IMS, then you must understand what strategies to adopt to implement and profit from this technology now to safeguard medium to long term growth in subscribers and usage.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 May 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Social Networking and User Generated Content Market Insight 2009-2014</title>
		<link>http://www.visiongain.com/Report/391/Mobile-Social-Networking-and-User-Generated-Content-Market-Insight-2009-2014</link>
		<guid>http://www.visiongain.com/Report/391/Mobile-Social-Networking-and-User-Generated-Content-Market-Insight-2009-2014</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile social networking is already here on a phone near you. Due to media attention, no one in your industry can have failed to have noticed not only the success but also the hitherto unrealised potential of social networks and user generated content on mobile. You need to react now. If you wait, the opportunity may be gone. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 May 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Monoclonal Antibodies in Cancer Therapy 2009-2024</title>
		<link>http://www.visiongain.com/Report/394/Monoclonal-Antibodies-in-Cancer-Therapy-2009-2024</link>
		<guid>http://www.visiongain.com/Report/394/Monoclonal-Antibodies-in-Cancer-Therapy-2009-2024</guid>
		<category>pharma</category>
		<description>Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapies. The monoclonal antibodies oncology market has been growing at a significant rate and holds high potential for continued growth in both mature and emerging geographical markets. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 07 May 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmacovigilance Report and Analysis 2009:  Present Challenges and Future Goals</title>
		<link>http://www.visiongain.com/Report/395/Pharmacovigilance-Report-and-Analysis-2009-Present-Challenges-and-Future-Goals</link>
		<guid>http://www.visiongain.com/Report/395/Pharmacovigilance-Report-and-Analysis-2009-Present-Challenges-and-Future-Goals</guid>
		<category>pharma</category>
		<description>Pharmacovigilance has been expanding in recent years, as companies are required to monitor drug safety post launch. Drug safety issues, such as those raised by Vioxx earlier this decade, have led to increased risk-averseness by regulators, with greater post-marketing assessment of drugs. Many regulatory agencies require detailed pharmacovigilance, with companies bearing extra costs, our new report also observes.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 21 Apr 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Money Transfer Report 2009: Profiting from cross-border remittance and global banking</title>
		<link>http://www.visiongain.com/Report/385/Mobile-Money-Transfer-Report-2009-Profiting-from-cross-border-remittance-and-global-banking</link>
		<guid>http://www.visiongain.com/Report/385/Mobile-Money-Transfer-Report-2009-Profiting-from-cross-border-remittance-and-global-banking</guid>
		<category>telecoms &amp; IT</category>
		<description>Despite the impact of the 2008-2009 global downturn, remittances as a source of liquidity will likely prove to be resilient, and could potentially play a role in restoring or increasing prosperity across regions. Whereas the sharp contraction of credit in the global banking sector has directly and instantaneously ravaged FDI alongside private debt and equity flows, remittances to the developing world are slowing down more gradually and indirectly as a result of declining personal consumption, lay-offs, and lower salaries impacting the real economy. This adds the resilience of remittances, where migrant workers will continue sending money to relatives in their countries of origin during uncertain economic times, albeit at less regular intervals and/or in smaller amounts.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 17 Apr 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Airlift Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/380/The-Military-Airlift-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/380/The-Military-Airlift-Market-2009-2019</guid>
		<category>defence</category>
		<description>This brand new visiongain report examines current trends and future prospects for the military airlift products market. This is an established market that is expected to see steady growth from 2009 onwards. Visiongain estimates that the global military airlift market generated sales of over $7bn in 2008, predicting that annual sales will increase to over $10bn by next decade. Do you want to know where the sales growth will occur?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Apr 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024</title>
		<link>http://www.visiongain.com/Report/381/Biosimilars-and-Follow-On-Biologics-Report-The-Global-Outlook-2009-2024</link>
		<guid>http://www.visiongain.com/Report/381/Biosimilars-and-Follow-On-Biologics-Report-The-Global-Outlook-2009-2024</guid>
		<category>pharma</category>
		<description>This report predicts how the biosimilar market will evolve from 2009 to 2024. We indentify and discuss the biosimilar drugs and manufacturers that will achieve commercial success during the coming fifteen years. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Apr 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Email 2009: Challenging Blackberry and succeeding in the consumer market</title>
		<link>http://www.visiongain.com/Report/377/Mobile-Email-2009-Challenging-Blackberry-and-succeeding-in-the-consumer-market</link>
		<guid>http://www.visiongain.com/Report/377/Mobile-Email-2009-Challenging-Blackberry-and-succeeding-in-the-consumer-market</guid>
		<category>telecoms &amp; IT</category>
		<description>As handset technology continues to improve, increasingly more mobile devices are offering mobile email services. Consequently email is being positioned as a feasible communication method around the world. The days of mobile email being predominantly used by enterprise users are fading. So what are the financial opportunities in the consumer email market?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 06 Apr 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Apple's iPhone &amp; Mobile Report 2009: Competing successfully with Devices, Content &amp; Services from Apple</title>
		<link>http://www.visiongain.com/Report/378/Apple's-iPhone-Mobile-Report-2009-Competing-successfully-with-Devices-Content-Services-from-Apple</link>
		<guid>http://www.visiongain.com/Report/378/Apple's-iPhone-Mobile-Report-2009-Competing-successfully-with-Devices-Content-Services-from-Apple</guid>
		<category>telecoms &amp; IT</category>
		<description>Having long harboured ambitions to enter the mobile space, Apple has blazed a convincing trail through the market across the mobile board, i.e. devices, content and services. After upgrading the iPhone's network connectivity fom EDGE to 3.5G in 2008, Apple has witnessed the iPhone becoming a cultural near-phenomenon, and managed to maintain a delicate balance for its AppStore and iTunes offerings on the device via partner mobile operators' networks.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 06 Apr 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The mVoIP market 2009-2014 - Successfully profiting from VoIP over mobile</title>
		<link>http://www.visiongain.com/Report/379/The-mVoIP-market-2009-2014-Successfully-profiting-from-VoIP-over-mobile</link>
		<guid>http://www.visiongain.com/Report/379/The-mVoIP-market-2009-2014-Successfully-profiting-from-VoIP-over-mobile</guid>
		<category>telecoms &amp; IT</category>
		<description>mVoIP is now lining up to challenge the established technologies with the introduction of products and services that meet the needs of modern business and technology savvy consumers. Consequently, service providers are aggressively looking for ways to offer mVoIP to consumers.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 06 Apr 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Stem Cells - The Hype &amp; Hope - World Analysis 2009-2024</title>
		<link>http://www.visiongain.com/Report/376/Stem-Cells-The-Hype-Hope-World-Analysis-2009-2024</link>
		<guid>http://www.visiongain.com/Report/376/Stem-Cells-The-Hype-Hope-World-Analysis-2009-2024</guid>
		<category>pharma</category>
		<description>Stem cells represent one of the most promising medical breakthroughs of all time, as our new market report explains. Currently, in 2009, the new US administration is lifting some major restrictions on stem cells technologies. This developmental obstacle now removed, all types of stem cells are available for expanding the therapeutic and commercial potentials.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 23 Mar 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Rural Mobile Connectivity Prospects 2009-2014 - Increasing Business Growth and Development from Rural Mobile Expansion</title>
		<link>http://www.visiongain.com/Report/372/Rural-Mobile-Connectivity-Prospects-2009-2014-Increasing-Business-Growth-and-Development-from-Rural-Mobile-Expansion</link>
		<guid>http://www.visiongain.com/Report/372/Rural-Mobile-Connectivity-Prospects-2009-2014-Increasing-Business-Growth-and-Development-from-Rural-Mobile-Expansion</guid>
		<category>telecoms &amp; IT</category>
		<description>Are the rural markets of China, India and Africa the next phase of mobile development?
In most countries, rural communities present a wide and untapped market for many products and services including telecommunications services that were initially targeted at mainly urban populations.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Mar 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Google Android and Nokia Symbian: Increasing content, service and advertising market opportunities from competition in mobile OS, 2009-2014</title>
		<link>http://www.visiongain.com/Report/373/Google-Android-and-Nokia-Symbian-Increasing-content-service-and-advertising-market-opportunities-from-competition-in-mobile-OS-2009-2014</link>
		<guid>http://www.visiongain.com/Report/373/Google-Android-and-Nokia-Symbian-Increasing-content-service-and-advertising-market-opportunities-from-competition-in-mobile-OS-2009-2014</guid>
		<category>telecoms &amp; IT</category>
		<description>With a new generation of improved smart phones, with fuller sized screen and keyboard and an improved user interface, the smart phone is a key element in providing greater user access to the mobile internet. If Smart phones are essentially highly handheld computers with wireless connectivity, then as with the PC, the operating system is critical. Will whoever captures this market be the Microsoft of the mobile?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Mar 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Multiple Sclerosis Market 2009-2024</title>
		<link>http://www.visiongain.com/Report/374/The-Global-Multiple-Sclerosis-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/374/The-Global-Multiple-Sclerosis-Market-2009-2024</guid>
		<category>pharma</category>
		<description>The multiple sclerosis (MS) market has total global revenues of over $6bn in 2008. Those revenues will exceed $9bn during the second half of next decade, our new study shows. This report will provide you with the analytical information that you need to understand current trends and future directions in the MS market area, the successful drugs being introduced and where the future successful growth of the market lies.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Mar 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Military Communications &amp; COTS 2009-2019: A Market in Retreat?</title>
		<link>http://www.visiongain.com/Report/375/Military-Communications-COTS-2009-2019-A-Market-in-Retreat</link>
		<guid>http://www.visiongain.com/Report/375/Military-Communications-COTS-2009-2019-A-Market-in-Retreat</guid>
		<category>defence</category>
		<description>Adoption of new commercially-available platforms and technologies has fuelled a global military communications industry worth more than $15bn per annum. Prime beneficiaries of this trend have included suppliers of commercial off-the-shelf (COTS) products and services to the military. Given the onset of the global economic recession in late 2008 and new potential constraints on defence budgets across the world, visiongain revisits the military communications market to ask whether the recent growth trend will be sustainable over the next decade.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Mar 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile iTunes - Mobile Music 2009 - Can any mobile music provider compete with iTunes?</title>
		<link>http://www.visiongain.com/Report/371/Mobile-iTunes-Mobile-Music-2009-Can-any-mobile-music-provider-compete-with-iTunes</link>
		<guid>http://www.visiongain.com/Report/371/Mobile-iTunes-Mobile-Music-2009-Can-any-mobile-music-provider-compete-with-iTunes</guid>
		<category>telecoms &amp; IT</category>
		<description>The dominance of iTunes has been reinforced via the success of the iPhone and is threatening to marginalise other handset manufacturers and operators, much to the detriment of free choice. This scenario is feared and unwanted by the other major stakeholders in this sphere, the record labels. How can your company benefit from being involved in this market, given this latter scenario and the possible ways of competing with Apple?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 12 Mar 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Music Report - Analysis, Forecasts and Markets 2009</title>
		<link>http://www.visiongain.com/Report/370/Mobile-Music-Report-Analysis-Forecasts-and-Markets-2009</link>
		<guid>http://www.visiongain.com/Report/370/Mobile-Music-Report-Analysis-Forecasts-and-Markets-2009</guid>
		<category>telecoms &amp; IT</category>
		<description>Music on the mobile platform has extended past the confines of the ringtone and has developed on the mobile handset and the mobile web. Mobile music has become a business in its own right with players both on and off the mobile platform. The growing reach of mobile handsets and the mobile web has driven the reach of mobile music and, given the size of the mobile audience, this remains a valuable market to invest in content.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 04 Mar 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Statins: The World Market, 2009-2024</title>
		<link>http://www.visiongain.com/Report/369/Statins-The-World-Market-2009-2024</link>
		<guid>http://www.visiongain.com/Report/369/Statins-The-World-Market-2009-2024</guid>
		<category>pharma</category>
		<description>The world statins market is changing, with patent expires and maturity of the landmark product Lipitor (atorvastatin). Statins are at the forefront of strategies to combat dyslipidaemia, being pivotal in the prevention of coronary heart disease. Consequently, those drugs are one of the most widely-prescribed and most lucrative sectors of the pharmaceutical industry, with total revenues exceeding $26 billion in 2008.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 03 Mar 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Inflammatory Bowel Diseases: World Market Report 2009-2024</title>
		<link>http://www.visiongain.com/Report/366/Inflammatory-Bowel-Diseases-World-Market-Report-2009-2024</link>
		<guid>http://www.visiongain.com/Report/366/Inflammatory-Bowel-Diseases-World-Market-Report-2009-2024</guid>
		<category>pharma</category>
		<description>This brand new in-depth market analysis examines the current and future prospects of the inflammatory bowel diseases (IBD) market. The world market for intestinal anti-inflammatories was worth over $2400 million in 2008, and had grown at 9% over the previous year.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 23 Feb 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Anti-Obesity Treatments Report - Analysis &amp; Forecasts 2009-2024</title>
		<link>http://www.visiongain.com/Report/367/Anti-Obesity-Treatments-Report-Analysis-Forecasts-2009-2024</link>
		<guid>http://www.visiongain.com/Report/367/Anti-Obesity-Treatments-Report-Analysis-Forecasts-2009-2024</guid>
		<category>pharma</category>
		<description>Obesity has been described as a 'public health time-bomb'. In 2005, the World Health Organization estimated that approximately 400 million individuals are obese. Prevalence of obesity is rising worryingly in many countries, despite campaigns emphasising the link between being overweight and contracting diabetes. This new report - Anti-Obesity Treatments 2009-2024 - explains those trends in commercial terms.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 23 Feb 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Soldier Modernisation Market 2009-2019</title>
		<link>http://www.visiongain.com/Report/368/The-Soldier-Modernisation-Market-2009-2019</link>
		<guid>http://www.visiongain.com/Report/368/The-Soldier-Modernisation-Market-2009-2019</guid>
		<category>defence</category>
		<description>This new visiongain defence report - The Soldier Modernisation Market 2009-2019 - examines current trends and future prospects for the soldier modernisation market. Those products and systems are becoming characteristic of 21st century warfare. Visiongain estimates that soldier modernisation applications generated a total $440 million in sales worldwide during 2008.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 23 Feb 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Near Field Communications - the future of m-payments? An analysis and forecast for NFC applications and markets 2009-2014</title>
		<link>http://www.visiongain.com/Report/365/Near-Field-Communications-the-future-of-m-payments-An-analysis-and-forecast-for-NFC-applications-and-markets-2009-2014</link>
		<guid>http://www.visiongain.com/Report/365/Near-Field-Communications-the-future-of-m-payments-An-analysis-and-forecast-for-NFC-applications-and-markets-2009-2014</guid>
		<category>telecoms &amp; IT</category>
		<description>Near Field Communication (NFC) has changed the technological environment for the mobile communication and mobile payments. The technology has proven its potential to lead as the m-payments market in the future. A consistent amount of efforts have been made on the development on the NFC to increase the number of its applications, and also their scope. The technology has now started to move into commercial phase.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 13 Feb 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Diabetes Market Analysis, 2009-2023</title>
		<link>http://www.visiongain.com/Report/364/World-Diabetes-Market-Analysis-2009-2023</link>
		<guid>http://www.visiongain.com/Report/364/World-Diabetes-Market-Analysis-2009-2023</guid>
		<category>pharma</category>
		<description>Incidence and prevalence of diabetes mellitus are increasing worldwide, in line with lifestyle changes and population aging. In particular, the rising prevalence of diabetes is closely linked with that of obesity, creating significant market opportunities. The World Health Organization estimates the number of diabetics to exceed 350 million by 2030. Governments and other healthcare providers around the world are investing in health education, diagnosis and treatments for this chronic, debilitating - but controllable - disorder.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 10 Feb 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>IED Defence Market 2009-2018</title>
		<link>http://www.visiongain.com/Report/362/IED-Defence-Market-2009-2018</link>
		<guid>http://www.visiongain.com/Report/362/IED-Defence-Market-2009-2018</guid>
		<category>defence</category>
		<description>Improvised explosive devices (IEDs) are a significant threat in many conflict zones, most notably in Afghanistan and Iraq currently. Those makeshift bombs can be presented surreptitiously and used without warning, to devastating effect, especially against patrolling troops. Main threats take the form of roadside bombs, car bombs and suicide bombing. The IED countermeasures and defence market is an important defence sector that will exhibit significant growth over the coming years, as this new visiongain defence report shows.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 05 Feb 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Video Forecasts: Networking, Advertising and Entertainment 2009</title>
		<link>http://www.visiongain.com/Report/363/Mobile-Video-Forecasts-Networking-Advertising-and-Entertainment-2009</link>
		<guid>http://www.visiongain.com/Report/363/Mobile-Video-Forecasts-Networking-Advertising-and-Entertainment-2009</guid>
		<category>telecoms &amp; IT</category>
		<description>How can your company utilise mobile video to maximise advertising revenue?
Will mobile video integrate smoothly into mobile social networking?
Can mobile companies have significant revenue benefits through mobile video entertainment?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 05 Feb 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Smoking Cessation Report, 2009-2024</title>
		<link>http://www.visiongain.com/Report/361/Smoking-Cessation-Report-2009-2024</link>
		<guid>http://www.visiongain.com/Report/361/Smoking-Cessation-Report-2009-2024</guid>
		<category>pharma</category>
		<description>Smoking is the leading cause of preventable death in the world. The effects of smoking represent a global pandemic of enormous proportions. Currently-marketed smoking cessation aids typically lack high levels of efficacy in practice and are associated with marked side-effects. There are clear market opportunities for novel, more-efficacious and safer smoking cessation agents, in both prescription and OTC forms.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 03 Feb 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Undersea Warfare Systems, 2009</title>
		<link>http://www.visiongain.com/Report/359/Undersea-Warfare-Systems-2009</link>
		<guid>http://www.visiongain.com/Report/359/Undersea-Warfare-Systems-2009</guid>
		<category>defence</category>
		<description>Brand new unqiue insight into the full-spectrum of research, development, test and evaluation, engineering and fleet support centre for submarines, autonomous underwater systems, and offensive and defensive weapons systems associated with undersea warfare. Are you fully informed?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 21 Jan 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Apple in Mobile 2009</title>
		<link>http://www.visiongain.com/Report/360/Apple-in-Mobile-2009</link>
		<guid>http://www.visiongain.com/Report/360/Apple-in-Mobile-2009</guid>
		<category>telecoms &amp; IT</category>
		<description>Apple Inc has made its name in providing consumer electronics and demonstrating brand strength and recognisability among a variety of computer products. In 2007 Apple entered the mobile market with its now famous iPhone and the product has become synonymous with mobile ubiquity and high end user experience. The mobile market represents a market that continues to grow and offers diverse scope for development of technologies, both on and off the mobile platform.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 21 Jan 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics - 2009-2023</title>
		<link>http://www.visiongain.com/Report/358/Ophthalmic-Pharmaceuticals-Market-Analysis-Forecasts-and-Dynamics-2009-2023</link>
		<guid>http://www.visiongain.com/Report/358/Ophthalmic-Pharmaceuticals-Market-Analysis-Forecasts-and-Dynamics-2009-2023</guid>
		<category>pharma</category>
		<description>The global market for ophthalmic pharmaceuticals is a large and profitable segment of the healthcare market, with ophthalmic sales of over $10bn in 2007. The recent therapeutic and commercial success of Lucentis has increased the number of blockbuster ophthalmic drugs and highlighted the lucrative commercial rewards on offer in this sector. Which will be the blockbusters of the future?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 15 Jan 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Dermatological Market Outlook, 2009-2023</title>
		<link>http://www.visiongain.com/Report/357/The-World-Dermatological-Market-Outlook-2009-2023</link>
		<guid>http://www.visiongain.com/Report/357/The-World-Dermatological-Market-Outlook-2009-2023</guid>
		<category>pharma</category>
		<description>This new market analysis by visiongain is to examine the current and future prospects for the world dermatological market. The world dermatological market generated total sales revenues of over $18bn in 2007. Visiongain predicts that this market area will expand further, increasing its total revenues significantly based on expansion of the market for modern drugs to treat skin disorders in developing countries, most notably China, India and Brazil.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 08 Jan 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Quad-Play and Service Bundling Strategy, Market Analysis &amp; Forecasts 2009</title>
		<link>http://www.visiongain.com/Report/356/Quad-Play-and-Service-Bundling-Strategy-Market-Analysis-Forecasts-2009</link>
		<guid>http://www.visiongain.com/Report/356/Quad-Play-and-Service-Bundling-Strategy-Market-Analysis-Forecasts-2009</guid>
		<category>telecoms &amp; IT</category>
		<description>Quad play and the idea of service bundling have existed for a few years now. There have been a number of companies trying to initiate the concept, such as the likes of Virgin Media and France Telecom. But how successfully have these original pioneers been in promoting quad play to consumers?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 05 Jan 2009 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Top-10 Biotech Companies - Market Outlook, 2008-2023</title>
		<link>http://www.visiongain.com/Report/355/Top-10-Biotech-Companies-Market-Outlook-2008-2023</link>
		<guid>http://www.visiongain.com/Report/355/Top-10-Biotech-Companies-Market-Outlook-2008-2023</guid>
		<category>pharma</category>
		<description>The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has experienced great expansion since its emergence during the 1970's.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 04 Dec 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile payments: markets, analysis and forecast 2008-2013</title>
		<link>http://www.visiongain.com/Report/354/Mobile-payments-markets-analysis-and-forecast-2008-2013</link>
		<guid>http://www.visiongain.com/Report/354/Mobile-payments-markets-analysis-and-forecast-2008-2013</guid>
		<category>telecoms &amp; IT</category>
		<description>The technology available on mobile phones has rapidly evolved over the past few years. The mobile phone is now becoming an "essential life management tool" for users. Alongside the mobile Web and mobile multimedia, mobile payment, also called M-payment or mpayment, lies at the forefront of this technological innovation and development.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 03 Dec 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Generics Market, 2008-2013</title>
		<link>http://www.visiongain.com/Report/353/World-Generics-Market-2008-2013</link>
		<guid>http://www.visiongain.com/Report/353/World-Generics-Market-2008-2013</guid>
		<category>pharma</category>
		<description>The generics market remains a major growth area in the global healthcare market. That growth has been partly driven by cost-containment in several national healthcare sectors, with governments seeking to promote the use of generic products over higher-priced originator products. The global generic pharmaceuticals market was worth over $100bn in 2007, with market growth noticeably higher that that of the overall pharmaceutical market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 24 Nov 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Pain Market, 2008-2023</title>
		<link>http://www.visiongain.com/Report/351/The-Global-Pain-Market-2008-2023</link>
		<guid>http://www.visiongain.com/Report/351/The-Global-Pain-Market-2008-2023</guid>
		<category>pharma</category>
		<description>The global pain market generated total sales of $34bn in 2007 – but what will the figures be in the next 5 and 10 years? This report tells you.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 13 Nov 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Seamless Multimedia and Vertical Handover Report 2008</title>
		<link>http://www.visiongain.com/Report/350/Seamless-Multimedia-and-Vertical-Handover-Report-2008</link>
		<guid>http://www.visiongain.com/Report/350/Seamless-Multimedia-and-Vertical-Handover-Report-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>During the 4G era, GSM, CDMA, 3G, WiFi, WiMAX, LTE, UMB, Bluetooth and UWB networks are all expected to co-exist. Handover between heterogeneous access technologies which is also known as vertical handover is therefore expected to become particularly significant in the future.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 12 Nov 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Cyberwarfare, 2008-2018</title>
		<link>http://www.visiongain.com/Report/347/Cyberwarfare-2008-2018</link>
		<guid>http://www.visiongain.com/Report/347/Cyberwarfare-2008-2018</guid>
		<category>defence</category>
		<description>Cyber attacks have for some time been no longer in the realm of fiction or film, but a cause for concern in the real world. There is now a realisation among many governments and militaries that "cyberspace" has become a new battleground, possibly on par with other recognised battle spaces in conventional warfare and defensive operations.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 06 Nov 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Anti-Addiction Market, 2008-2023</title>
		<link>http://www.visiongain.com/Report/346/The-Global-Anti-Addiction-Market-2008-2023</link>
		<guid>http://www.visiongain.com/Report/346/The-Global-Anti-Addiction-Market-2008-2023</guid>
		<category>pharma</category>
		<description>The global addiction market is significantly undervalued. The world's population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents? The brand new report, The Global Anti-Addiction Market, 2008-2023, provides an in-depth analysis of the current state of the market for addiction therapy drugs, from the present looking forward.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 05 Nov 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Gastrointestinal Disorders Market 2008-2023</title>
		<link>http://www.visiongain.com/Report/344/World-Gastrointestinal-Disorders-Market-2008-2023</link>
		<guid>http://www.visiongain.com/Report/344/World-Gastrointestinal-Disorders-Market-2008-2023</guid>
		<category>pharma</category>
		<description>The gastrointestinal (GI) disorders market has been one of the largest and most profitable therapeutic areas in the world pharmaceutical industry. However. the market is now mature, with well-established treatments now nearing the end of their patent life. So can you and your company continue to benefit from this market?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 30 Oct 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile ID Fraud Report 2008</title>
		<link>http://www.visiongain.com/Report/345/Mobile-ID-Fraud-Report-2008</link>
		<guid>http://www.visiongain.com/Report/345/Mobile-ID-Fraud-Report-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>Identity fraud is a growing global concern. Consumers are growing more protective of their personal data in fear of identity theft and fraud being committed against them. Recent high media profile cases of identities being lost, stolen or fraudulently used have heightened public concern.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 30 Oct 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Airborne ISR Market 2008-2018</title>
		<link>http://www.visiongain.com/Report/343/The-Global-Airborne-ISR-Market-2008-2018</link>
		<guid>http://www.visiongain.com/Report/343/The-Global-Airborne-ISR-Market-2008-2018</guid>
		<category>defence</category>
		<description>Since the Global War on Terrorism began, the airborne intelligence, surveillance and reconnaissance (ISR) systems market has flourished. Unmanned aerial vehicles (UAVs) have played an increasing role in military and defence operations. Increasing demands for national security, situational awareness and timely intelligence are all set to boost the airborne ISR market over from 2008 onwards.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 22 Oct 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Japanese Pharmaceutical Market 2008-2023</title>
		<link>http://www.visiongain.com/Report/342/The-Japanese-Pharmaceutical-Market-2008-2023</link>
		<guid>http://www.visiongain.com/Report/342/The-Japanese-Pharmaceutical-Market-2008-2023</guid>
		<category>pharma</category>
		<description>Last year, the Japanese pharmaceutical market was the second largest in the world, with a value of $58.5bn. However, Japan’s market has experienced growth at a much lower rate than the other major pharmaceutical markets. It is at a key stage in its development. You need to take notice of these changes.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 10 Oct 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Film Content Forecasts &amp; Analysis 2008-2013</title>
		<link>http://www.visiongain.com/Report/341/Mobile-Film-Content-Forecasts-Analysis-2008-2013</link>
		<guid>http://www.visiongain.com/Report/341/Mobile-Film-Content-Forecasts-Analysis-2008-2013</guid>
		<category>telecoms &amp; IT</category>
		<description>The film industry is hugely profitable. "Titanic," the highest grossing film to date grossed $1.8 billion in cinemas, just an indication of the huge amount of money involved in the industry. Mobile companies of all description are taking notice of the revenue generation potential possibilities that movies on mobile can bring them.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 03 Oct 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Women's Reproductive Disorders Therapeutics 2008-2018</title>
		<link>http://www.visiongain.com/Report/340/Women's-Reproductive-Disorders-Therapeutics-2008-2018</link>
		<guid>http://www.visiongain.com/Report/340/Women's-Reproductive-Disorders-Therapeutics-2008-2018</guid>
		<category>pharma</category>
		<description>This visiongain report provides a detailed analysis of the market for women's reproductive health pharmaceutical products. The report discusses current and future products and market climates for the following areas:
- Hormonal contraceptive use
- Use of hormone replacement therapy (HRT) for menopause
- Infertility therapeutics.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 30 Sep 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biometrics for Homeland Security Analysis &amp; Forecasts 2008-2018</title>
		<link>http://www.visiongain.com/Report/339/Biometrics-for-Homeland-Security-Analysis-Forecasts-2008-2018</link>
		<guid>http://www.visiongain.com/Report/339/Biometrics-for-Homeland-Security-Analysis-Forecasts-2008-2018</guid>
		<category>defence</category>
		<description>The September 11, 2001, terrorist attacks in the United States and later bombings in Madrid in 2004 and London in 2005 have made it imperative for countries worldwide to tighten national security. These security measures require more-accurate, suitable and efficient ways to identify and monitor individuals passing through airports, border stations and other points of entry.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 19 Sep 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Antivirals Market Analysis &amp; Forecasts 2008-2023</title>
		<link>http://www.visiongain.com/Report/338/Global-Antivirals-Market-Analysis-Forecasts-2008-2023</link>
		<guid>http://www.visiongain.com/Report/338/Global-Antivirals-Market-Analysis-Forecasts-2008-2023</guid>
		<category>pharma</category>
		<description>Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market.  Twenty years from the inception of focused antiviral drug research, there are 8 blockbuster drugs currently on the market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 10 Sep 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Geotagging - the next killer wireless application? Analysis and Forecasts 2008-2013</title>
		<link>http://www.visiongain.com/Report/337/Geotagging-the-next-killer-wireless-application-Analysis-and-Forecasts-2008-2013</link>
		<guid>http://www.visiongain.com/Report/337/Geotagging-the-next-killer-wireless-application-Analysis-and-Forecasts-2008-2013</guid>
		<category>telecoms &amp; IT</category>
		<description>Geotagging, sometimes referred to as Geocoding, is the process of adding geographical identification data to various media. It is usually used to tag photos or images of a certain location, but clearly has potential beyond this into the realms of mobile search, mapping and advertising.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 05 Sep 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Vaccines Market 2008-2023</title>
		<link>http://www.visiongain.com/Report/336/The-Global-Vaccines-Market-2008-2023</link>
		<guid>http://www.visiongain.com/Report/336/The-Global-Vaccines-Market-2008-2023</guid>
		<category>pharma</category>
		<description>The key growth driver for vaccines is their cost-effectiveness in combating disease. This situation will encourage greater use of vaccines by governments and private healthcare providers. New disease targets that could be mitigated through vaccination, including high profile (and potentially profitable) targets such as cancer.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 01 Sep 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Device Management 2008-2013: Evaluating the business case for FOTA alongside trends in configuration and security</title>
		<link>http://www.visiongain.com/Report/335/Mobile-Device-Management-2008-2013-Evaluating-the-business-case-for-FOTA-alongside-trends-in-configuration-and-security</link>
		<guid>http://www.visiongain.com/Report/335/Mobile-Device-Management-2008-2013-Evaluating-the-business-case-for-FOTA-alongside-trends-in-configuration-and-security</guid>
		<category>telecoms &amp; IT</category>
		<description>Growth in mobile data services and the surge in sales of high-end mobile devices has drawn greater attention to the issue of mobile device management (MDM), among operators and handset manufacturers.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 29 Aug 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Biotech Market Analysis and Forecasts, 2008-2023</title>
		<link>http://www.visiongain.com/Report/333/Global-Biotech-Market-Analysis-and-Forecasts-2008-2023</link>
		<guid>http://www.visiongain.com/Report/333/Global-Biotech-Market-Analysis-and-Forecasts-2008-2023</guid>
		<category>pharma</category>
		<description>The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has experienced great expansion since its emergence during the 1970s.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 26 Aug 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Military Simulation and Virtual Training Market Analysis 2008-2018</title>
		<link>http://www.visiongain.com/Report/334/The-Military-Simulation-and-Virtual-Training-Market-Analysis-2008-2018</link>
		<guid>http://www.visiongain.com/Report/334/The-Military-Simulation-and-Virtual-Training-Market-Analysis-2008-2018</guid>
		<category>defence</category>
		<description>The military simulation and virtual training market has seen dramatic growth in the last decade and it is expected to grow steadily over the next ten years. Increasing concerns over training costs, time and risk of life have forced military forces around the world to adapt technologies such as computer-based simulators and computer wargames in military training.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 26 Aug 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Contract Pharma 2008-2023</title>
		<link>http://www.visiongain.com/Report/330/Contract-Pharma-2008-2023</link>
		<guid>http://www.visiongain.com/Report/330/Contract-Pharma-2008-2023</guid>
		<category>pharma</category>
		<description>The revenue for world contract manufacturing business in 2007 was approximately $30bn, with a growth rate of 6% from 2006. The technical expertise and cost savings offered by contract manufacturing organisations (CMOs) make them increasingly essential to you and your organisation.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Aug 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Osteoporosis &amp; Bone Metabolism Disorders Market 2008-2023 Management Report</title>
		<link>http://www.visiongain.com/Report/331/Osteoporosis-Bone-Metabolism-Disorders-Market-2008-2023-Management-Report</link>
		<guid>http://www.visiongain.com/Report/331/Osteoporosis-Bone-Metabolism-Disorders-Market-2008-2023-Management-Report</guid>
		<category>pharma</category>
		<description>In 2007, the world market for bone metabolism disorder pharmaceuticals generated sales of over $10bn - how much of this market have you captured?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Aug 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pfizer - Market Outlook for a Global Leader, 2008-2013</title>
		<link>http://www.visiongain.com/Report/326/Pfizer-Market-Outlook-for-a-Global-Leader-2008-2013</link>
		<guid>http://www.visiongain.com/Report/326/Pfizer-Market-Outlook-for-a-Global-Leader-2008-2013</guid>
		<category>pharma</category>
		<description>Pfizer is the world's largest and most profitable pharmaceutical company. Its pharmaceutical division generates sales of $44671m in 2007. Pfizer is recognised as being one of the strongest performing pharmaceutical companies in terms of sales, revenue growth, acquisitions, breadth of portfolio, product launches and pipeline developments.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 08 Aug 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biometrics for Defence 2008</title>
		<link>http://www.visiongain.com/Report/327/Biometrics-for-Defence-2008</link>
		<guid>http://www.visiongain.com/Report/327/Biometrics-for-Defence-2008</guid>
		<category>defence</category>
		<description>Biometrics refers to automated identification methods using unique human identifiers such as fingerprints and iris and facial patterns. Biometrics, regarded as a sophisticated means for identity management, is useful not only for securing airports and borders but it has many current and potential uses for the world's armed forces, such as identifying adversaries who hide among the civilian population, controlling access to military facilities and even in providing medical and other services to personnel.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 08 Aug 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Business and the 2008 Olympics: Analysis &amp; Insight </title>
		<link>http://www.visiongain.com/Report/332/Mobile-Business-and-the-2008-Olympics-Analysis-Insight</link>
		<guid>http://www.visiongain.com/Report/332/Mobile-Business-and-the-2008-Olympics-Analysis-Insight</guid>
		<category>telecoms &amp; IT</category>
		<description>The Olympic Games is the most watched global event attracting audiences from all around the world during an 18 day period. The Olympic Winter Games, meanwhile has also seen an upsurge in its popularity with more nations competing and more countries passing a keen eye over the unfolding events.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 05 Aug 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Therapeutic Monoclonal Antibodies Report 2008-2023</title>
		<link>http://www.visiongain.com/Report/319/Therapeutic-Monoclonal-Antibodies-Report-2008-2023</link>
		<guid>http://www.visiongain.com/Report/319/Therapeutic-Monoclonal-Antibodies-Report-2008-2023</guid>
		<category>pharma</category>
		<description>This brand new report investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical industry as a whole is suffering from single digit growth, thinner pipelines than before and pressure from an ever-aggressive generics industry, the segment of monoclonal antibodies therapeutics is thriving and growing at a double-digit rate.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 25 Jul 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Ad funded mobile content: Forecasts and Analysis 2008</title>
		<link>http://www.visiongain.com/Report/328/Ad-funded-mobile-content-Forecasts-and-Analysis-2008</link>
		<guid>http://www.visiongain.com/Report/328/Ad-funded-mobile-content-Forecasts-and-Analysis-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile content is evolving. What was previously expensive and difficult to obtain is now becoming accessible to a large section of the mobile audience. Mobile content has been driven to the mobile audience in a cheaper and more accessible form through sponsorship of mobile advertising.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 24 Jul 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Clinical Trial Business Report &amp; Analysis 2008-2018</title>
		<link>http://www.visiongain.com/Report/315/Global-Clinical-Trial-Business-Report-Analysis-2008-2018</link>
		<guid>http://www.visiongain.com/Report/315/Global-Clinical-Trial-Business-Report-Analysis-2008-2018</guid>
		<category>pharma</category>
		<description>The global clinical trials business is worth an estimated $50bn in 2008, with a growth of rate of 10%. The market will show considerable growth in the future, as this visiongain report, Global Clinical Trial Business 2008-2018, explains in detail. In recent years, the nature of clinical trials has changed considerably.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Military Communications and COTS 2008: Analysing the Expanding Defence-Related Market</title>
		<link>http://www.visiongain.com/Report/316/Military-Communications-and-COTS-2008-Analysing-the-Expanding-Defence-Related-Market</link>
		<guid>http://www.visiongain.com/Report/316/Military-Communications-and-COTS-2008-Analysing-the-Expanding-Defence-Related-Market</guid>
		<category>defence</category>
		<description>Military communications remain an essential part of security operations. The technology extends in range from equipping military personnel with devices so they can communicate on operations to providing centralised systems for organising battle and security operations on land, sea and in the air.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The BRIC Telecoms Report - The 4 largest Emerging Markets Compared, Analysed &amp; Forecast</title>
		<link>http://www.visiongain.com/Report/317/The-BRIC-Telecoms-Report-The-4-largest-Emerging-Markets-Compared-Analysed-Forecast</link>
		<guid>http://www.visiongain.com/Report/317/The-BRIC-Telecoms-Report-The-4-largest-Emerging-Markets-Compared-Analysed-Forecast</guid>
		<category>telecoms &amp; IT</category>
		<description>Brazil, Russia, India and China are regarded as the four biggest emerging markets. Between the end of 2001 and the end of 2007, BRIC nations added 660 million new mobile subscribers, 40% of the world total new subscriptions. These countries represent enormous opportunities for you whether you are an operator, manufacturer or content distributors, you must benefit from establishing business in these regions. Can you afford not to?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Oncology Market Leaders - Analyses and Outlook, Market Report  2008-2023</title>
		<link>http://www.visiongain.com/Report/323/Oncology-Market-Leaders-Analyses-and-Outlook-Market-Report-2008-2023</link>
		<guid>http://www.visiongain.com/Report/323/Oncology-Market-Leaders-Analyses-and-Outlook-Market-Report-2008-2023</guid>
		<category>pharma</category>
		<description>The UK government have told kidney cancer patients that new drugs cannot be offered on the National Health Service. Roche's Avastin, Bayer's Nexavar, Pfizer's Sutent and Wyeth's Torisel were not cost-effective. The drugs -- known generically as bevacizumab, sorafenib, sunitinib and temsirolimus -- should therefore not be a treatment option for advanced and/or metastatic kidney cancer, NICE said.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Managed services and hosting Analysis &amp; Forecasts Report 2008-2013</title>
		<link>http://www.visiongain.com/Report/310/Managed-services-and-hosting-Analysis-Forecasts-Report-2008-2013</link>
		<guid>http://www.visiongain.com/Report/310/Managed-services-and-hosting-Analysis-Forecasts-Report-2008-2013</guid>
		<category>telecoms &amp; IT</category>
		<description>As operators look for more innovative ways to gain competitive advantage and increase operating profits, the outsourcing of network operation, application hosting and service delivery is gaining increasing traction. Is this something that will benefit your organisation? What is the most effective approach to take? One report has the answers you need to succeed in this.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 02 Jul 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Emerging UMV and UGV Markets 2008-2018</title>
		<link>http://www.visiongain.com/Report/311/The-Emerging-UMV-and-UGV-Markets-2008-2018</link>
		<guid>http://www.visiongain.com/Report/311/The-Emerging-UMV-and-UGV-Markets-2008-2018</guid>
		<category>defence</category>
		<description>The continuous evolution of unmanned vehicle systems and the emergence of new technologies, coupled with recent operational successes in Iraq and Afghanistan, have led to the increased use of unmanned systems across the operational spectrum. Unmanned systems, in the form of unmanned aerial, ground and maritime vehicles, have become an integral part of modern military operations and, indeed, of the modern military arsenal. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 27 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>In Vitro Diagnostics Market Report &amp; Analysis 2008-2023</title>
		<link>http://www.visiongain.com/Report/303/In-Vitro-Diagnostics-Market-Report-Analysis-2008-2023</link>
		<guid>http://www.visiongain.com/Report/303/In-Vitro-Diagnostics-Market-Report-Analysis-2008-2023</guid>
		<category>pharma</category>
		<description>Technological solutions are playing an increasingly important role in both clinical practice and pharmaceutical R&amp;D - increasing safety, speeding up clinical development and facilitating regulatory acceptance. Furthermore, current developments in diagnostics - especially molecular diagnostics - are paving the way towards the long-held goal of personalised medicine, to the benefit of patients, companies and healthcare providers.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 25 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023</title>
		<link>http://www.visiongain.com/Report/308/Amgen-The-Biotech-Leader-Market-Analyses-and-Outlook-2008-2023</link>
		<guid>http://www.visiongain.com/Report/308/Amgen-The-Biotech-Leader-Market-Analyses-and-Outlook-2008-2023</guid>
		<category>pharma</category>
		<description>In 2007, Amgen Inc - the world's largest biotechnology company - achieved total sales of $14.7bn, despite a turbulent year marked by regulatory, pricing and reimbursement issues. Amgen has now firmly established itself as a Top-20 international pharmaceutical company. According to sales data for 2007, Amgen is also ranked as the 11th largest pharmaceutical company worldwide based on total sales value. This is a remarkable achievment for a biotechnology company founded in 1980. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>MC-CDMA and the moves towards 4G networks and services: Analysis and Forecasts</title>
		<link>http://www.visiongain.com/Report/321/MC-CDMA-and-the-moves-towards-4G-networks-and-services-Analysis-and-Forecasts</link>
		<guid>http://www.visiongain.com/Report/321/MC-CDMA-and-the-moves-towards-4G-networks-and-services-Analysis-and-Forecasts</guid>
		<category>telecoms &amp; IT</category>
		<description>Code Division Multiple Access (CDMA) technology is a continuing driving force behind wireless networks around the globe and according to the CDMA Development Group (CDG), there were 431 million CDMA subscribers and 91million CDMA 2000 1x subscribers worldwide by the end of the year 2007.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World OTC Pharmaceutical Market Analysis &amp; Forecasts, 2008-2023</title>
		<link>http://www.visiongain.com/Report/322/The-World-OTC-Pharmaceutical-Market-Analysis-Forecasts-2008-2023</link>
		<guid>http://www.visiongain.com/Report/322/The-World-OTC-Pharmaceutical-Market-Analysis-Forecasts-2008-2023</guid>
		<category>pharma</category>
		<description>Visiongain have the pleasure of announcing the latest edition of their industry leading report - The World OTC Pharmaceutical Market, 2008-2023. This edition updates the world OTC market at present and predicts its sales revenues and trends from 2008-2023, including drivers and restraints on the market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 18 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Environmental &amp; Ethical Strategies for the Mobile &amp; Telecoms Market</title>
		<link>http://www.visiongain.com/Report/267/Environmental-Ethical-Strategies-for-the-Mobile-Telecoms-Market</link>
		<guid>http://www.visiongain.com/Report/267/Environmental-Ethical-Strategies-for-the-Mobile-Telecoms-Market</guid>
		<category>telecoms &amp; IT</category>
		<description>Global warming, our impact on the environment, and resultant environmental strategies have been at the forefront of the media in recent years and will continue to remain there while the effects of climate change continue to have such a dramatic impact on our environment.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 18 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Football Content 2008-2013: Strategies and tactics for engaging supporters through mobile content</title>
		<link>http://www.visiongain.com/Report/307/Mobile-Football-Content-2008-2013-Strategies-and-tactics-for-engaging-supporters-through-mobile-content</link>
		<guid>http://www.visiongain.com/Report/307/Mobile-Football-Content-2008-2013-Strategies-and-tactics-for-engaging-supporters-through-mobile-content</guid>
		<category>telecoms &amp; IT</category>
		<description>With the UEFA Euro 2008 tournament now upon us, is this really the time for football to shine as the premium source of mobile content? Football is a huge business, followed by billions of people around the world. The FIFA World Cup 2006 was watched by a cumulative audience of 5.9 billion viewers in 200 different countries.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 06 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The UAV Market Report: Forecasts and analysis 2008-2018</title>
		<link>http://www.visiongain.com/Report/302/The-UAV-Market-Report-Forecasts-and-analysis-2008-2018</link>
		<guid>http://www.visiongain.com/Report/302/The-UAV-Market-Report-Forecasts-and-analysis-2008-2018</guid>
		<category>defence</category>
		<description>The UAV market has grown rapidly in the last decade providing considerable value strategically and tactically. The global appetite for UAVs shows no sign of abating. Instead, there is a growing indication that countries are increasingly looking for an even greater variety of systems and capabilities, both military and civilian.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 05 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Google in Mobile 2008</title>
		<link>http://www.visiongain.com/Report/268/Google-in-Mobile-2008</link>
		<guid>http://www.visiongain.com/Report/268/Google-in-Mobile-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>Google is the world's most popular internet search engine. However with more people in the world having access to a mobile phone than a computer, Google is turning its attentions to the mobile market. Many of its web services and applications are now making its way to the mobile platform. How will this affect your mobile service? Will Google come to monopolise the mobile industry as it has done with the internet? How can you work with Google? </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 03 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Pharmaceutical Wholesale and Distribution Industry Outlook &amp; Analysis 2008</title>
		<link>http://www.visiongain.com/Report/320/The-Pharmaceutical-Wholesale-and-Distribution-Industry-Outlook-Analysis-2008</link>
		<guid>http://www.visiongain.com/Report/320/The-Pharmaceutical-Wholesale-and-Distribution-Industry-Outlook-Analysis-2008</guid>
		<category>pharma</category>
		<description>The major problem facing the Wholesale &amp; Distribution industry is its low profit margin which is in the region of only 1-2%. However, this market is entering into a crucial period with many key products losing patent protection, facing heavy generic competition.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 02 Jun 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Indian Pharmaceutical Market</title>
		<link>http://www.visiongain.com/Report/269/The-Indian-Pharmaceutical-Market</link>
		<guid>http://www.visiongain.com/Report/269/The-Indian-Pharmaceutical-Market</guid>
		<category>pharma</category>
		<description>The pharmaceutical industry is one of the fastest growing sectors in Indian economy. Visiongain predicts that market for pharmaceuticals in India has strong potential for increased growth from 2008 right through to 2023. The industry's leading Indian Pharma report contains unique market-based research, including detailed interviews with key opinion leaders based in India and abroad.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 16 May 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Silverlight Mobile 2008</title>
		<link>http://www.visiongain.com/Report/270/Silverlight-Mobile-2008</link>
		<guid>http://www.visiongain.com/Report/270/Silverlight-Mobile-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>When Microsoft creates a new product that it intends to roll out across its future operating systems to enable an enhanced multimedia experience from the internet, then web developers and the internet community need to pay attention. When Microsoft generates this capability for mobile phones in the same product, AND Nokia signs up to the service, then the telecoms industry needs to pay attention too. Do you know what Silverlight offers the mobile world?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 16 May 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Adult Content 2008</title>
		<link>http://www.visiongain.com/Report/271/Mobile-Adult-Content-2008</link>
		<guid>http://www.visiongain.com/Report/271/Mobile-Adult-Content-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>Adult content is a huge business and is one of the few entertainment industries to have withstood economic pressures which have led to sectors such as the music industry, witnessing a decline. On the internet, pornography has been one of the few success stories in terms of revenue generation.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 09 May 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Lipitor Market analysis and forecasts Report</title>
		<link>http://www.visiongain.com/Report/272/Lipitor-Market-analysis-and-forecasts-Report</link>
		<guid>http://www.visiongain.com/Report/272/Lipitor-Market-analysis-and-forecasts-Report</guid>
		<category>pharma</category>
		<description>In 2006, Pfizer's Lipitor (atorvastatin) generated global revenues of $13.6bn, making it the best selling drug in pharmaceutical history. The blockbuster medicine has single-handedly driven the overall revenue margins of the cardiovascular segment, as this area continues to dominate the pharmaceutical market.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 06 May 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Chinese Pharmaceutical Outlook 2008-2023</title>
		<link>http://www.visiongain.com/Report/306/Chinese-Pharmaceutical-Outlook-2008-2023</link>
		<guid>http://www.visiongain.com/Report/306/Chinese-Pharmaceutical-Outlook-2008-2023</guid>
		<category>pharma</category>
		<description>This brand new report examines the prospects for the growth of pharmaceutical revenues in China. Visiongain predicts that total pharmaceutical revenues in China will increase from approximately $12bn in 2007 to over $30bn in 2013. This is a considerable increase, one that will represent a near tripling of total sales over six years. Strong growth will continue well beyond that period, as this report shows and explains.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 16 Apr 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Remittance - A Window for the Financial Empowerment of Global Communities through Mobility</title>
		<link>http://www.visiongain.com/Report/329/Mobile-Remittance-A-Window-for-the-Financial-Empowerment-of-Global-Communities-through-Mobility</link>
		<guid>http://www.visiongain.com/Report/329/Mobile-Remittance-A-Window-for-the-Financial-Empowerment-of-Global-Communities-through-Mobility</guid>
		<category>telecoms &amp; IT</category>
		<description>While the use of high-tech electronic substitutes for cash was always expected to infiltrate developed markets such as Japan, mobile wallets and electronic transfers were perceived as requiring much time to reach poorer countries.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 16 Apr 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmaceutical Control of Blood Diseases Market Analysis &amp; Forecasts Report 2008</title>
		<link>http://www.visiongain.com/Report/352/Pharmaceutical-Control-of-Blood-Diseases-Market-Analysis-Forecasts-Report-2008</link>
		<guid>http://www.visiongain.com/Report/352/Pharmaceutical-Control-of-Blood-Diseases-Market-Analysis-Forecasts-Report-2008</guid>
		<category>pharma</category>
		<description>In 2007, blood diseases cost the US's economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white blood cell disorders and thrombosis collectively.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 14 Apr 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile search 2008-2013</title>
		<link>http://www.visiongain.com/Report/273/Mobile-search-2008-2013</link>
		<guid>http://www.visiongain.com/Report/273/Mobile-search-2008-2013</guid>
		<category>telecoms &amp; IT</category>
		<description>Search has transported from the internet to the mobile and has been identified as an area of enormous growth. Mobile subscribers are currently tentative. But with growing confidence they are exploring the internet over their mobile devices. Mobile search will be a key market in the mobile Web. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 28 Mar 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Sleep Disorders: Market Analysis 2008-2018</title>
		<link>http://www.visiongain.com/Report/274/Sleep-Disorders-Market-Analysis-2008-2018</link>
		<guid>http://www.visiongain.com/Report/274/Sleep-Disorders-Market-Analysis-2008-2018</guid>
		<category>pharma</category>
		<description>The market penetration for insomnia drugs has not reached saturation point. Opportunities remain. But with the introduction of several new products the market is set to see changes, but expansion. This expansion is based on increased general awareness physicians better comprehension of the significance of this disease and the positive role that a sleep medication prescription plays.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 25 Mar 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Antibacterial Drug Market: Analysis 2008-2013</title>
		<link>http://www.visiongain.com/Report/275/The-Antibacterial-Drug-Market-Analysis-2008-2013</link>
		<guid>http://www.visiongain.com/Report/275/The-Antibacterial-Drug-Market-Analysis-2008-2013</guid>
		<category>pharma</category>
		<description>This brand new market analysis by visiongain examines the prospects for antibacterial drugs from 2008-2013, including sales forecasts for leading pharmaceutical products. The antibacterial market is large in terms of disease area as well as the different drug classes used to treat these infections. However, this market is entering into a crucial period with many key products losing patent protection, facing heavy generic competition.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 19 Mar 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Generic  League</title>
		<link>http://www.visiongain.com/Report/276/Generic-League</link>
		<guid>http://www.visiongain.com/Report/276/Generic-League</guid>
		<category>pharma</category>
		<description>The generic industry is a fast evolving market; with significant lucrative opportunities. The generic market is structurally set to experience high growth potential. That wave is partly driven by cost-containment in several national healthcare sectors and partly by the need for governments to promote the use of generic products over high-priced originator products without compromising quality.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 27 Feb 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Fixed-Mobile Convergence Market Analysis 2008</title>
		<link>http://www.visiongain.com/Report/277/Fixed-Mobile-Convergence-Market-Analysis-2008</link>
		<guid>http://www.visiongain.com/Report/277/Fixed-Mobile-Convergence-Market-Analysis-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>The GSM Association is to test out a carrier ENUM service, which the trade body says will make it easier to send IMs, MMS, emails, videos and any other IP content between mobiles and fixed line phones, as well as mobile-to-mobile transmissions. The pilot will start in 2008, with the aim of going live with a full commercial service later on this year.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 21 Feb 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Antipsychotics Market Insight &amp; Analysis 2008</title>
		<link>http://www.visiongain.com/Report/278/The-Antipsychotics-Market-Insight-Analysis-2008</link>
		<guid>http://www.visiongain.com/Report/278/The-Antipsychotics-Market-Insight-Analysis-2008</guid>
		<category>pharma</category>
		<description>The total antipsychotics market revenue in 2006 was $18.1bn. Visiongain predicts that total revenues in the antipsychotics market will peak to $18.6bn by 2007. But what will it be in 2012?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 19 Feb 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Social Networking and User Generated Content Market Insight 2008</title>
		<link>http://www.visiongain.com/Report/279/Mobile-Social-Networking-and-User-Generated-Content-Market-Insight-2008</link>
		<guid>http://www.visiongain.com/Report/279/Mobile-Social-Networking-and-User-Generated-Content-Market-Insight-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>Facebook has launched a platform for operators designed to make its social networking application work better on portable devices. Vodafone is the first operator to use the Facebook for Mobile Operators platform and has started services in the UK and Germany. Vodafone will soon expand the programme to Greece, Italy, Spain, Ireland and Portugal.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 12 Feb 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Respiratory Market Insight 2008</title>
		<link>http://www.visiongain.com/Report/280/Respiratory-Market-Insight-2008</link>
		<guid>http://www.visiongain.com/Report/280/Respiratory-Market-Insight-2008</guid>
		<category>pharma</category>
		<description>This brand new report examines the forthcoming prospects for respiratory drugs over the next 5 year. With in-depth sales forecasts for leading pharmaceutical products, the report has been produced to inform you of future developments and strategies. The respiratory market generated revenues of $30503m in 2006, but what will it be in 2013,? Which year will see it reach its peak?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 11 Feb 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Google's Android and Mobile Linux Report 2008</title>
		<link>http://www.visiongain.com/Report/281/Google's-Android-and-Mobile-Linux-Report-2008</link>
		<guid>http://www.visiongain.com/Report/281/Google's-Android-and-Mobile-Linux-Report-2008</guid>
		<category>telecoms &amp; IT</category>
		<description>Google have launched the Android mobile operating system. The announcement was welcomed across large sections of the mobile industry, however the future prospects for this new Linux-based platform and for the shape of the mobile industry have been frequently called into question. When Google begin to get offer mobile systems, the market must take notice. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 23 Jan 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Live-Licensing &amp; In-life testing: R&amp;D Processes and Regulation for New Drugs, 2008-2020</title>
		<link>http://www.visiongain.com/Report/282/Live-Licensing-In-life-testing-R-D-Processes-and-Regulation-for-New-Drugs-2008-2020</link>
		<guid>http://www.visiongain.com/Report/282/Live-Licensing-In-life-testing-R-D-Processes-and-Regulation-for-New-Drugs-2008-2020</guid>
		<category>pharma</category>
		<description>Visiongain predict that the current phase I to IV clinical testing process will eventually be selectively or wholly replaced by a system known as "in-life testing" or "live-licensing". Those proposals involve cumulative testing of the drug throughout its lifecycle. The industry would continually test drugs with smaller, more focused clinical trials. If a trial shows efficacy and safety, a live license would be given, allowing the company to market the drug in a limited manner.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 17 Jan 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Parkinson's Disease: Market analysis and forecasts, 2008-2012, 2017 &amp; 2022</title>
		<link>http://www.visiongain.com/Report/283/Parkinson's-Disease-Market-analysis-and-forecasts-2008-2012-2017-2022</link>
		<guid>http://www.visiongain.com/Report/283/Parkinson's-Disease-Market-analysis-and-forecasts-2008-2012-2017-2022</guid>
		<category>pharma</category>
		<description>Parkinson's disease (PD) is the second most common neurological disorder, affecting approximately 4.1m people worldwide. As the prevalence rate of PD is set to rise significantly in the coming years, clinical interventions will play a major role in combating the wide spectrum of unmet needs associated with the disease. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 08 Jan 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>UMTS 900: successfully delivering 3G in low-frequency bands</title>
		<link>http://www.visiongain.com/Report/284/UMTS-900-successfully-delivering-3G-in-low-frequency-bands</link>
		<guid>http://www.visiongain.com/Report/284/UMTS-900-successfully-delivering-3G-in-low-frequency-bands</guid>
		<category>telecoms &amp; IT</category>
		<description>UMTS is now a firmly established technology. It is gaining mass market adoption, with DoCoMo admitting to having over 40 million 3G subs, and other markets also gaining a higher 3G penetration. As GSM is phased out UMTS will become the dominant standard. Europe's CEPT has given a EC-wide clearance for the roll-out of UMTS900 in its 47 member states.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 08 Jan 2008 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Erectile Dysfunction Market Assessment &amp; Analysis 2007-2022</title>
		<link>http://www.visiongain.com/Report/285/Erectile-Dysfunction-Market-Assessment-Analysis-2007-2022</link>
		<guid>http://www.visiongain.com/Report/285/Erectile-Dysfunction-Market-Assessment-Analysis-2007-2022</guid>
		<category>pharma</category>
		<description>The market for Erectile Dysfunction (ED) drugs is growing fast with a CAGR of 4.9% for the period 2006-2012. The ED market contains three leading drugs Viagra, Levitra and Cialis. Viagra, already a blockbuster drug, is the most popular and recognised brand on the market. Furthermore, high revenues are predicted by visiongain for the top three ED drugs, with Cialis reaching blockbuster status by 2007.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Sat, 15 Dec 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Dermatological Market Analysis &amp; Forecasts 2007-2022</title>
		<link>http://www.visiongain.com/Report/286/The-World-Dermatological-Market-Analysis-Forecasts-2007-2022</link>
		<guid>http://www.visiongain.com/Report/286/The-World-Dermatological-Market-Analysis-Forecasts-2007-2022</guid>
		<category>pharma</category>
		<description>Most skin disorders are not fatal but most people are affected globally. The revenue of dermatological market in 2006 was $16bn, which is a 5.1% when compared with 2003. The common skin disorders include acne, dermatitis, psoriasis, rosacea, urticaria and hair loss. Due to the aesthetic awareness increases in Western countries, botulinum toxin and other cosmetic treatments become more and more popular. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 26 Nov 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Quad-Play and Service bundling strategy 2007-2012</title>
		<link>http://www.visiongain.com/Report/287/Quad-Play-and-Service-bundling-strategy-2007-2012</link>
		<guid>http://www.visiongain.com/Report/287/Quad-Play-and-Service-bundling-strategy-2007-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>These are just some of the questions this in-depth report will help you answer. Customers and service providers are actively reaping the benefits of bundled services. However, some companies are reporting customer losses across the quad-play structure - why? Though quad play is relatively new and an unproven service, many companies are only just starting to look to explore it.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 23 Nov 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Anti-Migraine Market 2007-2022</title>
		<link>http://www.visiongain.com/Report/288/The-Anti-Migraine-Market-2007-2022</link>
		<guid>http://www.visiongain.com/Report/288/The-Anti-Migraine-Market-2007-2022</guid>
		<category>pharma</category>
		<description>Migraine is a serious neurological disorder characterised by recurrent headaches, varying in severity and frequency. Accounting for the loss of over 100 million working days in the US alone, the economic cost and social impact of migraine is significant.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 13 Nov 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Yahoo in Mobile, Analysis and Market Insight to 2012</title>
		<link>http://www.visiongain.com/Report/289/Yahoo-in-Mobile-Analysis-and-Market-Insight-to-2012</link>
		<guid>http://www.visiongain.com/Report/289/Yahoo-in-Mobile-Analysis-and-Market-Insight-to-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>Yahoo, the number two Internet search engine, currently leads in mobile web destinations due to an aggressive play to capitalize on the still emerging mobile search and advertising space. Although the market has yet to take a defined shape, visiongain maintains Yahoo's moves are not too early.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 13 Nov 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Advertising and Marketing 2007 - Market analysis and forecasts 2007-2012</title>
		<link>http://www.visiongain.com/Report/290/Mobile-Advertising-and-Marketing-2007-Market-analysis-and-forecasts-2007-2012</link>
		<guid>http://www.visiongain.com/Report/290/Mobile-Advertising-and-Marketing-2007-Market-analysis-and-forecasts-2007-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile advertising is coming to a phone near you - but simply translating existing models won't work. Your industry has woken to the potential of offering advertisements on mobile. You need to react now. If you wait, the opportunity may be gone. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 12 Nov 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Non-Opioid Market in Pain Management, 2007-2022</title>
		<link>http://www.visiongain.com/Report/291/The-Global-Non-Opioid-Market-in-Pain-Management-2007-2022</link>
		<guid>http://www.visiongain.com/Report/291/The-Global-Non-Opioid-Market-in-Pain-Management-2007-2022</guid>
		<category>pharma</category>
		<description>Visiongain believe that the market for non-opioid drugs is the fastest growing segments in pain management with a CAGR of 8.12% for the period 2006-2012. The brand new report entitled “The Global Non-Opioid Market in Pain Management" has highlighted a number of innovative pipeline developments that are set to shape the industry over the medium term. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 24 Oct 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Blockbuster Drugs - Create, Develop and Market a Billion Dollar Drug 2007-2012</title>
		<link>http://www.visiongain.com/Report/292/Blockbuster-Drugs-Create-Develop-and-Market-a-Billion-Dollar-Drug-2007-2012</link>
		<guid>http://www.visiongain.com/Report/292/Blockbuster-Drugs-Create-Develop-and-Market-a-Billion-Dollar-Drug-2007-2012</guid>
		<category>pharma</category>
		<description>This unique in-depth management report examines the future prospects for blockbuster drugs from 2007-2012. It delivers direct to you future sales forecasts for leading pharmaceutical blockbuster products. In 2006, there were over a hundred of those high revenue generating drugs in the global market. This detailed report also highlights pipeline developments, potential blockbusters on the market and important contemporary issues, especially commercial drivers and restraints.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 23 Oct 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Alzheimer's Disease Market analysis and forecasts, 2007-2012, 2017 &amp; 2022</title>
		<link>http://www.visiongain.com/Report/293/Alzheimer's-Disease-Market-analysis-and-forecasts-2007-2012-2017-2022</link>
		<guid>http://www.visiongain.com/Report/293/Alzheimer's-Disease-Market-analysis-and-forecasts-2007-2012-2017-2022</guid>
		<category>pharma</category>
		<description>Alzheimers disease (AD) is the third leading cause of death in recent times and with an unprecedented patient potential, this disease area attracts awareness from a broad base of stake holders. With the grey population being the single most influencial factor in driving the economic growth within this sector, Visiongain believes the real market of the AD industry still remains untapped.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 15 Oct 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile gaming 2007-2012: Will Sony Ericsson's PSP variant be a catalyst for the market?</title>
		<link>http://www.visiongain.com/Report/294/Mobile-gaming-2007-2012-Will-Sony-Ericsson's-PSP-variant-be-a-catalyst-for-the-market</link>
		<guid>http://www.visiongain.com/Report/294/Mobile-gaming-2007-2012-Will-Sony-Ericsson's-PSP-variant-be-a-catalyst-for-the-market</guid>
		<category>telecoms &amp; IT</category>
		<description>Prior to 2003, mobile gaming had only ever made an impact in Japan and South Korea, particularly in terms of NTT DoCoMo's i-mode business model. Crucially for mobile gaming in those countries, i-mode was and remains based on a revenue share model designed in favour of content providers, who receive 90% of download fees. This model thus spawned unprecedented growth but has never been favoured by European and North American operators to the detriment of mobile gaming in the West.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 05 Oct 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Diabetes Market, 2007-2025: A Key Pharmaceutical Market of the Future</title>
		<link>http://www.visiongain.com/Report/295/The-World-Diabetes-Market-2007-2025-A-Key-Pharmaceutical-Market-of-the-Future</link>
		<guid>http://www.visiongain.com/Report/295/The-World-Diabetes-Market-2007-2025-A-Key-Pharmaceutical-Market-of-the-Future</guid>
		<category>pharma</category>
		<description>Diabetes affects approximately 246 million people worldwide and this number is increasing. The IDF predict 380 million diabetics by 2025. The Global Diabetes drug treatment market was valued at over $21 billion in 2006 and the market is still expanding rapidly due to the high prevalence of diabetes and lifestyle changes.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 03 Oct 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Pain Pharmaceutical Market Analysis &amp; Forecasts 2007-2022</title>
		<link>http://www.visiongain.com/Report/296/The-Global-Pain-Pharmaceutical-Market-Analysis-Forecasts-2007-2022</link>
		<guid>http://www.visiongain.com/Report/296/The-Global-Pain-Pharmaceutical-Market-Analysis-Forecasts-2007-2022</guid>
		<category>pharma</category>
		<description>The global pain pharmaceutical market is set to become a serious growth area experiencing a compound annual growth rate of 4.56% to 2012. Visiongain's latest report, “The Global Pain Pharmaceutical Market 2007-2022“, explains just how this market will experience growth over the medium term future. The report also highlights forecast for 2022, so that you and your company can make longer term plans.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 27 Sep 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Service Delivery Platforms &amp; Service Orientated Architecture Report 2007-2012</title>
		<link>http://www.visiongain.com/Report/297/Service-Delivery-Platforms-Service-Orientated-Architecture-Report-2007-2012</link>
		<guid>http://www.visiongain.com/Report/297/Service-Delivery-Platforms-Service-Orientated-Architecture-Report-2007-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>Service Delivery Platforms (SDPs) generally simplify architectures, eliminate the need for costly and inflexible vertical structures and also significantly reduce the need for specialized skills in the service development field. Through the use of SDPs processes are automated and service deployment time is reduced. This suggests that the average revenue per user (ARPU) for each new service and application introduced by an operator can be increased by approximately 2.5 times. That is the simple fact that can ensure your company increases profitability and increases it now.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 17 Sep 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Hypertension Market 2007-2023</title>
		<link>http://www.visiongain.com/Report/298/The-World-Hypertension-Market-2007-2023</link>
		<guid>http://www.visiongain.com/Report/298/The-World-Hypertension-Market-2007-2023</guid>
		<category>pharma</category>
		<description>The market for hypertensives - led by the angiotensin II antagonists - is one of the largest and most profitable in the global pharmaceutical market, with total anti-hypertensive sales of $36600m in 2006. Hypertension, or high blood pressure, is a worldwide epidemic: by 2025 visiongain predict that worldwide there will be more than 1.5 billion sufferers of this disease.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 17 Sep 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Qualcomm : Insight &amp; Market Analysis 2007- 2012</title>
		<link>http://www.visiongain.com/Report/299/Qualcomm-Insight-Market-Analysis-2007-2012</link>
		<guid>http://www.visiongain.com/Report/299/Qualcomm-Insight-Market-Analysis-2007-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>The year 2007 has so far proven difficult for US technology giant, Qualcomm, having spawned consecutive setbacks in its IPR battles with chipmaker Broadcom and mobile phone manufacturer Nokia. However, focusing purely on such divisive issues detracts from the essence of Qualcomm as a first class innovator and exponent of wireless communications which now underpin the modern world.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 31 Aug 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Multiple Sclerosis Market Analysis &amp; Forecasts Report 2007-2022</title>
		<link>http://www.visiongain.com/Report/300/Multiple-Sclerosis-Market-Analysis-Forecasts-Report-2007-2022</link>
		<guid>http://www.visiongain.com/Report/300/Multiple-Sclerosis-Market-Analysis-Forecasts-Report-2007-2022</guid>
		<category>pharma</category>
		<description>The World Health Organization (WHO) estimates that over 2.5 million people globally suffer from Multiple Sclerosis (MS). With the present global population growing to an unprecedented height of 6.5 billion in 2005 and growth rate anticipated to reach 7.6 billion by 2020, the prevalence and onset of MS in children and particularly adults is expected to rise exponentially. </description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 30 Aug 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Ultra Low Cost Handsets 2007-2012: Market Analysis and forecasts of 2G &amp; 3G communications in developing markets</title>
		<link>http://www.visiongain.com/Report/301/Ultra-Low-Cost-Handsets-2007-2012-Market-Analysis-and-forecasts-of-2G-3G-communications-in-developing-markets</link>
		<guid>http://www.visiongain.com/Report/301/Ultra-Low-Cost-Handsets-2007-2012-Market-Analysis-and-forecasts-of-2G-3G-communications-in-developing-markets</guid>
		<category>telecoms &amp; IT</category>
		<description>Ultra Low Cost Handsets (ULCH) are critical for subscriber growth in emerging markets and for the growth of 3G services in both emerging and saturated markets. Since 2005, the ULCH strategy for emerging markets has generated huge attention of the key players in the wireless value chain and visiongain believes that many vendors are now evaluating market potential for affordable 3G handsets in saturated markets.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 28 Aug 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Security &amp; Anti-virus Report</title>
		<link>http://www.visiongain.com/Report/265/Mobile-Security-Anti-virus-Report</link>
		<guid>http://www.visiongain.com/Report/265/Mobile-Security-Anti-virus-Report</guid>
		<category>telecoms &amp; IT</category>
		<description>Malware is targeting mobile phones and networks. So far it hasn't been as infectious as its PC counterparts, but visiongain believes it is only a matter of time before a large scale case makes network operators and handset manufacturers really sit up and take notice. Is your company up-to-speed? It should be and this new report will ensure you are.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 15 Aug 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Lou Gehrig Disease Report: Is there a link between Lipitor and ALS?</title>
		<link>http://www.visiongain.com/Report/264/Lou-Gehrig-Disease-Report-Is-there-a-link-between-Lipitor-and-ALS</link>
		<guid>http://www.visiongain.com/Report/264/Lou-Gehrig-Disease-Report-Is-there-a-link-between-Lipitor-and-ALS</guid>
		<category>pharma</category>
		<description>Amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's disease in the US, Maladie de Charcot in France and Motor Neuron Disease (MND) in the UK is a progressive neuromuscular disease characterised by the progressive degeneration of motor nerve cell in the brain (upper motor neurons) and spinal cord (lower motor).</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 02 Aug 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>M-Payments 2007-2012: Commerce and banking in the mobile world</title>
		<link>http://www.visiongain.com/Report/263/M-Payments-2007-2012-Commerce-and-banking-in-the-mobile-world</link>
		<guid>http://www.visiongain.com/Report/263/M-Payments-2007-2012-Commerce-and-banking-in-the-mobile-world</guid>
		<category>telecoms &amp; IT</category>
		<description>The spread of mobile payments and banking in Europe is dependent on Near Field Communications and network operators must take the NFC plunge and must make it now.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 27 Jul 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The challenge of turning technology into therapy</title>
		<link>http://www.visiongain.com/Report/262/Top-Companies-and-Products-in-the-RNA-DNA-Therapy-Products-Market-Forecasts-The-challenge-of-turning-technology-into-therapy</link>
		<guid>http://www.visiongain.com/Report/262/Top-Companies-and-Products-in-the-RNA-DNA-Therapy-Products-Market-Forecasts-The-challenge-of-turning-technology-into-therapy</guid>
		<category>pharma</category>
		<description>Increasingly the large pharmaceutical companies are pumping money and ambition into the DNA/RNA therapy market. Whether its through forming collaboration/licensing agreements, or acquiring smaller companies they can see the financial opportunities.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 23 Jul 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Vodafone Insight 2007 acquisition, management change &amp; caution</title>
		<link>http://www.visiongain.com/Report/261/Vodafone-Insight-2007-acquisition-management-change-caution</link>
		<guid>http://www.visiongain.com/Report/261/Vodafone-Insight-2007-acquisition-management-change-caution</guid>
		<category>telecoms &amp; IT</category>
		<description>Vodafone was set to become the largest mobile operator in the world, but then things started to go wrong. With China Telecom staking that claim by virtue of its gigantic subscriber base sourced from the fast-growing Chinese market, Vodafone has had to settle for the title of largest operator outside of China. Its once brave growth strategy by acquisition seems to have been superseded by a measure of caution.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Jul 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Anti-Obesity Treatments 2007-2012: A blockbuster target market</title>
		<link>http://www.visiongain.com/Report/260/Anti-Obesity-Treatments-2007-2012-A-blockbuster-target-market</link>
		<guid>http://www.visiongain.com/Report/260/Anti-Obesity-Treatments-2007-2012-A-blockbuster-target-market</guid>
		<category>pharma</category>
		<description>By 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight. For pharmaceutical companies looking to target growing successful markets, the anti-obesity drug treatment market offers unique opportunities.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 13 Jul 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Location Based Advertising 2007-2012: maximising the revenue potential of location discovery</title>
		<link>http://www.visiongain.com/Report/259/Location-Based-Advertising-2007-2012-maximising-the-revenue-potential-of-location-discovery</link>
		<guid>http://www.visiongain.com/Report/259/Location-Based-Advertising-2007-2012-maximising-the-revenue-potential-of-location-discovery</guid>
		<category>telecoms &amp; IT</category>
		<description>Location Based Advertising is already here and starting to happen. The ability to target consumers based on their locale will have a significant effect on the way that companies advertise, not just in the mobile medium, but it will also impact on their entire advertising strategies and channels. Do you know what impact it will have on the marketing mix of your company? How can you make the most from Mobile Local Search?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 06 Jul 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Smoking Cessation Market Analysis &amp; Forecasts - Preparing for the first blockbuster</title>
		<link>http://www.visiongain.com/Report/258/Global-Smoking-Cessation-Market-Analysis-Forecasts-Preparing-for-the-first-blockbuster</link>
		<guid>http://www.visiongain.com/Report/258/Global-Smoking-Cessation-Market-Analysis-Forecasts-Preparing-for-the-first-blockbuster</guid>
		<category>pharma</category>
		<description>Cigarette smoking is the most important source of preventable and premature morbidity worldwide. Currently, the number of smokers across the globe is estimated at 1.3 billion. Political moves are leading to national bans of smoking in public places, with the long-term aim to reduce the cost to the health sector. But what will be the short-term spending on smoking cessation therapies?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 04 Jul 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>TD-SCDMA and the Chinese 4G trials, vendors and handset manufacturers</title>
		<link>http://www.visiongain.com/Report/257/TD-SCDMA-and-the-Chinese-4G-trials-vendors-and-handset-manufacturers</link>
		<guid>http://www.visiongain.com/Report/257/TD-SCDMA-and-the-Chinese-4G-trials-vendors-and-handset-manufacturers</guid>
		<category>telecoms &amp; IT</category>
		<description>Chinese technology vendors have been struggling with high patent fees as they loose at least 5% of their sales income to royalty costs if they adopt WCDMA or CDMA 2000 technology in their equipment. The Chinese have therefore invested heavily in the research of homegrown wireless standards and aim to become as self-sufficient as possible in cellular technology. Their 3G standard known as TD-SCDMA is a technically strong standard and trials have shown that it can be 10%-15% more spectrally efficient than WCDMA and CDMA 2000.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 29 Jun 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Parallel Trade - US Lawmakers allow imported prescriptions drugs</title>
		<link>http://www.visiongain.com/Report/256/Parallel-Trade-US-Lawmakers-allow-imported-prescriptions-drugs</link>
		<guid>http://www.visiongain.com/Report/256/Parallel-Trade-US-Lawmakers-allow-imported-prescriptions-drugs</guid>
		<category>pharma</category>
		<description>Parallel trade is on the verge of breaking its confines of the EU and diffusing into other global markets. This global practice is far from simple, and the loopholes that have made it possible refuse to close. Whether you think parallel trade is a benefit or a cost, the reality is that it is affecting the whole pharma industry on a wide scale. It started out a North-South divide but even this is changing. The European Commission and other trade regulation bodies won't protect the pharma companies pricing structures.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 21 Jun 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>DVB-H Mobile TV Services - Demand, Handsets, Analysis &amp; Forecasts to 2012</title>
		<link>http://www.visiongain.com/Report/255/DVB-H-Mobile-TV-Services-Demand-Handsets-Analysis-Forecasts-to-2012</link>
		<guid>http://www.visiongain.com/Report/255/DVB-H-Mobile-TV-Services-Demand-Handsets-Analysis-Forecasts-to-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile TV will be successful. DVB-H is the one technology that has gained headway in Europe and the US, but various alternatives remain. Questions still remain about demand, cost-effectiveness, user's willingness to pay and handset design. With an industry move towards various FMC services, is the technology and formats currently in place for mobile TV, the most effective?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 19 Jun 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Rimonabant: The first of the Cannabinoid blockbusters</title>
		<link>http://www.visiongain.com/Report/253/Rimonabant-The-first-of-the-Cannabinoid-blockbusters</link>
		<guid>http://www.visiongain.com/Report/253/Rimonabant-The-first-of-the-Cannabinoid-blockbusters</guid>
		<category>pharma</category>
		<description>Marinol®, Cesamet®, Sativex® and Rimonabant are all commercially-marketed cannabinoids. They treat a variety of conditions from weight-loss to pain relief. The introduction of cannabinoids into the pharmaceutical marketplace has begun, and attitudes to the drugs are changing. This increased acceptance will lead to greater market penetration, and the importance of the area will be seen with the first cannabinoid reaching blockbuster status before the end of the decade.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Jun 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Neurodegenerative Disease Drug Market Analysis and Forecasts 2007</title>
		<link>http://www.visiongain.com/Report/254/Neurodegenerative-Disease-Drug-Market-Analysis-and-Forecasts-2007</link>
		<guid>http://www.visiongain.com/Report/254/Neurodegenerative-Disease-Drug-Market-Analysis-and-Forecasts-2007</guid>
		<category>pharma</category>
		<description>With the recent Alzheimer's Association International Conference suggesting a new era of hope for sufferers of the illness, drug trials have shown some enlightening discoveries.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Jun 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Microsoft in Mobile (TM): Market analysis and forecasts 2007-2012</title>
		<link>http://www.visiongain.com/Report/252/Microsoft-in-Mobile-(TM)-Market-analysis-and-forecasts-2007-2012</link>
		<guid>http://www.visiongain.com/Report/252/Microsoft-in-Mobile-(TM)-Market-analysis-and-forecasts-2007-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>After many years developing and pushing its Operating System onto handsets, Microsoft(TM) is still gaining relatively slow increases in market share, losing out to Symbian(TM), which dominates the Smartphone market. However, Microsoft has a major advantage over Symbian, find out what.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 30 May 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Gastrointestinal Disorders Market Intelligence to 2012</title>
		<link>http://www.visiongain.com/Report/251/Gastrointestinal-Disorders-Market-Intelligence-to-2012</link>
		<guid>http://www.visiongain.com/Report/251/Gastrointestinal-Disorders-Market-Intelligence-to-2012</guid>
		<category>pharma</category>
		<description>Gastrointestinal (GI) disorders are set to affect over 250 million people in the seven largest pharma markets, by 2012. As generations of people become more obese and consume increasingly poor diets then so too will the number of people suffering from these disorders rise.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 25 May 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Teva Pharmaceutical Industries Market Forecasts &amp; Analysis 2007-2012</title>
		<link>http://www.visiongain.com/Report/250/Teva-Pharmaceutical-Industries-Market-Forecasts-Analysis-2007-2012</link>
		<guid>http://www.visiongain.com/Report/250/Teva-Pharmaceutical-Industries-Market-Forecasts-Analysis-2007-2012</guid>
		<category>pharma</category>
		<description>In 2006, Teva Pharmaceutical Industries generated $8408m in net sales worldwide from both innovative branded and generic drugs, firmly establishing itself as a Top-20 international pharmaceutical company and leader in generics.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 17 May 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>UMA-enabled dual-mode handsets and 3G femtocells 2007-2012: Market analysis and forecasts</title>
		<link>http://www.visiongain.com/Report/249/UMA-enabled-dual-mode-handsets-and-3G-femtocells-2007-2012-Market-analysis-and-forecasts</link>
		<guid>http://www.visiongain.com/Report/249/UMA-enabled-dual-mode-handsets-and-3G-femtocells-2007-2012-Market-analysis-and-forecasts</guid>
		<category>telecoms &amp; IT</category>
		<description>The aim of UMA-enabled dual-mode handsets is that it enables you as a GSM mobile operator to offer fully converged connectivity using your existing core network and WLAN access points in the home or enterprise. Your subscribers will seamlessly roam from your cellular network to a WLAN, maintaining the call as they move from one to the other.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 01 May 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Global Ophthalmic Market Analysis &amp; Forecasts to 2012</title>
		<link>http://www.visiongain.com/Report/247/Global-Ophthalmic-Market-Analysis-Forecasts-to-2012</link>
		<guid>http://www.visiongain.com/Report/247/Global-Ophthalmic-Market-Analysis-Forecasts-to-2012</guid>
		<category>pharma</category>
		<description>Driven by demographic trends, such as an increasing aged population, the global ophthalmic pharmaceutical market is set to become a serious growth area experiencing a compound annual growth rate of 11.11 per cent to 2012. This report explains just how this market will experience growth over the medium term future. Also do you know what the drivers and restraints of the market are? This report not only reveals these, but also details what strategies can be used to maximize profits from the drivers and restraints.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 30 Apr 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile music stores 2007-2012: Will a mobile-focussed solution hold more potential than Microsoft, Nokia or even Apple's iTunes' ambitions in OTA downloads?</title>
		<link>http://www.visiongain.com/Report/246/Mobile-music-stores-2007-2012-Will-a-mobile-focussed-solution-hold-more-potential-than-Microsoft-Nokia-or-even-Apple's-iTunes'-ambitions-in-OTA-downloads</link>
		<guid>http://www.visiongain.com/Report/246/Mobile-music-stores-2007-2012-Will-a-mobile-focussed-solution-hold-more-potential-than-Microsoft-Nokia-or-even-Apple's-iTunes'-ambitions-in-OTA-downloads</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile music downloading is on the increase. The market for full-track music downloads to mobile devices approximately doubled in 2006. Will this adoption rate continue? How can your company benefit from being involved in this market space?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 17 Apr 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012</title>
		<link>http://www.visiongain.com/Report/245/Dr-Reddy's-Market-Outlook-Forecasts-and-Analysis-to-2012</link>
		<guid>http://www.visiongain.com/Report/245/Dr-Reddy's-Market-Outlook-Forecasts-and-Analysis-to-2012</guid>
		<category>pharma</category>
		<description>Founded by Indian Scientist Dr Anji Reddy in 1984, the company has developed into a fast-growing international corporation, with headquarters in Hyderabad, Andhra Pradesh, India. During the fiscal year 2006, Dr. Reddy's was the third-largest Indian pharmaceutical company, with net revenue of $546m.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 11 Apr 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>GSK's Cervarix - a future blockbuster of 2007</title>
		<link>http://www.visiongain.com/Report/243/GSK's-Cervarix-a-future-blockbuster-of-2007</link>
		<guid>http://www.visiongain.com/Report/243/GSK's-Cervarix-a-future-blockbuster-of-2007</guid>
		<category>pharma</category>
		<description>The number of blockbusters continues to increase. The number is set to increase to 112 in 2007. Of the products set to receive FDA approval this year and generate blockbuster status on an annual basis, GSK's Cervarix, intended for the prevention of infection and lesions from the two cancer-causing types of HPVs holds great potential.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 22 Mar 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Cannabinoid Market Forecasts &amp; Analysis to 2012</title>
		<link>http://www.visiongain.com/Report/244/Cannabinoid-Market-Forecasts-Analysis-to-2012</link>
		<guid>http://www.visiongain.com/Report/244/Cannabinoid-Market-Forecasts-Analysis-to-2012</guid>
		<category>pharma</category>
		<description>With 4 drugs now in the marketplace (a 100% rise from 2 years ago), the cannabinoid market continues to grow. Attitudes to the drugs are changing ensuring greater market penetration, and the first cannabinoid blockbuster is now a certainty.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 22 Mar 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>AMD Market Outlook to 2012</title>
		<link>http://www.visiongain.com/Report/242/AMD-Market-Outlook-to-2012</link>
		<guid>http://www.visiongain.com/Report/242/AMD-Market-Outlook-to-2012</guid>
		<category>pharma</category>
		<description>AMD is the most common cause of vision loss in the developed world for those over 50 years of age. We estimate there are over 20 million cases in the US and Europe. Dry AMD accounts for 90% of cases and has no suitable cure. Wet AMD drug sales will soon see the first blockbuster. Novartis achieved first to market success with their Visudyne drug in 1999. However work from Pfizer selling Macugen and Lucentis from Genentech have seen it sales reduced. These drugs are referred to in the press as “miracle drugs" - saving sight for millions.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 16 Mar 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile TV Analysis &amp; Forecasts to 2012</title>
		<link>http://www.visiongain.com/Report/240/Mobile-TV-Analysis-Forecasts-to-2012</link>
		<guid>http://www.visiongain.com/Report/240/Mobile-TV-Analysis-Forecasts-to-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>Visiongain believes that Mobile TV will be successful, however it will not be the "killer application" that some had believed it would be. Rather, the service is likely to be a stepping stone to a broader, more complete mobile multimedia experience and convergence. This is just one of the findings of visiongain's brand new Mobile TV: Market Analysis and Forecasts to 2012.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 13 Mar 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Rheumatoid Arthritis Market Forecasts to 2012</title>
		<link>http://www.visiongain.com/Report/238/The-Global-Rheumatoid-Arthritis-Market-Forecasts-to-2012</link>
		<guid>http://www.visiongain.com/Report/238/The-Global-Rheumatoid-Arthritis-Market-Forecasts-to-2012</guid>
		<category>pharma</category>
		<description>In a market believed to approach 5 million people in the leading pharma markets, the market for rheumatic anti-inflammatory drugs is both profitable and set to increase due to new launches. The annual revenue to Q3 2006, from the main prescription anti-inflammatory drugs worldwide, including non steroidal anti-inflammatories (NSAIDs), anti-rheumatic corticosteroid combinations and specific anti-rheumatics was in the order of $16bn worldwide.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 09 Mar 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Emerging UUV &amp; UGV Markets: Forecasts and Business Opportunities to 2020</title>
		<link>http://www.visiongain.com/Report/237/The-Emerging-UUV-UGV-Markets-Forecasts-and-Business-Opportunities-to-2020</link>
		<guid>http://www.visiongain.com/Report/237/The-Emerging-UUV-UGV-Markets-Forecasts-and-Business-Opportunities-to-2020</guid>
		<category>defence</category>
		<description>The continuous evolution of Unmanned Vehicle Systems (UVs) and the emergence of new capabilities, coupled with recent operational successes in Iraq and Afghanistan, have led to the increased use of unmanned systems across the operational spectrum. Unmanned systems, in the form of unmanned aerial, ground and maritime vehicles, have become an integral part of modern military operations and, indeed, of the modern military arsenal.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 05 Mar 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The IMS Report Market Forecast to 2012</title>
		<link>http://www.visiongain.com/Report/236/The-IMS-Report-Market-Forecast-to-2012</link>
		<guid>http://www.visiongain.com/Report/236/The-IMS-Report-Market-Forecast-to-2012</guid>
		<category>telecoms &amp; IT</category>
		<description>Virtually every major telecom industry player must now be dealing with IMS. News of planned IMS-compatible products and services are arriving almost every day. Are you one of them? If you are testing IMS, then you must understand what strategies to adopt to implement and profit from this technology now.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 02 Mar 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Tissue Engineering &amp; Stem Cell Technology Report 2007</title>
		<link>http://www.visiongain.com/Report/235/Tissue-Engineering-Stem-Cell-Technology-Report-2007</link>
		<guid>http://www.visiongain.com/Report/235/Tissue-Engineering-Stem-Cell-Technology-Report-2007</guid>
		<category>pharma</category>
		<description>The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!!  With a complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the the commercial opportunities within Tissue Engineering &amp; Stem Cell Technology.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 28 Feb 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Novartis Market Outlook, Forecasts and Analysis to 2012</title>
		<link>http://www.visiongain.com/Report/234/Novartis-Market-Outlook-Forecasts-and-Analysis-to-2012</link>
		<guid>http://www.visiongain.com/Report/234/Novartis-Market-Outlook-Forecasts-and-Analysis-to-2012</guid>
		<category>pharma</category>
		<description>With headquarters in Basel, Switzerland, Novartis is recognised as being one of the strongest performing pharmaceutical companies in terms of sales, high revenue growth, acquisitions, breadth of portfolio, product launches and pipeline developments. In 2006 - ten years after its inception - Novartis generated total net sales of $37bn worldwide.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 27 Feb 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile WiMAX Market Forecasts to 2012 - With comparisons to LTE or 4G</title>
		<link>http://www.visiongain.com/Report/233/Mobile-WiMAX-Market-Forecasts-to-2012-With-comparisons-to-LTE-or-4G</link>
		<guid>http://www.visiongain.com/Report/233/Mobile-WiMAX-Market-Forecasts-to-2012-With-comparisons-to-LTE-or-4G</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile wimax equipment which utilize beam-forming and MIMO technologies will become available towards the end of this year. Broadband wireless deployments using pre-802.16e compliant equipment have already begun. In Korea both KT and SK Telecom have implemented mobile broadband wireless networks in specific locations throughout the country.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 21 Feb 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biotech Drug Delivery Systems - Key Company Intelligence &amp; Market Outlook to 2012</title>
		<link>http://www.visiongain.com/Report/232/Biotech-Drug-Delivery-Systems-Key-Company-Intelligence-Market-Outlook-to-2012</link>
		<guid>http://www.visiongain.com/Report/232/Biotech-Drug-Delivery-Systems-Key-Company-Intelligence-Market-Outlook-to-2012</guid>
		<category>pharma</category>
		<description>The two major problems for biotech drugs are their mode of delivery and relative instability. The majority of delivery methods for biological drugs involve injection, which is not necessarily ideal for most indications. As the biotech sector starts to heat up, the industry has started to look for new ways of delivering these highly successful drugs.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 19 Feb 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>VoIP in Europe: Fixed &amp; Wireless Market Outlook to 2011 - enabling voice in FMC</title>
		<link>http://www.visiongain.com/Report/231/VoIP-in-Europe-Fixed-Wireless-Market-Outlook-to-2011-enabling-voice-in-FMC</link>
		<guid>http://www.visiongain.com/Report/231/VoIP-in-Europe-Fixed-Wireless-Market-Outlook-to-2011-enabling-voice-in-FMC</guid>
		<category>telecoms &amp; IT</category>
		<description>Wireless VoIP has been one of the loudest voices at the GSM Congress this year. As consumers get use to fixed wireless VoIP they are then turning to reduce their mobile bill through wireless VoIP. Fixed-mobile converged services are receiving high marketing spends, linking to broadband services and VoIP opportunities.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 13 Feb 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Autoimmune Inflammatory Bowel Disease Market Outlook to 2012</title>
		<link>http://www.visiongain.com/Report/230/The-Autoimmune-Inflammatory-Bowel-Disease-Market-Outlook-to-2012</link>
		<guid>http://www.visiongain.com/Report/230/The-Autoimmune-Inflammatory-Bowel-Disease-Market-Outlook-to-2012</guid>
		<category>pharma</category>
		<description>'The Autoimmune Inflammatory Bowel Disease Market Outlook to 2012' is a new report from visiongain providing analysis of the current and future market for IBD drugs across all major indications.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 06 Feb 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Theranostics Report 2007-2012</title>
		<link>http://www.visiongain.com/Report/229/Theranostics-Report-2007-2012</link>
		<guid>http://www.visiongain.com/Report/229/Theranostics-Report-2007-2012</guid>
		<category>pharma</category>
		<description>Key questions remain over theranostics. How can your company secure key successes and ideals in personalized medicine - aiming the right drug at the right person and at the right time. Plus with increased FDA regulation, how can we guarantee that that specific drug is safe for that individual. These issues are not going away, but one report can make it alot easier for you and your company...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 31 Jan 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Stem Cells The hype and the hope - Business opportunities and forecasts</title>
		<link>http://www.visiongain.com/Report/228/Stem-Cells-The-hype-and-the-hope-Business-opportunities-and-forecasts</link>
		<guid>http://www.visiongain.com/Report/228/Stem-Cells-The-hype-and-the-hope-Business-opportunities-and-forecasts</guid>
		<category>pharma</category>
		<description>The news has been full of industry developments and financial investments in stem cell research in recent weeks. Your company must be aware of the latest developments immediately...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 23 Jan 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Quad-play FMC strategies 2006-2011: Adding mobile services to the triple play package</title>
		<link>http://www.visiongain.com/Report/226/Quad-play-FMC-strategies-2006-2011-Adding-mobile-services-to-the-triple-play-package</link>
		<guid>http://www.visiongain.com/Report/226/Quad-play-FMC-strategies-2006-2011-Adding-mobile-services-to-the-triple-play-package</guid>
		<category>telecoms &amp; IT</category>
		<description>Sky in the UK have already begun to prepare for the introduction of Quadruple play and its impact on their business. The opportunity of offering a bundled mobile, fixed line, broadband and TV solution was too much for NTL to ignore and Sky must do all they can early to try and see off this competition. But this isnt only true of the UK, as Italian operators prepare for increased reductions and competition throughout their market. With BT's Fusion offering also available competition is increasing rapidly...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 17 Jan 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World market for cancer vaccines 2007-2012</title>
		<link>http://www.visiongain.com/Report/227/World-market-for-cancer-vaccines-2007-2012</link>
		<guid>http://www.visiongain.com/Report/227/World-market-for-cancer-vaccines-2007-2012</guid>
		<category>pharma</category>
		<description>Previously the cancer vaccine market has consisted of HBV (hepatitis B virus) vaccines to prevent liver cancer. 2006 saw the launch of Gardasil the first vaccine against HPV (human papilloma virus) to protect against cervical cancer. Another HPV vaccine, Cervarix, is due to be launched in 2007...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 17 Jan 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Voice handover in FMC 2006-2011: IMS-based Voice Call Continuity between fixed and mobile</title>
		<link>http://www.visiongain.com/Report/225/Voice-handover-in-FMC-2006-2011-IMS-based-Voice-Call-Continuity-between-fixed-and-mobile</link>
		<guid>http://www.visiongain.com/Report/225/Voice-handover-in-FMC-2006-2011-IMS-based-Voice-Call-Continuity-between-fixed-and-mobile</guid>
		<category>telecoms &amp; IT</category>
		<description>Voice Call Continuity is being driven by both mobile operators and fixed telcos, eager to deploy an all-IP solution quickly to make the most of Fixed-Mobile Convergence.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 15 Jan 2007 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Google phone: Will Microsoft let it happen?</title>
		<link>http://www.visiongain.com/Report/224/The-Google-phone-Will-Microsoft-let-it-happen</link>
		<guid>http://www.visiongain.com/Report/224/The-Google-phone-Will-Microsoft-let-it-happen</guid>
		<category>telecoms &amp; IT</category>
		<description>According to a news story in The Observer recently, Orange executives have met with the people at Google to see if they can collaborate on producing a co-branded Google Phone (GPhone) with Taiwanese handset manufacturer HTC. Three brands on one screen (Orange, Google and Microsoft). Is it going to happen? And if it does, how will it affect you?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 21 Dec 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile consumer email: Where Blackberry challenges Hotmail and Gmail</title>
		<link>http://www.visiongain.com/Report/223/Mobile-consumer-email-Where-Blackberry-challenges-Hotmail-and-Gmail</link>
		<guid>http://www.visiongain.com/Report/223/Mobile-consumer-email-Where-Blackberry-challenges-Hotmail-and-Gmail</guid>
		<category>telecoms &amp; IT</category>
		<description>Is consumer email likely to cause the death of texting? In 2006, there were around 1.45 billion email accounts, consisting of enterprise and consumer inboxes. Enterprise email has made its way to mobile, most notably in the BlackBerry devices from RIM...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Dec 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Therapeutic Monoclonal Antibodies, 2006-2011 Maximising the Growth Potential of a Stocked Pipeline</title>
		<link>http://www.visiongain.com/Report/222/Therapeutic-Monoclonal-Antibodies-2006-2011-Maximising-the-Growth-Potential-of-a-Stocked-Pipeline</link>
		<guid>http://www.visiongain.com/Report/222/Therapeutic-Monoclonal-Antibodies-2006-2011-Maximising-the-Growth-Potential-of-a-Stocked-Pipeline</guid>
		<category>pharma</category>
		<description>While the pharmaceutical as a whole is suffering from single digit growth, thin uninspiring pipelines and pressure from an ever-aggressive generics industry - not so for monoclonal antibody therapies. The market for monoclonal antibody treatments is one of the most exciting segments of the pharmaceutical industry today...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 07 Dec 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Central and Eastern European (CEE) Developing Markets for Pharmaceuticals, 2006-2011</title>
		<link>http://www.visiongain.com/Report/221/Central-and-Eastern-European-(CEE)-Developing-Markets-for-Pharmaceuticals-2006-2011</link>
		<guid>http://www.visiongain.com/Report/221/Central-and-Eastern-European-(CEE)-Developing-Markets-for-Pharmaceuticals-2006-2011</guid>
		<category>pharma</category>
		<description>Central and Eastern European Developing Markets for Pharmaceuticals, 2006-2011, examines developing pharmaceutical markets critically through comprehensive research and analysis. Visiongain applied techniques such as financial forecasting, SWOT analyses and discussion of qualitative factors...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 23 Nov 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The UAV Market Report 2006</title>
		<link>http://www.visiongain.com/Report/189/The-UAV-Market-Report-2006</link>
		<guid>http://www.visiongain.com/Report/189/The-UAV-Market-Report-2006</guid>
		<category>defence</category>
		<description>Unmanned aerial vehicles (UAVs) have become a key force in the modern battlespace. Originally used as target drones and remotely piloted combat vehicles early in their history, it was the Vietnam War that saw them take on an entirely new role, that of stealth surveillance...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 22 Nov 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Latin American Developing Markets for Pharmaceuticals, 2006-2011</title>
		<link>http://www.visiongain.com/Report/220/Latin-American-Developing-Markets-for-Pharmaceuticals-2006-2011</link>
		<guid>http://www.visiongain.com/Report/220/Latin-American-Developing-Markets-for-Pharmaceuticals-2006-2011</guid>
		<category>pharma</category>
		<description>The purpose of visiongain's Developing Markets Series is to examine the prospects for the growth of pharmaceutical revenues in the developing economies of Asia, Latin America and Eastern/Central Europe...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 16 Nov 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Asian Developing Markets for Pharmaceuticals, 2006-2011</title>
		<link>http://www.visiongain.com/Report/218/Asian-Developing-Markets-for-Pharmaceuticals-2006-2011</link>
		<guid>http://www.visiongain.com/Report/218/Asian-Developing-Markets-for-Pharmaceuticals-2006-2011</guid>
		<category>pharma</category>
		<description>Will the economic growth in new Asian markets allow you to offset global problems? With the Japan market slow and stagnant what other countries in the region offer you the greatest opportunities and how can you succeed in them?</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Nov 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Content convergence 2006-2011: Shifting the value chain dynamics</title>
		<link>http://www.visiongain.com/Report/219/Content-convergence-2006-2011-Shifting-the-value-chain-dynamics</link>
		<guid>http://www.visiongain.com/Report/219/Content-convergence-2006-2011-Shifting-the-value-chain-dynamics</guid>
		<category>telecoms &amp; IT</category>
		<description>Consumers are changing the way they access digital content, demanding that they be able to access the same content through multiple CE devices and platforms. The move to this form of content convergence is being driven by factors such as a shift towards â€œall-IPâ€ and embedded networking connectivity.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Nov 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Bioinformatics Report - The forecasts and future of the market 2006-2011</title>
		<link>http://www.visiongain.com/Report/217/Bioinformatics-Report-The-forecasts-and-future-of-the-market-2006-2011</link>
		<guid>http://www.visiongain.com/Report/217/Bioinformatics-Report-The-forecasts-and-future-of-the-market-2006-2011</guid>
		<category>pharma</category>
		<description>This report delivers answers on how you can benefit from the commercial prospects of bioinformatics, now. The ultimate goal of bioinformatics is to uncover the wealth of biological information hidden in the mass of data, to obtain a clearer insight into the fundamental biology of organisms...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 26 Oct 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Voice Call Continuity and Multimedia Independent Handover Report 2006-2011: Enabling true FMC services</title>
		<link>http://www.visiongain.com/Report/215/Voice-Call-Continuity-and-Multimedia-Independent-Handover-Report-2006-2011-Enabling-true-FMC-services</link>
		<guid>http://www.visiongain.com/Report/215/Voice-Call-Continuity-and-Multimedia-Independent-Handover-Report-2006-2011-Enabling-true-FMC-services</guid>
		<category>telecoms &amp; IT</category>
		<description>If you are a mobile operator you probably regard Fixed Mobile Convergence as an effective way of increasing the functionality of the mobile handset and maintaining current ARPU levels. But if you are a fixed-line operator you are looking to FMC as a means of countering substitution and displacement trends...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Oct 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Anti-addiction Therapies, 2006-2011 The Pharmaceutical Industry's Next Viagra?</title>
		<link>http://www.visiongain.com/Report/216/Anti-addiction-Therapies-2006-2011-The-Pharmaceutical-Industry's-Next-Viagra</link>
		<guid>http://www.visiongain.com/Report/216/Anti-addiction-Therapies-2006-2011-The-Pharmaceutical-Industry's-Next-Viagra</guid>
		<category>pharma</category>
		<description>More money is spent advertising alcohol than any other product. For some, gambling and cigarettes are pleasant distractions, yet for others they are the generators of unbearable cravings and the cause of considerable distress. For them their addition is a disease...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Oct 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Allergy Market 2006-2011: The Rx-OTC Rush</title>
		<link>http://www.visiongain.com/Report/214/The-World-Allergy-Market-2006-2011-The-Rx-OTC-Rush</link>
		<guid>http://www.visiongain.com/Report/214/The-World-Allergy-Market-2006-2011-The-Rx-OTC-Rush</guid>
		<category>pharma</category>
		<description>The number of people suffering from some sort of allergy is on the rise and the demand for reliable treatments for allergic rhinitis and other allergic conditions is on the rise worldwide...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 12 Oct 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Video Ringtones 2006-2011: Rejuvenating revenues and extending the product life cycle</title>
		<link>http://www.visiongain.com/Report/213/Video-Ringtones-2006-2011-Rejuvenating-revenues-and-extending-the-product-life-cycle</link>
		<guid>http://www.visiongain.com/Report/213/Video-Ringtones-2006-2011-Rejuvenating-revenues-and-extending-the-product-life-cycle</guid>
		<category>telecoms &amp; IT</category>
		<description>Ringtones are the second most popular data service behind SMS, with expected revenues of $4.95 billion in 2006. However, revenues from monophonic and polyphonic ringtones are in decline and overall ringtone revenues will start to decline by 2008...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 05 Oct 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Carrier Ethernet 2006-2011: Market analysis and forecasts</title>
		<link>http://www.visiongain.com/Report/212/Carrier-Ethernet-2006-2011-Market-analysis-and-forecasts</link>
		<guid>http://www.visiongain.com/Report/212/Carrier-Ethernet-2006-2011-Market-analysis-and-forecasts</guid>
		<category>telecoms &amp; IT</category>
		<description>With a number of advancements made in the last two years, Carrier Ethernet has evolved into a reliable and scalable technology to help the transition to next-generation networks for fixed-line, cable and mobile operators...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 28 Sep 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Device Management Report 2006-2011: Evaluating the business case of FOTA and beyond</title>
		<link>http://www.visiongain.com/Report/211/Mobile-Device-Management-Report-2006-2011-Evaluating-the-business-case-of-FOTA-and-beyond</link>
		<guid>http://www.visiongain.com/Report/211/Mobile-Device-Management-Report-2006-2011-Evaluating-the-business-case-of-FOTA-and-beyond</guid>
		<category>telecoms &amp; IT</category>
		<description>As mobile devices increase in complexity and progress towards data-centric functionalities, the limited ability of wireless operators to effectively manage and control these terminals once they are deployed has become a critical issue to address...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 21 Sep 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Biotech Report 2006: The rise of the Biotech blockbusters</title>
		<link>http://www.visiongain.com/Report/210/The-Global-Biotech-Report-2006-The-rise-of-the-Biotech-blockbusters</link>
		<guid>http://www.visiongain.com/Report/210/The-Global-Biotech-Report-2006-The-rise-of-the-Biotech-blockbusters</guid>
		<category>pharma</category>
		<description>It is here. The industry's leading Annual Biotech report has just been announced. Only 20 copies are available. So order your copy today...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 15 Sep 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Developing Markets for Pharmaceuticals, 2006-2011</title>
		<link>http://www.visiongain.com/Report/209/Developing-Markets-for-Pharmaceuticals-2006-2011</link>
		<guid>http://www.visiongain.com/Report/209/Developing-Markets-for-Pharmaceuticals-2006-2011</guid>
		<category>pharma</category>
		<description>The purpose of this visiongain report is to examine the prospects for the growth of pharmaceutical revenues in the developing economies of Asia, Latin America and Eastern/Central Europe at both regional and national level...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 14 Sep 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Asthma and COPD Treatment Market, 2006-2011: A Changing Market with Increasing Potential</title>
		<link>http://www.visiongain.com/Report/207/The-World-Asthma-and-COPD-Treatment-Market-2006-2011-A-Changing-Market-with-Increasing-Potential</link>
		<guid>http://www.visiongain.com/Report/207/The-World-Asthma-and-COPD-Treatment-Market-2006-2011-A-Changing-Market-with-Increasing-Potential</guid>
		<category>pharma</category>
		<description>The asthma treatment market is a $15 billion market, driven by an increasing prevalence and yet without a treatment to cure this debilitating disease. All current drugs treat the symptoms but not the underlying cause. It is currently dominated by GSK with its $5.5 billion blockbuster, Advair/Seretide. However, this combination treatment is about to have its first real competition with Symbicort...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 24 Aug 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile communities and user generated content 2006-2011: Monetising mobile social networking</title>
		<link>http://www.visiongain.com/Report/208/Mobile-communities-and-user-generated-content-2006-2011-Monetising-mobile-social-networking</link>
		<guid>http://www.visiongain.com/Report/208/Mobile-communities-and-user-generated-content-2006-2011-Monetising-mobile-social-networking</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile operators are keen to replicate the growth of communities and user-generated content seen on the fixed line internet. Mobile communities and user-generated content are seen as potential drivers of data usage because they provide compelling content to subscribers. However, there are significant issues surrounding the successful transference of such services from fixed line to mobile. How can operators generate revenue from these services? Purchase this timely report now to find out...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 24 Aug 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Managed services and hosting 2006-2011: Rationalising network and content outsourcing</title>
		<link>http://www.visiongain.com/Report/206/Managed-services-and-hosting-2006-2011-Rationalising-network-and-content-outsourcing</link>
		<guid>http://www.visiongain.com/Report/206/Managed-services-and-hosting-2006-2011-Rationalising-network-and-content-outsourcing</guid>
		<category>telecoms &amp; IT</category>
		<description>As operators look for innovative ways to gain competitive advantage and increase operating profits through lower OpEx and CapEx, the outsourcing of network operation, application hosting and service delivery is gaining increasing traction. Is this something that will benefit your organisation? What is the most effective approach to take? Purchase this report to find out...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 10 Aug 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Contract Research  and Manufacturing Market, 2006-2011 (Trends in Outsourcing)</title>
		<link>http://www.visiongain.com/Report/205/The-World-Contract-Research-and-Manufacturing-Market-2006-2011-(Trends-in-Outsourcing)</link>
		<guid>http://www.visiongain.com/Report/205/The-World-Contract-Research-and-Manufacturing-Market-2006-2011-(Trends-in-Outsourcing)</guid>
		<category>pharma</category>
		<description>The Contract Pharma market in 2005 was worth an estimated $57bn. Attitudes within the pharmaceutical industry are slowly changing and the use of strategic outsourcing is becoming an accepted practice...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 03 Aug 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>ePharma: The Online Pharmaceutical Industry, 2006-2011</title>
		<link>http://www.visiongain.com/Report/204/ePharma-The-Online-Pharmaceutical-Industry-2006-2011</link>
		<guid>http://www.visiongain.com/Report/204/ePharma-The-Online-Pharmaceutical-Industry-2006-2011</guid>
		<category>pharma</category>
		<description>The purpose of this visiongain report is to examine the commercial prospects of online technologies in the pharmaceutical sector. In particular, this report examines the fast-growing fields of pharmaceutical eMarketing, eDetailing, ePrescribing and online drug sales...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 28 Jul 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Quadruple play and service bundling strategies: 2006-2011</title>
		<link>http://www.visiongain.com/Report/203/Quadruple-play-and-service-bundling-strategies-2006-2011</link>
		<guid>http://www.visiongain.com/Report/203/Quadruple-play-and-service-bundling-strategies-2006-2011</guid>
		<category>telecoms &amp; IT</category>
		<description>Service providers are increasingly looking at bundling as a means of reducing churn and increasing revenue. They hope to build on their success with two-play by deploying triple and quadruple play packages...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 27 Jul 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile handset batteries and fuel cells report: 2006-2013</title>
		<link>http://www.visiongain.com/Report/202/Mobile-handset-batteries-and-fuel-cells-report-2006-2013</link>
		<guid>http://www.visiongain.com/Report/202/Mobile-handset-batteries-and-fuel-cells-report-2006-2013</guid>
		<category>telecoms &amp; IT</category>
		<description>If handheld devices continue to improve and demand more power, then traditional batteries will soon be unable to deliver the required energy - FACT. Power-hungry multimedia applications will drain traditional batteries rapidly and users and the industry demand that the power gap is reduced quickly... 
</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 24 Jul 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Pharmacovigilance: Risk Management in Practice</title>
		<link>http://www.visiongain.com/Report/199/Pharmacovigilance-Risk-Management-in-Practice</link>
		<guid>http://www.visiongain.com/Report/199/Pharmacovigilance-Risk-Management-in-Practice</guid>
		<category>pharma</category>
		<description>At present ADRs are the sixth largest cause of death in the US. Drug safety is a huge issue facing the industry today and the risk is high with the possible loss of a key revenue producing drug coupled with potentially damaging litigation...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 17 Jul 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Network Based Operations Report</title>
		<link>http://www.visiongain.com/Report/196/The-Global-Network-Based-Operations-Report</link>
		<guid>http://www.visiongain.com/Report/196/The-Global-Network-Based-Operations-Report</guid>
		<category>defence</category>
		<description>Network Centric Warfare (NCW) is the new buzz phrase in the defence community. The U.S. in particular is spending billions of dollars to transform its military forces into strong, highly mobile networked units...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 17 Jul 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Global Airborne IFF Subsystems Report</title>
		<link>http://www.visiongain.com/Report/197/The-Global-Airborne-IFF-Subsystems-Report</link>
		<guid>http://www.visiongain.com/Report/197/The-Global-Airborne-IFF-Subsystems-Report</guid>
		<category>defence</category>
		<description>A host of new aircraft acquisitions and upgrades throughout the next decade will drive the airborne IFF market. The armed forces of Asia will have the largest requirement for over 2,900 airborne IFF subsystems, which could be worth up to $386 million...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 17 Jul 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Nanomedicine 2006-2011</title>
		<link>http://www.visiongain.com/Report/198/Nanomedicine-2006-2011</link>
		<guid>http://www.visiongain.com/Report/198/Nanomedicine-2006-2011</guid>
		<category>pharma</category>
		<description>The purpose of this visiongain report is to examine the commercial prospects of nanotechnology in medicine - the fast-developing and increasingly lucrative field of nanomedicine...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 29 Jun 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile roaming 2006-2011: Increasing usage and revenue to counter regulatory burdens</title>
		<link>http://www.visiongain.com/Report/200/Mobile-roaming-2006-2011-Increasing-usage-and-revenue-to-counter-regulatory-burdens</link>
		<guid>http://www.visiongain.com/Report/200/Mobile-roaming-2006-2011-Increasing-usage-and-revenue-to-counter-regulatory-burdens</guid>
		<category>telecoms &amp; IT</category>
		<description>The importance of roaming can be seen from operator revenues, accounting for 17% of total mobile revenues globally. However, controversy surrounds the issue due to the perception of exorbitant charges made to subscribers for using their mobile services whilst abroad...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 29 Jun 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Biogenerics 2006: Challenges ahead for an emerging market</title>
		<link>http://www.visiongain.com/Report/194/Biogenerics-2006-Challenges-ahead-for-an-emerging-market</link>
		<guid>http://www.visiongain.com/Report/194/Biogenerics-2006-Challenges-ahead-for-an-emerging-market</guid>
		<category>pharma</category>
		<description>The world biogenerics market is about to develop on a very large scale. The approval of generic growth hormones in the US and Europe has finally occurred and this has created a new source of revenue for generic companies...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 14 Jun 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>In-building wireless solutions: Stimulating greater mobile usage through better indoor coverage</title>
		<link>http://www.visiongain.com/Report/195/In-building-wireless-solutions-Stimulating-greater-mobile-usage-through-better-indoor-coverage</link>
		<guid>http://www.visiongain.com/Report/195/In-building-wireless-solutions-Stimulating-greater-mobile-usage-through-better-indoor-coverage</guid>
		<category>telecoms &amp; IT</category>
		<description>As mobile subscriber growth reaches saturation, one solution to increasing mobile traffic stems from increased indoor usage of the mobile phone. In 2006, in-building mobile account for approximately 30% of total mobile revenues. However, upwards of 70% of 3G data traffic originates indoors...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 14 Jun 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Indian Pharmaceutical Market, 2006-2011</title>
		<link>http://www.visiongain.com/Report/193/Indian-Pharmaceutical-Market-2006-2011</link>
		<guid>http://www.visiongain.com/Report/193/Indian-Pharmaceutical-Market-2006-2011</guid>
		<category>pharma</category>
		<description>The Indian pharmaceutical market is the 15th largest individual market by sales, but the 4th by volume of product. With domestic drug sales of almost $5 billion, Indian companies have also developed a considerable service industry for the global pharmaceutical market...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 12 Jun 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>HSDPA 2006-2011: Market analysis and forecasts</title>
		<link>http://www.visiongain.com/Report/192/HSDPA-2006-2011-Market-analysis-and-forecasts</link>
		<guid>http://www.visiongain.com/Report/192/HSDPA-2006-2011-Market-analysis-and-forecasts</guid>
		<category>telecoms &amp; IT</category>
		<description>HSDPA is now beginning to make market inroads worldwide, with 29 commercial launches as of June 2006, and at least a further 32 live networks expected by the end of 2006. Visiongain expects accelerated momentum in 2007 onwards as the benefits of HSDPA lure investments from 3G operators...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 08 Jun 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Land-Based Air Defence Systems Report</title>
		<link>http://www.visiongain.com/Report/191/The-Land-Based-Air-Defence-Systems-Report</link>
		<guid>http://www.visiongain.com/Report/191/The-Land-Based-Air-Defence-Systems-Report</guid>
		<category>defence</category>
		<description>Since the early 1990s, military air defence systems and programs have transitioned from a Cold War mindset to focusing on a completely different future enemy, one that launches terrorist attacks or military strikes in the form of cruise missiles, UAVs and aircraft used as weapons...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 02 Jun 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Instant Messaging Report 2006-2011: Deploying successful mobile IM services</title>
		<link>http://www.visiongain.com/Report/190/Mobile-Instant-Messaging-Report-2006-2011-Deploying-successful-mobile-IM-services</link>
		<guid>http://www.visiongain.com/Report/190/Mobile-Instant-Messaging-Report-2006-2011-Deploying-successful-mobile-IM-services</guid>
		<category>telecoms &amp; IT</category>
		<description>Mobile operators across Europe and Asia are looking to deploy customised (operator owned and branded) mobile IM (MIM) services by the end of 2006 in an effort to cement their position in the value chain. This renewed interest is being driven by perceived benefits such as increasing data ARPU...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 30 May 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Product Lifecycle Management, 2006</title>
		<link>http://www.visiongain.com/Report/187/Product-Lifecycle-Management-2006</link>
		<guid>http://www.visiongain.com/Report/187/Product-Lifecycle-Management-2006</guid>
		<category>pharma</category>
		<description>The global pharmaceutical market with sales of approximately $550 billion is about to enter a pivotal period in its history. The industry has been used to double digit growth rates but growth has now dropped to below 10% for the first time...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 18 May 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Generics Market 2006-2011</title>
		<link>http://www.visiongain.com/Report/188/The-World-Generics-Market-2006-2011</link>
		<guid>http://www.visiongain.com/Report/188/The-World-Generics-Market-2006-2011</guid>
		<category>pharma</category>
		<description>In sharp contrast to the branded pharmaceutical market, which has stalled in recent year, the generics market is enjoying a period of unprecedented success. In 2005 the world generics market was worth $45bn, a growth of 14% on the previous year...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 18 May 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>RFID Report 2006-2011: Opportunities and challenges with cellular RFID</title>
		<link>http://www.visiongain.com/Report/186/RFID-Report-2006-2011-Opportunities-and-challenges-with-cellular-RFID</link>
		<guid>http://www.visiongain.com/Report/186/RFID-Report-2006-2011-Opportunities-and-challenges-with-cellular-RFID</guid>
		<category>telecoms &amp; IT</category>
		<description>Radio Frequency Identification (RFID) technology has the potential to change mobile phones as well as supply chain management. The obstacles are many, but the opportunity is equally significant. Purchase this report to find out how RFID is evolving, how challenges can be overcome...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 11 May 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Google in mobile and wireless: Analysing the impact and assessing the threat of the search giant's market entry</title>
		<link>http://www.visiongain.com/Report/185/Google-in-mobile-and-wireless-Analysing-the-impact-and-assessing-the-threat-of-the-search-giant's-market-entry</link>
		<guid>http://www.visiongain.com/Report/185/Google-in-mobile-and-wireless-Analysing-the-impact-and-assessing-the-threat-of-the-search-giant's-market-entry</guid>
		<category>telecoms &amp; IT</category>
		<description>Google, the world's most popular search engine, is continuing its business growth and is starting to push into the mobile and wireless markets with increasing focus. The company, synonymous with web searching, sees the mobile and wireless sectors as highly important areas...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 05 May 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Fixed and Wireless VoIP in Europe 2006-2011: Market analysis and forecasts</title>
		<link>http://www.visiongain.com/Report/184/Fixed-and-Wireless-VoIP-in-Europe-2006-2011-Market-analysis-and-forecasts</link>
		<guid>http://www.visiongain.com/Report/184/Fixed-and-Wireless-VoIP-in-Europe-2006-2011-Market-analysis-and-forecasts</guid>
		<category>telecoms &amp; IT</category>
		<description>Vonage's announcement that it has teamed up with UK Wi-Fi service provider The Cloud to offer free VoIP calls is the first major move in this direction, which will force mobile operators to follow suit...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 27 Apr 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Apple in Wireless: Strategic options in a converged marketplace</title>
		<link>http://www.visiongain.com/Report/183/Apple-in-Wireless-Strategic-options-in-a-converged-marketplace</link>
		<guid>http://www.visiongain.com/Report/183/Apple-in-Wireless-Strategic-options-in-a-converged-marketplace</guid>
		<category>telecoms &amp; IT</category>
		<description>The success of the iPod has redefined several markets, namely the MP3 player and digital content markets, as well as revitalised the Apple brand itself. This may in turn disrupt the computing and convergence landscape...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 18 Apr 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Military Communications &amp; COTS 2006</title>
		<link>http://www.visiongain.com/Report/182/Military-Communications-COTS-2006</link>
		<guid>http://www.visiongain.com/Report/182/Military-Communications-COTS-2006</guid>
		<category>defence</category>
		<description>Defence spending worldwide has steadily increased over the last decade, with expenditures in 2004 alone exceeding $1 trillion. The military communications market in particular has seen tremendous growth, as militaries look to effect greater battlefield interoperability by networking their forces through advanced communications systems...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 07 Apr 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>User Interface report: Enabling a compelling user experience</title>
		<link>http://www.visiongain.com/Report/181/User-Interface-report-Enabling-a-compelling-user-experience</link>
		<guid>http://www.visiongain.com/Report/181/User-Interface-report-Enabling-a-compelling-user-experience</guid>
		<category>telecoms &amp; IT</category>
		<description>The user interface (UI) is becoming increasingly important as devices and services become more complex. Without an intuitive UI, users will not utilise their handsets in the best way possible...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 29 Mar 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Diabetes Market, 2005-2011</title>
		<link>http://www.visiongain.com/Report/180/The-World-Diabetes-Market-2005-2011</link>
		<guid>http://www.visiongain.com/Report/180/The-World-Diabetes-Market-2005-2011</guid>
		<category>pharma</category>
		<description>Diabetes effects approximately 170 million people worldwide and is increasing, with the WHO predicting 300 million diabetics by 2025. The US alone has 20.8 million people suffering with diabetes. This equates to approximately 6% of the population. It was the 6th most common cause of death...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Mon, 27 Mar 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Handset Outsourcing: Market analysis and forecasts 2006-2011</title>
		<link>http://www.visiongain.com/Report/179/Mobile-Handset-Outsourcing-Market-analysis-and-forecasts-2006-2011</link>
		<guid>http://www.visiongain.com/Report/179/Mobile-Handset-Outsourcing-Market-analysis-and-forecasts-2006-2011</guid>
		<category>telecoms &amp; IT</category>
		<description>The outsourcing of mobile handset manufacture is a growing industry trend that sees traditionally shy outsourcers such as Nokia and LG looking to increase their reliance on contract manufacturers. In 2006, over 35% of all handset production is outsourced to contract manufacturers...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 24 Mar 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile advertising and marketing: Market analysis and forecasts 2006-2011</title>
		<link>http://www.visiongain.com/Report/178/Mobile-advertising-and-marketing-Market-analysis-and-forecasts-2006-2011</link>
		<guid>http://www.visiongain.com/Report/178/Mobile-advertising-and-marketing-Market-analysis-and-forecasts-2006-2011</guid>
		<category>telecoms &amp; IT</category>
		<description>The increasing availability of multimedia content is opening a large opportunity for sophisticated forms of mobile advertising. As content that already incorporates advertising - like live TV programming - makes its way to mobile handsets, brands and entertainment content providers are beginning to see the value of presenting full multimedia ads with programs.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 17 Mar 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Ultra Wideband: Market analysis and forecasts 2006-2010</title>
		<link>http://www.visiongain.com/Report/177/Ultra-Wideband-Market-analysis-and-forecasts-2006-2010</link>
		<guid>http://www.visiongain.com/Report/177/Ultra-Wideband-Market-analysis-and-forecasts-2006-2010</guid>
		<category>telecoms &amp; IT</category>
		<description>Ultra Wideband (UWB) is set to revolutionise the way that devices are connected to each other, representing a major step forward towards making the concept of the wireless digital home a reality. It allows high-bandwidth, wireless data transfer between a myriad of digital devices of various types...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Wed, 08 Mar 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Venture capital in wireless and telecoms: Funding technology innovation</title>
		<link>http://www.visiongain.com/Report/176/Venture-capital-in-wireless-and-telecoms-Funding-technology-innovation</link>
		<guid>http://www.visiongain.com/Report/176/Venture-capital-in-wireless-and-telecoms-Funding-technology-innovation</guid>
		<category>telecoms &amp; IT</category>
		<description>VC investment in wireless is about to hit an all-time high - ensure your company doesn't miss out.
The portion dedicated to wireless investments has been increasing, and will continue to do so. In 2005, wireless accounted for 7% of total VC investment, and it now contributes to 60% of all telecoms investment...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 23 Feb 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The Clinical Trials Market 2006</title>
		<link>http://www.visiongain.com/Report/175/The-Clinical-Trials-Market-2006</link>
		<guid>http://www.visiongain.com/Report/175/The-Clinical-Trials-Market-2006</guid>
		<category>pharma</category>
		<description>Will the current trend to outsource clinical trials to Asia be successful? How will the emerging discipline of pharmacogenomics affect drug development in the future? What kind of restrictions will authorities such as the FDA and the EMEA impose in the future? Read visiongain's brand new report...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 10 Feb 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile Segmentation Strategies: Developments and Strategic Options</title>
		<link>http://www.visiongain.com/Report/174/Mobile-Segmentation-Strategies-Developments-and-Strategic-Options</link>
		<guid>http://www.visiongain.com/Report/174/Mobile-Segmentation-Strategies-Developments-and-Strategic-Options</guid>
		<category>telecoms &amp; IT</category>
		<description>As the number of mobile subscribers increases throughout much of the world and penetration rates reach saturation levels, service providers and handset manufacturers must invent new ways to differentiate themselves and attract new customers and higher revenues.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 09 Feb 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Municipal Broadband Networks: Market impact and implications, 2006-2011</title>
		<link>http://www.visiongain.com/Report/172/Municipal-Broadband-Networks-Market-impact-and-implications-2006-2011</link>
		<guid>http://www.visiongain.com/Report/172/Municipal-Broadband-Networks-Market-impact-and-implications-2006-2011</guid>
		<category>telecoms &amp; IT</category>
		<description>The emergence of Muni broadband offers opportunities as well as threats to your business.
For a large number of reasons, municipalities are considering the concept of a Municipal Broadband Network as the "fifth utility." These communities are choosing between deploying fibre and a wireless broadband network using Wi-Fi hotspots</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 26 Jan 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Gastrointestinal Disorders Market 2006-2011</title>
		<link>http://www.visiongain.com/Report/173/The-World-Gastrointestinal-Disorders-Market-2006-2011</link>
		<guid>http://www.visiongain.com/Report/173/The-World-Gastrointestinal-Disorders-Market-2006-2011</guid>
		<category>pharma</category>
		<description>The purpose of this visiongain report is to examine the prospects of the world gastrointestinal market. The gastrointestinal (GI) disorders market is one of the largest and most important in the pharmaceutical industry, generating revenues of over $16 billion in 2004.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 26 Jan 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Japanese Pharmaceutical Market, 2006-2011</title>
		<link>http://www.visiongain.com/Report/171/Japanese-Pharmaceutical-Market-2006-2011</link>
		<guid>http://www.visiongain.com/Report/171/Japanese-Pharmaceutical-Market-2006-2011</guid>
		<category>pharma</category>
		<description>The Japanese pharmaceutical market is the second largest individual market and with sales of $60 billion constitutes approximately 11% of the world market. However, it is a market that frustrates the major pharmaceutical companies as it is growing at a significantly lower rate of growth...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Tue, 24 Jan 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>World Cup 2006: Scoring with mobile content and services</title>
		<link>http://www.visiongain.com/Report/170/World-Cup-2006-Scoring-with-mobile-content-and-services</link>
		<guid>http://www.visiongain.com/Report/170/World-Cup-2006-Scoring-with-mobile-content-and-services</guid>
		<category>telecoms &amp; IT</category>
		<description>The football World Cup is the most viewed global TV event, with the 2002 tournament in Japan and Korea attracting a cumulative audience of 28.8 billion global viewers, of which an estimated one billion watched the final itself. In June and July 2006, the tournament will be held in Germany ...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 19 Jan 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Motorola: Innovating to become the handset market leader</title>
		<link>http://www.visiongain.com/Report/169/Motorola-Innovating-to-become-the-handset-market-leader</link>
		<guid>http://www.visiongain.com/Report/169/Motorola-Innovating-to-become-the-handset-market-leader</guid>
		<category>telecoms &amp; IT</category>
		<description>Widely predicted to be overtaken by Samsung to second place in 2004/05, Motorola has now turned the corner and is setting its sights on challenging Nokia to become the handset market leader.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 05 Jan 2006 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Billing in convergence: Analysing the next-generation billing market</title>
		<link>http://www.visiongain.com/Report/168/Billing-in-convergence-Analysing-the-next-generation-billing-market</link>
		<guid>http://www.visiongain.com/Report/168/Billing-in-convergence-Analysing-the-next-generation-billing-market</guid>
		<category>telecoms &amp; IT</category>
		<description>Good billing practices are critical for the success of any business, and billing is set to gain an even more important role in telecoms, as the onset of convergence makes services and service provisioning more complex. As service complexity increases, so transactions have to be simplified and usage has to be billed appropriately.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 15 Dec 2005 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>The World Market for Antidepressants, 2006</title>
		<link>http://www.visiongain.com/Report/167/The-World-Market-for-Antidepressants-2006</link>
		<guid>http://www.visiongain.com/Report/167/The-World-Market-for-Antidepressants-2006</guid>
		<category>pharma</category>
		<description>In 2004 total world revenues for branded antidepressant drugs was worth over $13bn, but with only ten drugs on the market. However, nine out of these ten drugs faces a loss of patent in the period 2006-2010.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Fri, 09 Dec 2005 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Wireless Enterprise 2005-2010: Successfully generating revenue in the enterprise market</title>
		<link>http://www.visiongain.com/Report/166/Wireless-Enterprise-2005-2010-Successfully-generating-revenue-in-the-enterprise-market</link>
		<guid>http://www.visiongain.com/Report/166/Wireless-Enterprise-2005-2010-Successfully-generating-revenue-in-the-enterprise-market</guid>
		<category>telecoms &amp; IT</category>
		<description>This report is about the wireless enterprise market, specifically how mobile operators and handset makers can more effectively target this segment. The corporate sector is important because business users tend to be high spenders of mobile services, but the mobile industry has so far not penetrated these users as well as it could have done.</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 08 Dec 2005 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Hutchison 3: Market dynamics and opportunities for growth</title>
		<link>http://www.visiongain.com/Report/165/Hutchison-3-Market-dynamics-and-opportunities-for-growth</link>
		<guid>http://www.visiongain.com/Report/165/Hutchison-3-Market-dynamics-and-opportunities-for-growth</guid>
		<category>telecoms &amp; IT</category>
		<description>Hutchison 3G (H3G) is at a critical point in its short history. After initially encountering a myriad of problems and struggling for subscribers, H3G has increased its global customer base to 10m. However, this subscriber growth has stagnated recently and the need is now for H3G to increase revenues whilst continuing to grow market share...</description>
		<author>info@visiongain.com (visiongain)</author>
		<pubDate>Thu, 01 Dec 2005 00:00:00 GMT</pubDate>
	</item>
	<item>
		<title>Mobile CRM: Re-energising the CRM market</title>
		<link>http://www.visiongain.com/Report/164/Mobile-CRM-Re-energising-the-CRM-market</link>
		<guid>http://www.visiongain.com/Report/164/Mobile-CRM-Re-energising-the-CRM-market</guid>
		<
